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Exercise-induced pain (EIP) is a natural consequence of exercising intensely, and results 
due to an accumulation of endogenous algesic substances, an increase in muscular pressure 
and muscular distortion or tissue damage. However, the presence of EIP may have negative 
consequences for exercise and endurance performance, brought about by the physiological 
and/or psychological effect of pain. EIP has not been widely addressed in sport and 
exercise science research, and much of the contemporary literature has ignored its potential 
role in endurance exercise performance, despite the wide acknowledgement it gains in 
interviews with athletes, coaches, exercise scientists and health and fitness practitioners. 
Therefore, more empirical research needs to be completed that explores the role of EIP in 
endurance performance, and the physiological and/or psychological contribution it may 
make to fatigue and work rate regulation. Therefore, the main purpose of this thesis was to 
examine the effect of EIP on endurance exercise performance, and identify strategies to 
mitigate its impact in various endurance exercise tasks. Consequently, this thesis consists 
of 5 experimental studies, as outlined below.  
 
The 1st experimental study (Chapter 3) assessed the relationship between traditional 
experimental measures of pain (the cold pressor test (CPT) and algometry), EIP tolerance 
DQG SDUWLFLSDQWV¶ SHUIRUPDQFH RI D 10 mile (16.1 km) cycling time trial. The primary 
finding was that no correlation was found between experimental pain measures and TT 
performance (mean pain in CPT; R = 0.222; time lasted in the CPT; R = -0.292; PPT; R = 
-0.016). However, there was a significant correlation between EIP tolerance and TT 
performance (R = -0.83, P < 0.01). Correlation analysis revealed significant (P < 0.01) 
relationships between TT completion time and VO2max (R = -0.816, P < 0.001), PPO (R = 
-0.864, P < 0.001), GET (R = -0.454, P = 0.009), and RPE tolerance (R = -0.736, P < 0.01). 
Hierarchical multiple regression for physiological parameters (VO2max, GET and PPO) 
revealed that a significant model emerged (F (1,30) = 88.586, P < 0.01) when only PPO was 
used to predict TT completion time. PPO explained 74.7% variance (R Square = 0.747, 
$GMXVWHG56TXDUH ǻ56TXDUH )
 (1,30) = 88.586, P < 0.01, Beta = - 0.864). 
xx 
 
Stepwise regression for pain and RPE predictor variables (mean pain in CPT, time lasted 
in the CPT, PPT, EIP tolerance, and RPE tolerance) revealed that all variables with the 
exception of time lasted in CPT and RPE tolerance contributed to a predictive model. EIP 
tolerance predicted TT completion time and explained 69.4% variance (R Square = 0.694, 
AdjuVWHG56TXDUH ǻ56TXDUH )(1, 30) = 68.075, P < 0.01, Beta = - 0.833), 
337H[SODLQHGDGGLWLRQDOYDULDQFH56TXDUH $GMXVWHG56TXDUH ǻ5
6TXDUH ǻ)(1, 29) = 4.390, P = 0.045, Beta = - 0.886), and mean pain in CPT also 
H[SODLQHG DGGLWLRQDO  YDULDQFH 6TXDUH    $GMXVWHG 5 6TXDUH    ǻ5
6TXDUH ǻ)(1, 28) = 5.543, P = 0.026, Beta = - 0.881). Therefore, EIP tolerance, PPT 
and mean pain in CPT explained 77.8% variance in TT completion time. Regression 
analysis for pain and physiological predictor variables (mean pain in CPT, PPT, EIP 
tolerance, VO2max, PPO, GET) revealed that a significant model (P < 0.01) emerged when 
RQO\332$GMXVWHG56TXDUH DQG(,3WROHUDQFHǻ56TXDUH ZHre used 
to predict TT performance. Therefore, PPO and EIP tolerance explained an overall 82.2% 
variance in the model. This study demonstrated for the first time that tolerance of EIP 
provides a good predictor of endurance performance, whereas traditional measures of pain 
do not. It is suggested that participants who are able to tolerate a greater pain for longer 
time period, are able to maintain a higher work rate and therefore finish the endurance 
performance task faster. The results suggest that EIP plays a crucial role in endurance 
performance, and that a high tolerance for EIP provides an important role as a predictor of 
endurance athletic performance. Finally, this study demonstrates that psychological 
variables (in this case pain tolerance), should be considered alongside physiological (e.g. 
VO2max, lactate threshold, exercise economy) variables, in identifying the determinants of 
endurance performance.   
 
The 2nd experimental study (Chapter 4) examined the effect of mirror visual feedback on 
EIP during isometric performance. Specifically, mirror visual feedback was used to 
deceive participants about the difficulty of the exercise task they were engaging in. It was 
hypothesised that increasing perceived task difficulty would increase expectation of EIP 
and reduce time to exhaustion, whereas decreasing perceived would elicit the opposite 
effect. The results supported the study hypothesis, and showed that the deception of task 
difficulty in the Experimental group led participants to produce significantly longer times 
to exhaustion when they thought the task was easier than it was, and significantly shorter 
times to exhaustion when they thought it was harder than it was (F
 (1,40) = 4.293, P = 0.045). 
The ANOVA revealed a significant main effect of condition for EIP during the TTE test 
xxi 
 
(F (1, 40) = 8.736, P = 0.005), and a significant interaction effect of EIP between groups for 
each time condition were observed (F (1,40) = 7.163, P = 0.011). The ANOVA revealed a 
significant main effect of condition for RPE during the TTE test (F (1, 40) = 33.403, P < 
0.001), and a significant interaction effect of RPE between groups for each time condition 
(F (1,40) = 13.367, P < 0.001). This was accompanied by significantly higher EIP and RPE 
when they thought the task was harder than it was, and significantly lower EIP and RPE 
when they thought the task was easier than it was. This is the first experimental study using 
the mirror box technique as a strategy to moderate EIP during isometric contractions. The 
results suggest that perceptions about exercise have a consequence for the EIP arising from 
them, supporting the psychological and subjective dimensions of pain perception.  
 
Previous experiments investigating transcutaneous electrical nerve stimulation (TENS) 
and interferential current (IFC) have been shown to elicit analgesic effects in a variety of 
conditions. Considering the emerging experiments and application of these techniques on 
exercise and the potential benefits of these strategies to mitigate of EIP impact, the 3rd 
experimental study (Chapter 5) investigated the effect of TENS and IFC on EIP during 
single limb, submaximal isometric contraction in healthy volunteers. The primary finding 
was that the ANOVA revealed a significant difference in the time to exhaustion between 
conditions (F (2, 34) = 6.763, P = 0.003). Pairwise comparisons revealed a significantly 
different TTE time between TENS (10 min 49 s ± 6 min 16 s) and SHAM conditions (7 
min 52 s ± 2 min 51 s) (P = 0. 031) and between IFC (11 min 17 s ± 6 min 23 s) and SHAM 
conditions (P = 0.02). No significant difference between TENS and IFC conditions was 
observed (P > 0.05). The ANOVA also revealed a significant main effect of condition for 
exercise-induced pain during the TTE test (P = 0.035). No significant changes in rating of 
perceived exertion (RPE) were found between the three conditions (P > 0.05). A 3 x 8 
(condition x iso-time) ANOVA revealed a significant interaction effect for exercise-
induced pain over time between conditions during the TTE test with lower pain intensity 
in the TENS and IFC conditions (F (3.4, 58.4) = 3.671, P = 0.013). No interaction and main 
effects for RPE were found between the three conditions (P > 0.05). For the MVC, paired-
sample t-tests demonstrated that MVC was significantly reduced following the TTE in the 
Sham (t (17) = 9.069, P < 0.001), TENS (t (17) = 7.037, P < 0.001) and IFC conditions (t (17) 
= 8.558, P < 0.001). No significant differences between conditions were found for the pre-
MVC (F (1.4, 23.4) = 1.758, P = 0.188) or the post-MVC (F (2, 34) = 1.499, P = 0.238). This is 
the first experiment investigating the analgesic effect of TENS during exercise that uses a 
randomised, crossover and placebo controlled design. This experiment demonstrated for 
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the first time that eliciting a reduction in EIP through TENS resulted in an improvement in 
single limb exhaustive exercise. An additional novel finding from this study was that the 
reduced EIP and improved endurance performance occurred despite no effect on RPE. The 
results suggest that TENS and IFC can elicit an analgesic effect on EIP, and that this 
reduction in muscle pain can improve time to exhaustion performance in the absence of 
changes to perceived exertion. The results suggest that EIP is a limiter of endurance 
performance in single limb exhaustive exercise, and questions the notion that changes to 
RPE must always occur when endurance performance is affected. 
 
The 4th experiment (Chapter 6) sought to apply the results obtained in the 3rd experiment 
to the performance of a 10-mile cycling TT in trained cyclists. The novel finding was that 
the ANOVA revealed a significant difference in completion time between conditions (F (2, 
42) = 6.597, P = 0.003). Pairwise comparisons revealed that participants performed a 
significantly faster TT (P = 0.001) in the TENS condition (29 min 6 s ± 3 min 20 s) 
compared to the SHAM (29 min 39 s ± 3 min 34 s) condition. There were no significant 
differences (P = 0.872) between the IFC condition (29 min 28 s ± 3 min 34 s) and the 
SHAM, or the TENS and IFC conditions (P = 0.116). The ANOVA also revealed a 
significant main effect of condition for power output (F (2, 38) = 3.48, P = 0.041), mean HR 
(F (1.38, 29.06) = 4.016, P = 0.042) and mean B[La] (F (1.49, 31.37) = 7.54, P = 0.004). There was 
a significant difference in the mean EIP between conditions during the TT (F (2, 44) = 4.210, 
P = 0.022). Paired t-tests revealed that participants perceived significantly less pain during 
the TENS condition (3.5 ± 1.8) than in the sham condition (4.0 ± 2.0) (t (21) = 3.037, P = 
0.006). No differences were observed between the TENS and the IFC condition (3.8 ± 1.9) 
or the IFC and Sham condition (P > 0.05). No significant differences in mean RPE were 
found between conditions during the TT (P > 0.05). Interestingly, this study also showed 
that TENS elicits an analgesic effect on EIP and improves the TT performance, whereas 
IFC technique does not elicit any reduction of EIP and consequently has no effect on 
whole-body endurance performance. This experiment demonstrated the first time that 
TENS intervention significantly improved completion time of the cycling TT, and that this 
was attained by the cyclists sustaining a greater power output (PO), heart rate (HR) and 
blood lactate (B[La]). Regardless of the increased physiological stress and metabolic rate 
induced by the higher PO, participants perceived EIP in the TENS strategy alongside in 
the absence of a difference in RPE between conditions. The improvement in dynamic 
endurance was probably the result of reduction in EIP for a given load. This is the first 
experiment showing that a TENS intervention can be used to elicit this analgesia to EIP, 
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and suggests that there may be scope for TENS to be used during exercise in those where 
EIP negatively effects their engagement in physical activity.   
 
The final experiment in this thesis (Chapter 7) examined the effect of mood and emotional 
state on EIP and endurance performance. The use of painful images prior to endurance 
cycling performance was used to negatively affect mood, which was hypothesised to 
increase EIP. The primary finding was that the ANOVA revealed a significant difference 
in completion time between conditions (F (2, 40) = 8.480, P = 0.001). Pairwise comparisons 
revealed that participants performed a significantly faster TT (P = 0.003) in the pleasant 
condition (29 min 38 s ± 4 min 35 s) and the neutral condition (29 min 39 s ± 3 min 34 s) 
compared to the painful condition (30 min 19 s ± 5 min 7 s). There were no significant 
differences between the neutral condition and the pleasant (P = 1.000). The ANOVA also 
revealed a significant difference in PO (F (2, 40) = 6.318, P = 0.004), mean HR ((F (2, 40) = 
4.502, P = 0.017) and mean B[La] (F (2, 40) = 5.724, P = 0.007) between conditions during 
the TT cycling performance, but no significant effect of condition for mean RPE or EIP (P 
> 0.05). In the FP, a significant main effect of condition for EIP (F (2, 40) = 4.363, P = 0.019), 
but no difference for RPE, HR or B[La]. This experiment demonstrated the first time that 
painful images negatively affect mood and elicit a compassionate hyperalgesia response to 
exercise. The results demonstrate that an increased pain sensation during exercise (induced 
via compassional hyperalgesia) can decrease TT performance, and highlights there is an 
emotional element to the processing of EIP that can be influenced by compassional 
hyperalgesia. This iVSUREDEO\WKHFRQVHTXHQFHRIµWop-GRZQ¶SURFHVVLQJ increasing the 
pain sensation elicited by a given µERWWRP-XS¶ VWLPXOXV These results highlight the 
importance of maintaining a positive mood and emotional state prior to and during 
exercise.  
The experimental studies performed as part of this thesis provides unique empirical 
evidence to advance scientific knowledge and understanding of the phenomenon of EIP. 
This thesis provides further new insights into how different interventions both alleviate 
and exacerbate EIP, which subsequently influences endurance exercise performance. 
Furthermore, considering the lack of knowledge regarding the testing and role of EIP in 
exercise, this thesis contributes to and enhances scientific understanding for how to test for 


























Pain perception has long been linked to success in sport and it is well-considered that 
intense and repetitive muscle contraction causes a noxious environment in the muscle that 
HOLFLWV µH[HUFLVH-LQGXFHGSDLQ¶ (,30DXJHUHWDO'DQQHFNHU	.ROW\Q
However, this concept is not well explored or identified in the most prominent models of 
endurance performance. Endurance exercise performance can be defined as the capacity 
of an organism (e.g. muscular, cardiovascular) to utilise itself during exercise such as 
cycling, running, swimming or aerobic exercise that is performed for an extended period 
of time (Rogers & Roberts, 1997). Exercise performance involves an integrated process of 
numerous physiological and psychological determinants. According to Joyner and Coyle 
(2008) the key physiological determinants of endurance exercise are maximal oxygen 
consumption VO2max, lactate threshold and economy of movement (Joyner & Coyle, 2008). 
The key psychological determinants of endurance exercise include self-efficacy (Martin & 
Gill, 1991), perfectionism, achievement goals, and personal goal setting (Stoeber, Uphill 
& Hotham, 2009), use of psychological strategies (Houston, Dolan & Martin, 2011), 
positive affect (Renfree et al., 2012), and self-talk (Blanchfield et al, 2014), mental fatigue 
and self-control (Inzlicht & Marcora, 2016) (McCormick, Meijen & Marcora, 2015). This 
review will only consider the physiological and the specific psychological determinants 
that interact with the physiological and how these can influence exercise performance in 
relation to pain.  
Therefore, the aim of this literature review is to classify and further describe the key 
components involved in the explanations and limitations of fatigue, including the 
following psycho/physiological models, central governor model, anticipatory-RPE 
regulation model, afferent feedback model, psychological models and the limiting effect 
of pain on endurance performance. To provide a context to these models in relation to pain, 
a broader background and introduction to the anatomy and physiology of pain, nociception 
and pain perception process in the spinal cord and brain levels, theories and thoughts of 
pain perception, causes of pain, modulation and assessment of pain will be reviewed. 
Ultimately, this review will work towards reviewing current understanding of the role and 
importance of exercise-induced pain as a contributor to fatigue and how this may be 
influence decisions to alter work-rate during exercise.  
 
I. Fatigue 
Fatigue is a very complex process, which is likely multifactorial and never absolute (Fitts, 
1994; Gandevia, 2001). Whilst the precise mechanisms underpinning its aetiology are still 
today not fully understood, it is well-accepted that maximising power output or speed while 
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limiting fatigue is the key determinant of success in endurance exercise (Joyner & Coyle, 
2008). Our basic knowledge and understanding of fatigue has generally arisen from 
laboratory methodologies that require the participant to produce a maximal voluntary 
contraction or the use the time to exhaustion tests at a fixed intensity, where µfatigue¶
occurs at task failure following a fatiguing task or intervention (Ament & Verkerke, 2009). 
In these instances, musclefatigue is more closely aligned to a particular point in time where 
an inability to produce a given force occurs (Mauger, 2014). Accordingly, while these 
methodologies have the ability to establish causes of fatigue such as an increased 
concentration of deleterious metabolites and substrate depletion (Coyle et al., 1983; Kent-
Braun, 1999), and reduced neural drive to the muscles and task failure (Gandevia, 2001), 
WKH\ DUH SHUKDSV QRW WUXO\ GHPRQVWUDWLYH RI WKH GHPDQGV RI µUHDO-OLIH¶ HQGXUDQFH
performance. Indeed, where completion time isthe measure of success in actual endurance 
performance, athletes are not required to produce maximal contractions and rarely cease 
exercising during or following the event (Mauger, 2014). Rather, it is the athlete¶s ability 
to regulate their own work rate during an endurance event and their physiological capacity 
to maintain a high work rate, that will determine optimal performance (Mauger et al., 
2009). A consequence of this is that different methodological and theoretical approaches 
are applied to both fixed intensity and self-paced exercise, despite the psychophysiological 
requirements for these being potentially different. This thesis will attempt to discuss 
fatigue and endurance performance in the context of both methodologies.  
 
1. Explanations of Fatigue in Endurance Performance 
Most previous studies addressing determinants of fatigue during exercise have shown that 
endurance exercise performance is limited by several physiological determinants, with  
maximal oxygen consumption (VO2max), lactate threshold and efficiency being the most 
recognised (Lucia et al., 1999; Balmer, Davison & Bird, 2000; Jeukendrup, Craig & 
Hawley, 2000; Lucia, Joyos & Chicharro, 2000; Laursen, Shing & Jenkins, 2003; Joyner 
& Coyle, 2008). In addition to this, biomechanical (positioning) (de Koning, Bobbert & 
Foster, 1999; Jeukendrup, Craig & Hawley, 2000; Garside & Doran, 2000) environment 
(wind, temperature, altitude andhumidity) (Lucia et al., 1999; Balmer, Davison & Bird, 
2000; Jeukendrup, Craig & Hawley, 2000; Lucia, Joyos & Chicharro, 2000; Kay et al., 
2001;Laursen, Shing & Jenkins, 2003), mechanical and psychological variables have also 
been suggested as important contributors. Ultimately, the capability of the athlete to 
tolerate or sustain a high power output during endurance performance is limited by the 
capability  of the athlete to resist fatigue (Abbiss, 2005), and so factors which affect this 
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are all important. However, whatever exactly causes this fatigue is debated. Indeed, for at 
least the last 90-100 years, explaining fatigue during endurance performance has been a 
major investigation for sport and exercise scientists (Hill, Long & Lupton, 1924). 
However, despite various models of fatigue being proposed, no single model has been 
agreed upon (Noakes, 2000). This is likely because the cognitive, biomechanical, 
biochemical, and physiological models used to understand exercise fatigue and the 
adaptations that correlate or boost athletic performance are diverse (Brooks et al., 2000; 
Noakes, 2000; Hampson et al., 2001; Hunter et al., 2003), as are the various forms of 
exercise to which these are relevant (Kay et al., 2001; Tordi et al., 2003).  
 
1.1 Models in Endurance Performance 
1.1.1 Central Governor Model (CGM) 
In 1997, the presence of a Central Governor was suggested by Tim Noakes, in his Central 
Governor Model (CGM), as shown in Figure 1.1. The CG is suggested to exist as a series 
of networks based in the central nervous system (CNS), that take into account the 
information about energy supply, current various physiological demands and motivational 
states to ensure that exercise terminates prior to a catastrophic biological failure (Noakes, 
2005, 2012). Consequently, the primary purpose of the CG is to serve as a protective 
function. Noakes et al. (2001) proposed that muscle recruitment is determined centrally, 
and used as a method by which to prevent biological failure arising from anaerobisis 
(Hampson et al., 2001; Lucia et al., 2003). This notion was originally based on a brain-
heart feedback loop to prevent cardiac failure, but was then expanded to the whole body in 
later updates to the CGM (Noakes 2000, 2011). The conception of the CGM likely arose 
from the original work by Ulmer (1996) on Teleoanticipation. This theory suggests that 
athletes have to regulate their energy consumption per unit of time with respect to a 
finishing point, so as to avoid both early fatigue and achieve optimal race time (Ulmer, 
1996). Ulmer suggested that changes in exercise intensity are proposed to be controlled by 
a continuous feedback system where afferent signals that contain information on force, 
displacement, time and muscular metabolism are fed back to the brain via somatosensory 
pathways. Based on motor learning and the anticipated exercise bout, the brain is then able 
to use afferent signals from the muscles, as well as feedback from other organs, in order to 
alter intensity and optimise performance (Ulmer, 1996). While these principles form the 
basis for the CGM, the CGM emphasises internal judgement of expectations of exercise 
(prior experience, knowledge of distance/duration, environment etc.) against the reality of 
exercise (i.e. the given physiological state of the body). If these two sets of information are 
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incompatible with the successful completion of the exercise, then this results in an altered 
µVHQVDWLRQ¶RIIDWLJXH7KLVis what is ultimately suggested to lead to changes in work rate. 
Indeed, it is the description of fatigue as a sensation, or emotion, which really sets the 
CGM apart from other models of endurance performance. Peripheral metabolites are not 
merely energy substrates or inert metabolic by-products, neither are they simply the sole 
or absolute regulators of the entire complex system. Instead they serve together to assist in 
the determination and constant resetting of the pacing strategy. Because of this reference 
to the importance of pacing in the CGM, much of the supporting literature for its existence 
has come from studies where pacing strategies have been examined. Indeed, a study by 
Amann and colleagues (2006) into various levels of hypoxia on pacing showed that within 
less than 60 s of exposure, participants altered their pacing strategies without their 
knowledge of changes to the environmental change. Activity of the electromyographic 
signal (EMG) was reduced along with power output, suggesting that the power output 
reduction on exposure to hypoxia related to a central motor drive reduction, a key tent of 
the CGM (Noakes, 2011).  
 
Figure 1.1 The most recent form of the Central Governor Model of Exercise Regulation 
proposed that the brain regulates exercise performance by continuously modifying the number of 
motor units that are recruited in the exercising limbs. From Noakes, 2011, p. 26. 
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A key observation used by supporters of the CGM is the presence of an µHQG-VSXUW¶± the 
last 5-10% of the race where competitors speed up despite experiencing the greatest levels 
of fatigue (Bartlett, Gratton & Rolf, 2006; Tucker, Lambert & Noakes,  2006b). This 
phenomenon is used as evidence for the presence of both pacing strategies and for the 
maintenance of a metabolic reserve capacity until the end of endurance events (Bartlett, 
Gratton & Rolf, 2006). Subjects performing the end spurt show a parallel increased activity 
of EMG in the skeletal muscle recruitment (Tucker et al. 2004, 2007; Ansley et al., 2004b), 
indicating that the end spurt results in an increased central motor drive (as anticipated by 
the CGM). In this context, the end-spurt is possible because the athlete knows the end-
point is near and an increased work rate can be achieved because the risk to a dangerous 
imbalance in homeostasis is reduced. Therefore, despite the greater accumulation of 
deleterious metabolites that are proposed to cause peripheral fatigue, the athlete is still able 
to increase work rate. Whilst this notion provides an interesting alternative to the traditional 
PRGHOVRIIDWLJXHLWFRPSOHWHO\LJQRUHVPRUHUHFHQWSURSRVLWLRQVUHODWLQJWRKRZ:¶LV
expended in relation to critical power during endurance events (Chidnok et al., 2013).  
,QGHHGLI:¶LVQRWFRPSOHWHO\H[SHQGHGE\WKHHQGRIWKHHYHQWWKHDWKOHWH¶s end sprint 
OLNHO\MXVWUHIOHFWVWKHDWKOHWHXVLQJWKHLUUHPDLQLQJ:¶, which is possible if a sufficient 
amount of the previous exercise is completed below critical power (Fukuba & Whipp, 
1999).  
A further key base of evidence supporting the CGM are studies which demonstrate an 
ergogenic effect despite eliciting no change in the peripheral parameters associated with 
performance. There is convincing evidence that certain drugs, such as amphetamines, 
which act solely on the brain, are capable of modifying the extent of skeletal muscle reserve 
and serve to increase power output and consequently, endurance performance (Swart et al., 
2009). Additionally, even mild analgesics such as paracetamol are capable of increasing 
power output in self-paced exercise (Mauger et al., 2010) or extending the time a fixed 
power output can be maintained (Mauger et al., 2013). These studies demonstrate that there 
are clearly other variables, alongside those influencing oxygen supply/utilisation, that limit 
endurance performance, and that many of these involve a role for the brain. Indeed, there 
are a long list of parameters which show a change in exercise performance independent to 
cardiovascular factors, including; the use of placebos (Beedie, Stuart,  Coleman & Foad, 
Beedie, Coleman & Foad, 2007; Foad, Beedie & Coleman, 2008; Trojian & Beedie, 2008); 
music (Barwood et al., 2009; Lim, Atkinson, Karageorghis & Eubank, 2009); prior 
experience (Mauger, Jones & Williams, 2009); self-belief (Micklewright, Papadopoulou, 
Swart & Noakes, 2010); time deception (Morton, 2009); psychological skills training 
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(Barwood, Thelwell & Tipton, 2008); knowledge of the endpoint (Wittekind, 
Micklewright & Beneke, 2009); mental fatigue (Marcora, Staiano & Manning, 2009); 
cooling of the palms (Kwon et al., 2010); glucose ingestion (Chambers, Bridge & Jones, 
2009; Rollo, Cole, Miller & Williams, 2010; Gant, Stinear & Byblow, 2010); cerebral 
oxygenation (Nybo & Rasmussen, 2007; Rupp et al., 2008; Seifert, Rasmussen,  Secher & 
Nielsen, 2009; Billaut et al., 2010; Rasmussen et al., 2010a, 2010b); pseudoephedrine 
(Pritchard-Peschek,  Jenkins,  Osborne & Slater, 2010), naloxone (Sgherza et al., 2002), 
and bupropion (Roelands et al., 2008, 2009; Roelands & Meeusen, 2010) and self-control 
(Inzlicht &  Marcora, 2016).  
However, the CGM has been widely criticised, largely because it is considered to be 
untestable (Inzlicht & Marcora, 2016), and therefore questionable as to whether it can be 
considered a true theory at all. Proposing theories in science that are unfalsifiable is a 
problem because the well-accepted hypothetico-deductive model of scientific reasoning is 
based on being able to objectively test key hypotheses that can be shown to be false. This 
is how knowledge and understanding progresses, by developing new theories that get 
progessivly closer to the truth (Popper, 2005). The CGM is so vast and complex, and 
potentially includes a role for every physiological and psychological variable, that almost 
any observation can be explained by it (Marcora, 2008). This also raises questions as to 
whether it actually progresses our understanding of endurance performance in a 
meaningful way. Whilst some of the criticism the CGM receives is perhaps justified, it 
cannot be ignored that since its conception in 1998, there has been a considerable shift in 
the way endurance performance studies are conducted (towards a self-paced, whole-body 
model) and a paradigm shift towards a recognition about the importance of the brain.  
 
1.1.2 Anticipatory-RPE Regulation Model 
Much of the development of the CGM occurred between 2002-2008, where the main 
authors included Tim Noakes, Ross Tucker and Alan St. Clair Gibson (St Clair Gibson et 
al., 2006). However, from 2009 it appears as though Tim Noakes continued to revise the 
CGM, whereas Ross Tucker developed his own model. He termed this the Anticipatory-
RPE Model (Tucker, 2009), in which the primary foundation is that the conscious 
perception of effort regulates exercise and protects the athlete as well as ensuring optimal 
performance under all conditions. This model attributes its name due to the notion that 
athletes utilise previous knowledge and experience of exercise duration/distance, in an 
anticipatory process, and use psychophysiological feedback for regulation of pacing 
strategy and performance during the exercise (Tucker, 2009). They key construct here is 
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that the athlete knows the end-point of the exercise, as without it an appropriate pacing 
strategy cannot be formed. However, when the exact end-point is not known, provided the 
athlete has sufficient experience of the exercise so that it can be estimated, a competitive 
pacing strategy can be formed (Mauger et al., 2009). Therefore, it appears as though prior 
experience is important, because it partly allows the athlete to better balance the projected 
exercise endpoint against remaining energy reserves. This model appears to play an 
important role in regulation of exercise performance under various environmental 
conditions (Tucker et al., 2006; Swart et al., 2009), as the initial setting of exercise intensity 
is gained from sensory afferent input from different external/environmental cues (Nielsen 
et al, 2001; Nybo & Nielsen, 2001a,b; Rasmussen et al., 2004) and physiological systems 
are utilised by the brain to predict the duration of exercise that could be safely sustained 
without harm (Tucker et al., 2006). The physiological afferent inputs largely rely on the 
exercise intensity (Noakes & St Clair Gibson, 2004; Noakes, Gibson & Lambert, 2005) 
and environmental conditions such as temperature and inspired partial pressure of oxygen 
(Tucker et al., 2006). Initially, the rate of incUHDVHLQ53(LVVHWWRSUHGLFWDQLQLWLDOµVDIH¶
ZRUNUDWHDQGWKLVLVWHUPHGWKH³WHPSODWH53(¶¶7XFNHU'XULQJLQWHQVHH[HUFLVH
afferent information from various physiological systems (which is interpreted by the brain) 
is responsible for generating the conscious RPE, which is compared to the subconscious 
template and results in adjustments to power output if rate of RPE increase is not 
compatible with the likely duration of exercise (Tucker, 2009). 
The split between the CGM and Anticipatory-RPE Model has caused some confusion, and 
it is not altogether clear where the two models differ significantly. Indeed, aside from the 
initial proposition of the Anticipatory-RPE Model (Tucker, 2009), there is little reference 
to it in subsequent studies. Similar criticisms to the CGM can be levelled at the model, and 
given its similarity, they will be considered as synonymous for the purposes of this thesis.  
 
1.1.3 Sensory Afferent Feedback Model 
Afferent feedback along spinal and supraspinal circuitries is integrated with central motor 
commands (CMC) and is contributed to by the activity of underling voluntary contractions 
of the muscle (Nielsen, 2016). With the onset of exercise, thermal, chemical and 
mechanical stimuli alter various intramuscular receptor activity, such as metaboceptive or 
nociceptive, which is specifically reflected in the firing rate of large- and small-
diameter primary afferents, including group I/II and group III/IV, respectively (Garland, 
1991; Garland & Kaufman, 1995; Amann & Dempsey, 2016; Nees et al., 2016). In the 
addition to the muscle fatigue which develops during prolonged exercise through 
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the accumulation of muscle metabolic by-products, the neural afferent feedback that 
occurs in addition to this is thought to mediate a reflex inhibition of alpha motor neurons 
involved in contracting single muscles at spinal and supraspinal levels (Gandevia et al., 
1990; Gandevia, 2001). The central fatigue that ensues for this is the basis for the sensory 
afferent feedback model (see Figure 1.2) (Amann & Dempsey, 2008; Amann & Secher, 
2010), as the somatosensory feedback associated with peripheral muscle fatigue inhibits 
central motor drive (CMD) and thereby limits endurance exercise performance (Amann et 
al., 2013).  
Amann and Dempsey (2016) claim that the rate of peripheral fatigue development is 
associated with increasing neural afferent feedback from locomotor muscles to the central 
nervous system (CNS). This feedback exerts an inhibitory influence central motor drive 
regulation, which is manifested in the observed muscle power output. This serves to limit 
the peripheral fatigue development level (i.e. a primarily central limitation of exercise), in 
order to avoid unbearable effort³SDLQ´DQGPDLQWDLQDµFULWLFDOWKUHVKROG¶$PDQQHWDO
2006, 2007KHNH\VHULHVRIVWXGLHVVXSSRUWLQJWKLVPRGHOFRPHIURP0DUNXV$PDQQ¶V
group, where complete afferent block is attained through the use of lumbar injection of 
fentanyl (Amann et al., 2006, 2007). In these studies, when afferent feedback is blocked, 
a greater level of peripheral fatigue ensues, suggesting that afferent feedback is required to 
prevent terminal levels of peripheral fatigue from occurring. In these studies, it is observed 
that participants have ambulatory problems on conclusion of the exercise (likely due to the 
severe peripheral fatigue), which suggests a potential protective function of the afferent 
feedback. Additionally, when afferent feedback is blocked by using fentanyl, participants 
show a disregard for physiologically sensible pacing strategies. Indeed, in these studies 
participants select an extreme positive pacing strategy, which results in a power output that 
cannot be maintained. This also suggests that the afferent feedback during exercise 
provides useful information regarding pacing strategy. Despite these fentanyl studies 
showing compelling evidence for the importance of afferent feedback, there are criticisms 
with this design. Most notably, the exercise pressor reflex is heavily dependent on afferent 
feedback, and participants in these studies likely suffered from impaired cardiovascular 
control which would have exacerbated peripheral fatigue through decreased oxygen 
saturation. Furthermore, the injected fentanyl could have also have migrated to the 
respiratory centre in the brain, which could explain why SaO2 was severely impeded in the 
fentanyl condition, and then could have exacerbated the level of peripheral fatigue the 
participants experienced.  Although these criticisms have substance, the sensory-afferent 
feedback model provides a testable construct, and provides important evidence to suggest 
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that sensory-afferent feedback is almost certainly required to set a pacing strategy, even if 
it is potentially not a primary cause of fatigue. 
 
Figure 1.2 Schematic illustration of the suprapinal reflex inhibition model of endurance 
exercise performance proposed by Amann and colleagues (2008, 2009). From Amann & Dempsey, 
2009, 2010, p 454. 
 
1.1.4 Psychobiological Model of Endurance Performance 
An alternative to the cardiovascular, afferent feedback and Central Governor models has 
been recently provided, which places primary emphasis on perception of effort. This model 
LV WHUPHG WKH ³3V\FKRELRORJLFDO PRGHO´ 0DUFRUD  a, 2008b, 2009, 2010, 
Marcora, Bosio & de Morree, 2008; Marcora & Staiano, 2009a, 2010b). This model gives 
greater attention to perception of effort and motivational factors than its predecessors, and 
explains how both of them influence the conscious decision-making process during 
endurance exercise performance (Smirmaul et al., 2013). The Psychobiological Model 
states that fatigue is solely a balance between perception of effort and motivation, and that 
DQDWKOHWH¶VGHFLVLRQWRWHUPLQDWHH[HUFLVHLVDFRQVFLRXVFKRLFHUDWKHUWKDQDPHFKDQLFDO
failure. However, the premLVHRIWKLVPRGHOLVQRWZHOODFFHSWHGE\ERWK+LOO¶VFODVVLFDO
model (i.e. the cardiovascular/anaerobic model) (Noakes 1988, 1997, 1998, Bassett & 
Howley, 1997) and proponents of physiology based determinants of endurance 
performance.  





effort available to satisfy a motive, whilst motivation intensity is the actual amount willing 
to be expended (Wright, 2008). Brehm's theory of motivational intensity postulates that 
athletes will exert effort in a task for as long as they remain motivated. When the level of 
effort required to maintain task, intensity goes above the level of motivation required, the 
individual will terminate the task (Wright, 2008). Therefore, according to the 
Psychobiological model, exhaustion during intense exercise is a procedure of task 
disengagement, in which athletes will exercise until perception of effort increases to a 
critical level in excess of the potential motivation. This model provides a valid explanation 
of performance change observed when purely psychological parameters are manipulated 
(e.g. mental fatigue) (Marcora, Staiano & Manning, 2009; Pageaux, Marcora & Lepers, 
2013). It also explains what would usually be called physiological fatigue, through the 
increased effort required to drive a fatigued limb (Marcora, Bosio & de Morree, 2008). 
Recently, Pageaux et al. (2014) also explored its validity in explaining regulation of work 
rate in self-paced exercise, where endurance performance was altered by manipulated 
through a psychological intervention (i. e. mental fatigue). 
To provide a theoretical framework for how the Psychobiological model can explain the 
conscious regulation of endurance performance, Marcora (2010) states that there are five 
key cognitive/motivational factors that are important: perception of effort, potential 
motivation (described above), knowledge of the distance/time to cover, knowledge of the 
distance/time remaining, previous experience/memory of perception of effort during 
exercise of varying intensity and duration (Brehm & Self, 1989; Marcora, 2010). 
According to the Psychobiological model, factors 3 to 5 are self-regulated tasks and can 
H[SODLQWKH³HQG-VSXUW´SKHQRPHQRQ0DUFRUD or why athletes begin various races 
at variety of paces (Josephet al., 2008). Since perception of effort (factor 1) is such a key 
element in the Psychobiological model, a deeper categorisation is essential, and in 
particular the exact mechanism of the perception of effort. The modern interpretation is 
that the perception of effort is thought to be dependent on efferent and afferent signals 
(Hampson et al., 2001; Meeusen, 2009). However, evidence put forward by Marcora 
(2009), suggested that the sense of effort is centrally generated and independent of afferent 
sensory feedback from skeletal muscle and other interoreceptors such as pain and 
temperature. Rather, it is suggested that perception of effort is the result of the conscious 
awareness of the corollary discharge associated with the central motor command 
transmitted to the active muscles (Ross & Bischof, 1981; Marcora, 2009; de Morree, Klein 
& Marcora, 2012). However, manipulation of the perception of effort can also be generated 
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from altered central processes during sustained intense exercise (Sacco et al., 1999). Thus, 
sensory afferent feedback from the active muscles may influence perception of effort, but 
RQO\LQGLUHFWO\&RQVHTXHQWO\0DUFRUDKDVGHILQHGWKHSHUFHSWLRQRIHIIRUWDVµµWKH
FRQVFLRXV VHQVDWLRQ RI KRZ KDUG KHDY\ DQG VWUHQXRXV D SK\VLFDO WDVN LV¶¶ DQG LV WKH
essential determinant of the Psychobiological model (Pageaux, 2014). Indeed, according 
to this model, the self-regulation of pacing is principally determined by the effort perceived 
(Pageaux, 2014). Thus, when perception of effort is increased by muscular (de Morree & 
Marcora, 2013) or mental fatigue (Pageaux et al., 2014), or decreased pharmacologically 
(Watson, Jenkinson, Kazmierski & Kenakin, 2005), the athlete will constantly alter their 
pace to compensate.  
There is a large body of experimental studies supporting the Psychobiological model (for 
example; Marcora, Bosio & de Morree, 2008; Haggard, 2008; Marcora, Staiano & 
Manning, 2009; de Morree, Klein & Marcora, 2012; de Morree & Marcora, 2013; Pageaux 
& Marcora, 2013; Blanchfield et al., 2014; Pageaux et al., 2014; Inzlicht & Marcora, 2016). 
However, there are criticisms of these studies, and the model as a whole too. Firstly, the 
PRGHOLVVXJJHVWHGWREHµVLPSOHU¶DQGWKHUHIRUHPRUHYDOLGWKDQWKH&*0KRZHYHUWKLV
relies on the basis of perception of effort being solely the result of the corollary discharge. 
It is perhaps misleading to suggest the Psychobiological model is inherently simple 
because of mechanistic basis of perception of effort, because even if afferent feedback is 
indirectly important, it will affect perception of effort and thus adds multiple layers of 
complexity. Furthermore, if muscle fatigue requires a greater central motor command to 
drive the limb, then classical explanations of human performance (e.g. oxygen 
supply/demand) remain just as important because they will set the boundaries of muscle 
fatigue. The redefining of perception of effort (i.e. excluding the role of pain, discomfort 
and dyspnoea) instructions to participants also poses problems, as it limits the degree to 
which prior studies can be interpreted through the Psychobiological model. Indeed, most 
previous research uses a definition of RPE that includes discomfort or pain (Noble and 
Robertson, 1996), and so comparisons of RPE data in these studies are hard to make. 
However, it has been demonstrated that participants can identify and rate pain and RPE 
separately (Cook et al., 1997, Pageaux 2016), and so studies that focus on these constructs 
should attempt to do this by using separate scales. In this thesis, such an approach is taken. 
However, when this is done caution should be taken in comparing RPE data to previous 
studies that do not take this approach. Finally, motivation is a construct which is 
notoriously hard to accurately measure in the laboratory, which makes it very difficult to 
truly test one of the key tenets of this model.   
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1.1.5 Pain Limitation of Endurance Performance 
Muscle pain is a common experience during exercise, with pain threshold in working 
muscles occurring at nearly 50% of anindividual peak power output(Cook et al., 1997).
However, studies have given peculiarly little focus to exercise-induced muscle pain (EIP), 
which is often raised by coaches, commentators, and athletes as a key factor in endurance 
performance. Indeed, it is often proposed that athletes who are better able to overcome or 
tolerate muscle  pain during exercise will be more successful and it is commonly stated as 
a key inhibitory factor during intense exercise (Mauger, 2013). EIP is also an important 
feedback source in the maintenance of exercise intensity and is consequently important for 
athletic performance (O'Connor & Cook, 2001; Bantick et al., 2002; Eccleston & Crombez, 
1999; Crombez et al., 1998; Davis et al., 1997). This indicates a need to better understand 
pain perception during exercise.  
 
1.2   Pain 
1.2.1 The Definition of Pain 
The International Association for the Study of Pain (IASP), deILQHVSDLQDV³DQXQSOHDVDQW
sensory and emotional experience associated with actual or potential tissue damage or 
GHVFULEHGLQWHUPVRIVXFKGDPDJH´0HUVNH\& Bogduk, 1994). This definition is the 
conclusion over several centuries of ideas and achievements that have further explored the 
concept of pain. From a neurobiological perspective, a distinction must be made between 
the perception of pain and the reception of signals provoked by specialised sensory 
receptors in peripheral tissues of the body (e.g., skeletal muscle) and central nervous 
system tissues (spinal and supraspinal neurons). This process is so-FDOOHG³QRFLFHSWLRQ´
arising from the individual stimulus-UHVSRQVHRI³QR[LRXVVWLPXOL´%ODFN 
 
1.2.2 Sensory Neurons of muscle pain: Anatomy and physiology  
Sensory neurons innervating skeletal muscle fibres are categorised into four primary 
groups in terms of size, conduction velocity, and myelination (Lloyd & Chang, 1948). 
Group I and II fibres are myelinated sensory nerve fibres with a large-diameter, and have 
the highest conduction velocity of all the nerves in the body, and play an important role in 
proprioception (Taylor & Finn, 2014). Group III and IV fibres are myelinated and 
unmyelinated sensory nerve fibres with a small-diameter, and have a lower conduction 
YHORFLW\UHVSHFWLYHO\FRUUHVSRQGLQJWR$DQG&ILEUHVRIWKHFXWDQHRXVWLVVXH:LOOLV	
Coggeshall, 2012). There is additional evidence that groups III and IV, but not groups I 
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or II, respond to application of noxious thermal, chemical and mechanical stimuli to the 
muscle, representing that they convey nociceptive input from the muscle (Mense, 1977; 
Pickar, Hill & Kaufman, 1994). Nociceptive bare nerve endings of group III and IV fibres 
are distributed throughout the muscle, and terminate in the connective tissue, fat, extrafusal 
and intrafusal muscle fibres, as well as the adventitia of both arterioles and venules (Walro 
& Kucera, 1999). The majority of these nerves terminate as free nerve endings in the 
adventitia of blood vessels in skeletal muscle of mammals, a perfect location for blood 
sampling of metabolites released as a by-product of muscle contraction (Stacey, 1969). In 
addition, the fascia around muscle may cause symptoms of muscle pain. Nociceptive fibres 
innervate the fascia (Tesarz et al., 2011), which are activated both by noxious chemical 
and mechanical stimuli (Taguchi, Matsuda, Tamura, Sato & Mizumura, 2005; Taguchi et 
al., 2013). These nociceptive muscle afferents can also be activated by muscle contractions 
(Itoh & Kawakita, 2002; Taguchi et al., 2005).  
Emerging from a muscle, nociception, mechanoreception and proprioception project to 
various layers of the spinal cord (Davis et al., 1989; Ozaki & Snider, 1997). Nociceptive 
nerve fibres subsequently signal to the brain through the spinothalamic tract (Foreman, 
Schmidt & Willis, 1979), where these fibres terminate in the thalamic nucleus submedius, 
ventral posterolateral nucleus (VPL) (Kniffki & Mizumura, 1983), and anterior 
paraventricular nucleus of the thalamus (Kawakita et al., 1993; Min, Zhang, Zwiers & 
Hegerl, 2011). Muscular pain excites or stimulates multiple brain regions, such as the 
anterior cingulate cortex, dorsolateral prefrontal cortex, the insula, and primary and 
secondary somatosensory cortex (Peyron, Laurent & Garcia-Larrea, 2000). However, 
muscular pain also sensitises the brain regions that are related with emotional processing, 
such as orbitofrontal cortex, parahippocampus, bilateral amygdala, hippocampus, superior 
temporal pole and caudate (Takahashi et al., 2011; Cheng & Lee, 2011).  
 
1.2.3 Pain Signal Transduction  
Muscle afferent feedback neurons are well-known for perceiving the condition of 
connective tissue (Mense, 1977; Mense & Meyer, 1985; Pickar et al., 1994; Mense & 
Craig, 1988), while cutaneous afferent neurons carry information about the external 
noxious environment around/in the muscle (Mense & Craig, 1988). Muscle afferents have 
a poor spatial resolution in comparison to cutaneous afferents, with mechanical fibres 
supporting multiple receptors as far as 2-cm apart (Kumazawa & Mizumura, 1977). In a 
clinical context, this matches the description of muscle pain as being diffusive and hard to 
localise (Mense, 1991). However, muscles are equipped with sensory fibres that are 
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activated by mechanical stimuli and capable of detecting noxious pressure, non-noxious 
pressure, and grading force of muscle contractions (Mense & Meyer, 1985). In addition to 
mechanical forces, muscle afferent neurons are attuned to the by-products released during 
sustained muscle contraction or under ischemic conditions (Sacchetti, Lampugnani, 
Battistini & Mandelli, 1980). Thermal stimuli can also be sensed in the muscle (Hertel, 
Howaldt & Mense, 1976; Kumazawa & Mizumura, 1977), but rises in temperature due to 
muscle activity are relatively small and do not approach the range that would stimulate 
heat nociceptors (Saltin et al., 1968; Brooks et al., 1971). 
Muscles themselves come under significant strain during exercise, which creates a unique 
metabolic environment that can be sensed by the afferent neurons (Li et al., 2003, Dessem 
et al., 2010). During exercise the muscle may also become damaged, which results in 
significantly more pain than non-damaging muscle (Faulkner, Brooks & Opiteck, 1993; 
Proske & Morgan, 2001; Gibson et al., 2009; Martin et al., 2009). The damaged muscle 
results in the recruitment of macrophages and neutrophils (Malm et al., 2000; Tidball, 
2005) and the release of a wide range of biochemicals (including: serotonin, bradykinin, 
prostaglandin E2, prostacyclin I2 (PGI2), thromboxane A2 (TXA2), and nerve growth factor 
(NGF) (Shah, Phillips, Danoff & Gerber, 2005; Ernberg et al., 1999; Murase et al., 2010; 
Urai, Murase & Mizumura, 2013).  
 
1.2.4 Nociception and Pain processing: Peripheral to Central 
Mechanisms 
The pain signal during exercise is usually instigated by stimulation of the peripheral 
nociceptors, the free (bare) nerve endings which exist in and around the small arterioles, 
arteries and veins, connective tissue and muscle fibres (Stacey, 1969). These Type III 
afferent nerve fibres (also known as A-delta fibres) synapse primarily on cell bodies in the 
dorsal rRRWJDQJOLD&HUYHWRHWDO1RFLFHSWLYH$įILEUHVDUHVWLPXODWHGE\KLJK
threshold noxious pressure and their activation in muscle level results in an aching, dull, 
or cramp (Marchettini et al., 1996). Type IV afferent nerve fibres (also known as cutaneous 
C-fibres) are unmyelinated, end solely in free nerve endings (Stacy, 1969), and respond to 
various noxious chemical stimuli (Mense, 1993).  
Nociceptive muscle afferents can be stimulated by mechanical pressure or chemical or 
thermal stimuli (Tadaki, Kumazawa, Mizumura & Tadaki, 1981). Implementation of a 
noxious stimulus to a nociceptor results in generating an electrical signal (Koltzenburg & 
Handwerker, 1994). When the stimulus is sufficiently great, then the electrical signal may 
exceed a threshold value, resulting in the generation of an action potential and the release 
16 
 
of neurotransmitter that is conveyed alongside the axon to the dorsal horn in the spinal 
cord (Black, 2012). In addition, a nociceptor may also be excited or sensitised by a given 
stimulus. During the sensitisation, the building of a noxious substance may lower the 
DFWLYDWLRQ WKUHVKROG RI WKH QRFLFHSWRU 2¶&RQQRU 	 &RRN  7KHUHIRUH DIWHU WKH
receptor has been sensitised, less input is required to cause activation(Mense, 2003). 
Receptors that respond to mechanical stimuli are FDOOHG³KLJKWKUHVKROGPHFKDQRUHFHSWRUV
+70´and require high intensities of tissue-threating mechanical pressure to respond to 
stimuli for muscle nociceptors, such as squeezing or pinching the muscle (Kumazawa & 
Mizumura, 1977). As a result, weak mechanical pressure stimuli (such as during most 
forms of exercise) are not perceived as muscle pain because the stimulus is not sufficiently 
large to activate HTM muscle receptors (Mense, 2003). In addition to mechanical pressure, 
a host of chemical substances directly sensitise and activate muscle nociceptors 
(Kumazawa & Mizumura, 1977). These biochemical substances include protons (hydrogen 
ions), bradykinin, serotonin, histamine, potassium, substance P, prostaglandin E, 
cytokines, and adenosine triphosphate (ATP) (Mense, 2009). During a single bout of 
exercise, not surprisingly, many of these algesic substances are released and produced in 
response to tissue damage and inflammatory processes that may occur as a consequently 
of exercise-LQGXFHG PXVFOH SDLQ 7KHVH VXEVWDQFHV PD\ DOVR VHQVLWLVH +70¶V WKXV
lowering the magnitude of the mechanical pressure required for them to fire.  
 
1.2.5 The Cause of Pain by Noxious Biochemicals  
1.2.5.1 Protons (hydrogen ions) 
During intense exercise, muscle ischemia, tissue damage and inflammation often occur 
alongside an increase in the concentration of protons, or hydrogen (H+) and a decrease in 
tissue pH (Hood et al., 1988, Issberner et al., 1996). The activation of proton-sensitive 
nociceptive fibres is a likely contributor for exercise-induced pain (Black, 2012). Tonic, 
low-force contractions can lead to increased ischemia of skeletal muscles and result in a 
lowering of muscle pH via accumulation of lactic acid (La) that disassociates into lactate 
and H+ ions (Black, 2012). Dynamic exercise at a moderate to high intensity such as 
cycling or running can also lead to enhanced production of lactic acid, resulting in cramp-
like or aching pain experienced during intense exercise (Black, 2012). Intramuscular 
injection of an acidic solution of pH 5.2-6.0 elicited a moderate-intensity pain that 
activated more that 50% of mechanosensitive afferent nociceptors and led to increased 
sensitivity to mechanical pressure (Hoheisel et al., 2004). H+ ions signal along acid-sensing 




Timmermann, & Ahring, 2004). ASIC3 homomeric channels are thought to play a crucial 
role in central sensitisation to noxious stimuli and are found in the dorsal root ganglion of 
the spinal cord (Price et al., 2001).   
 
1.2.5.2 Adenosine triphosphate (ATP) 
In muscles, ATP serves as the primary energy source for exercise metabolism (Green, 
1997). ATP is rapidly metabolized into adenosine, and damage to muscle cells may lead 
to membrane dissemination and result in the release of adenosine, ATP, or both (Black, 
2012). Adenosine receptor antagonists, specifically A1, and A2 receptors, are thought to be 
a crucial element in the nociception in human pain modulations (Sawynok, 1998; Millan, 
1999; Sawynok & Liu, 2003; Sawynok, 2006).  
Previous studies have shown that injection of a dose of ATP into the muscle as a stimulus 
for non-nociceptive and nociceptive muscle group IV receptors in animals (Reinöhl et al., 
2003; Hanna & Kaufman, 2004), produces painful stimuli in humans (Mørk et al., 2003). 
Injection of ATP into human subjects in the trapezius muscle induces pain at rest and 
mechanical hyperalgesia (Mørk et al., 2003), but low dose ATP into the thumb does not 
cause pain (Pollak et al., 2013). A study by Mørk et al. (2003) showed that no muscle 
hyperalgesia occurs despite the use of a much higher concentration of ATP. The 
interpretation for this difference is unclear, and perhaps represents differences in 
metabolism, the muscle injected, or volume of injection.  
 
1.2.5.3 Bradykinin (BKN) 
 One of the most important products of a series of pathophysiological processes and potent 
activator of skeletal muscle nociceptors is Bradykinin (BKN) (Beck & Handwerker, 1974). 
BKN has been long recognised as one of the most potent pro-inflammatory substances 
(Nishimura et al., 2002) and endogenous algesics (Steranka et al., 1988). Its actions have 
been most intensively considered in the periphery (Kozma, Ahmed, Best & Lim, 1995), 
although there is arising evidence that BKN may also play a crucial role within the central 
nervous system (CNS) following tissue damage, inflammation, and infection (Walker, 
Perkins & Dray, 1995). BKN is a polypeptide substance related to a precursor in the plasma 
globulin fraction and a separate system in tissues (e.g. muscular) (Silva, Beraldo & 
Rosenfeld, 1949). It is formed in response plasma extravasation, ischemia and when certain 
factors involved in the clotting system are activated (Webster & Pierce, 1963). Therefore, 
it is formed in response to tissue damage directly and other states common to exercise, 
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such as hypoxia, ischemia and acidification (Black, 2012). Additionally, at the tissue 
damage site, BKN promotes all the features of the acute inflammatory response including 
noxious stimuli and increased blood flow (Walker, Perkins & Dray, 1995). Group III and 
IV nociceptors in skeletal muscle are activated by BKN and injections of BKN into the 
muscle have been shown to be mildly painful (Kaufman et al., 1982; Babenko et al., 1999). 
BKN exerts its action by acting on the bradykinin B2 receptor and activating a G protein 
that regulates intracellular metabolic changes (Bandell et al., 2004). This change leads to 
excitability of free nerve ending in dorsal root ganglia (sensitisation) (Mense & Gerwin, 
2010). BKN also plays a crucial role in sensitising nociceptors in skeletal muscle (Dray & 
Perkins, 1993, Babenko et al., 1999). Excitation of the B1 and B2 receptors alters the 
resulting action potential of nociceptive afferents and can enhance their sensitivity to other 
noxious stimuli, such as serotonin (5-HT) (Hu et al., 2004). In addition, BKN enhances the 
production of prostaglandins, which are crucial inflammatory mediators that also function 
to excite or sensitise nociceptors and prolong and enhance the effect of BKN (Mense, 
1981).  
 
1.2.5.4 Serotonin (5-HT) 
Serotonin (5-HT) is a monoamine neurotransmitter with wide range of functions in the 
nervous system and throughout the body (Tecott et al., 1995). 5-HT is much like BKN, in 
that it activates both III and IV afferent fibres in skeletal muscle (Mense, 1977). Injections 
of 5-HT into the muscle in sufficiently large doses have been shown to result in noxious 
stimuli, whilst in lower doses, serotonin functions to activate nociceptors to BKN, leading 
to a greater noxious stimuli response to a given dose (Babenko et al., 1999). Animal 
experiments have been also found that 5-HT is a direct mediated to muscle pain and a 
hyperalgesic agent (Taiwo YO & Levine, 1992).  
 
1.2.5.5 Substance P (SP) 
SP is an endogenous neuropeptide, that acts as a neurotransmitter and neuromodulator 
(Harrison & Geppetti, 2001; Datar, Srivastava, Coutinho & Govil, 2004), and is found in 
skeletal muscular nociceptive fibres and in neuron of the dorsal root ganglion (Mense, 
Hoheisel & Reinert, 1996). Release of SP is induced by noxious stimulation and induced 
by exercise and inflammation (Lind, Brudin, Lindholm & Edvinsson,  1996).  Several lines 
of evidence indicate that SP and calcitonin gene-related peptide (CGRP), co-localized with 
prostaglandins (PGs), serotonin, bradykinin and nitric oxide (NO), contribute to the 
generation of noxious stimulation and hyperalgesia (McMahon, Lewin & Wall, 1993; 
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Meller & Gebhart, 1994). SP interacts with the neurokinin-1, -2, and -3 receptors, and is 
known to increase the release of other algesic agents, such us histamine and PGE2 (Levine, 
Fields & Basbaum, 1993, O¶Connor & Cook, 1999). In experimental and clinical studies, 
Anand and Bley (2011) indicate that depletion of SP in nociceptive afferent fibres is 
correlated with the substance capsaicin, and has been shown to attenuate the perception of 
pain in response to chemical and mechanical stimuli (Hoheisel et al., 2004).  
 
1.2.5.6 Prostaglandin E2 
Prostaglandin E2 (PGE2) is a cyclooxygenase (COX) product, and is associated with 
inflammatory pain (Kuehl & Egan, 1980; Harvey et al., 2004). Nonsteroidal anti-
inflammatory agents/analgesics (NSAIDs), inhibit COX-1 and/or COX-2, and repress 
inflammatory pain by attenuating prostanoid generation, mainly PGE2, in patients 
suffering from migraine, osteoarthritis, rheumatoid arthritis, and gout (Kawabata, 2011). 
PGE2 exhibits very little action on nociceptors but plays very important role in activating 
or sensitising nociceptors to Bradykinin and other substance stimuli (Mense, 1981). 
NSAIDs, such as ibuprofen and aspirin blunt of the action of the COX-1 enzyme (Vane, 
1978) and thus function to limit inflammation and resulting tissue damage (Black, 2012) 
and consequently pharmacological intervention downstream and upstream signals of PGE2 
may serve as novel strategies for the reduction of pain during exercise (Trappe et al., 2001; 
0RWO2¶&RQQRU	'LVKPDQ3HWHUVRQHWDO0RWOHWDO+XGVRQHWDO
2008; Mauger et al., 2010; Trappe et al., 2011).  
 
1.2.6 Nociception and Pain Processing in the Levels of Spinal Cord and 
Brain: Pathways of Pain Perception 
Following stimulation of peripheral nociceptive fibres in skeletal muscle an electrical 
signal is conveyed through afferent fibres to the spinal cord (SC) (Kumazawa, Mizumura 
& Tadaki, 1981). The SC subsequently conveys the electric signal to the brain, where it is 
perceived as pain. Early theories regarding pain pathways, which date back to Descartes 
(1644), present a widely accepted view of pain that nociceptive fibres convey input signals 
from the periphery to the brain as along simple cables. The early anatomists (e.g. Bell, 
1824) and neurophysiologists (e.g. Muller, 1833; Von Frey, 1896; Sherrington, 1906) 
outlined the classic picture of pain (Descartes, 1644), and provided a framework for how 
pain was relayed to the spinal cord and brain from the periphery. Advances in 
immunohistochemistry, genetics and neuroimaging have allowed scientists to look more 
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closely at the spinal cord and brain to gain an insight into how the stimulation of peripheral 
nociceptive fibres are processed at the level of spinal cord and brain, where it is ultimately 
perceived as painful. These techniques have confirmed that pain perception involves a 
series of complex connections from a peripheral receptor to the spinal cord and brain. 
Ultimately it is an integrative and complex sensation that is processed and modified in 
multiple regions (Melzack & Wall, 1965).    
Input from afferent nociceptive fibres synapse at the dorsal root ganglia (DRG) and the 
dorsal horn, primarily at laminae I and II, but also in laminae V (Mense, 1993). When the 
intensity of the stimulation is sufficiently large enough, it will produce a postsynaptic 
µH[FLWDELOLW\¶RXWSXWWKDWLVFRQYH\HGWRVXSUDVSLQDODUHDVDORQJRQHRIQXPHURXVSURMHFWLRQ
nerve tracts. Within the DRG in the SC, afferent nociceptive fibres and projection neurons 
communicate utilising a host of amino acid and peptide neurotransmitters such as 
glutamate and substance P (Miller, 1999; DeLeo, 2006). They will also possess 
neurotransmitter receptors for endogenous opioids, which play a crucial role in pain 
processing and especially hypoalgesia (Black, 2012).  
Relying on the type of nociceptor sensitised or activated, a stimulus is conveyed along the 
spinal cord to various regions within the brain via contralateral spinothalamic, 
spinohypothalamic, spinomesencephalic, spinorecicular, spinoparabrachial, and dorsal 
column tracts (Millan, 1999). The spinothalamic tract consists of two separate tracts, a 
neospinothalamic (lateral) tract, which projects along the medulla oblongata to the ventral 
posterolateral thalamic nucleus (VPL), and a paleospinothalamic (medial) tract, which 
projects to the reticular formation in the brainstem, the periaqueductal gray (PAG), 
hypothalamus, amygdala, and parts of the thalamus (Millan, 1999). Sending signals from 
Aį fibres may be transmitted through neospinothalamic and result primarily in fast, sharp 
pain, whilst sending signals from C fibres through the paleospinothalamic tract are thought 
to be responsible for dull, aching pain. Through the spinoreticular tract, nociceptive inputs 
transmit signals to the reticular formation and synapse in the nucleus paragigantocellularis 
(nPGi) and medial thalamus, which inputs to the locus coeruleus (Millan, 1999). The 
spinomesencephalic tract travels to the PAG, much more like spinothalamus, and the PAG 
provides inputs limbic system pathways such as anterior cingulate cortex (ACC) and 
amygdala (Black, 2012). 
Understanding of pain-related inputs is not in any way comprehensive, as numerous 
different brain regions have been shown to be stimulated or activated during processing of 
pain. However, this reveals the complex nature of the processing of noxious inputs at the 
spinal cord and supraspinal levels. Activation of the primary and secondary somatosensory 
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cortex via thalamocortical projections can provide information regarding the location and 
intensity of a painful stimulus. Other regions, such as the PAG, ACC, and amygdala, may 
provide information regarding the affective and emotional aspect of pain (Black, 2012).  
 
1.2.7 Theories and Thoughts of Pain Perception 
Numerous theories have been postulated to explain the process of pain perception, yet none 
of these can account for all features of the perception of pain, which demonstrates its 
complexity (Moayedi & Davis, 2013). The four most popular theories of perception of pain 
are the Specificity, Intensity, Pattern, and Gate Control Theories of Pain (Figure 1.7), and 
will be outlined here. 
 
1.2.7.1 The Specificity Theory of Pain 
The specificity theory of pain states each somatosensory modality (touch and pain) is 
separately encoded in pathways (Dubner, Sessle & Storey, 1978; Craig, 2003; Perl, 2007; 
Ma, 2010).Therefore, this theory proposes that pain is processed by a specific neuronal 
pathway (as a unique sensory experience) (see Figure 1.3. 1A). For example, the model 
suggests low threshold mechanoreceptors are encoded in non-noxious mechanical stimuli, 
ZKLFKDUHUHODWHGWRSULPDU\VHQVRU\QHXURQVWKDWSURMHFWWR³PHFKDQRUHFHSWLYH´VHFRQGDU\
sensors in the spinal cord or brain. A higher threshold mechanoreceptive sensor is projected 
to secondary neurons in the brain regions (Moayedi & Davis, 2013), which would be 
VWLPXODWHGE\DQRFLFHSWRUWKURXJKQR[LRXVVWLPXOLZKLFKZRXOGSURMHFWWRKLJKHU³SDLQ´
centres in the brain. Whilst specificity theory was perhaps the most dominant explanation 
of pain perceSWLRQLQWKHPLG¶VLWVSRSXODULW\UHGXFHGIROORZLQJWKHSRVWXODWLRQRI
Gate Control Theory in 1965 (Melzack & Wall, 1965). 
 
1.2.7.2 Intensity Theory of Pain 
Intensity Theory of Pain conceptualises that pain is not truly a unique sensory experience, 
but defines pain as an emotional experience when a stimulus sufficiently stronger than 
usual occurs (Plato, 1998). In 1859, Naunyn showed that a sub-threshold stimuli for sense 
of touch induced pain in individual patients with syphilis who had disintegrating dorsal 
columns [cited in Dallenbach (1939)]. They described this as unbearable pain when this 
stimulus was reproduced 60-600 times. Arthur Goldscheider further advanced the Intensity 
Theory, when he proposed a neurophysiological model to describe this framework (see 
Figure 1.3. 1B) (Moayedi & Davis, 2013) which suggested that the increase in sensory 
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afferent processing would produce a summation effect. Intensity theory originally 
competed with specificity theory, but lost support when specialist fibres (later coined 
nociceptors) for sensing pain were identified.  
 
1.2.7.3 Pattern Theory of Pain 
7KLVWKHRU\LJQRUHVILQGLQJVRIVSHFLDOLVHGQHUYHHQGLQJV³UHFHSWRUV´WKDWSURGXFHSDLQ
and instead suggests that a specific combination of stimuli and a particular pattern of neural 
firing elicits a given pain perception (Nafe, 1929) (see Figure 1.3. 1C). Goldschneider 
(1920) suggested that there were no specific receptors for pain or separate system for 
perceiving pain, and instead sensory receptor nerves respond to damaging stimuli and other 
non-damaging stimuli such as touch lead to painful or non-painful experiences as a factor 
of outcome of variances in the patterns of the signals transmitted through the central 
nervous system [cited in Moayedi & Davis, 2013]. 
 
1.2.7.4  Gate Control Theory of Pain 
In 1965, the Gate Control Theory of Pain was proposed by Melzack and Wall and provided 
a model that could support the apparently divergent concepts of the Specificity and Pattern 
Theories (see Figure 1.3. 1D). The model suggests that signals projected by primary 
afferent fibres from stimulus of the cutaneous tissue are conveyed to three regions within 
spinal cord: the dorsal column, the substantia gelatinosa and a group of cells termed 
transmission cells (T) cells. Melzack and Wall SURSRVHGWKDWWKHµJDWH¶LVWKHVXEVWDQWLD
gelatinosa, which modulates sensory information transmission from the primary afferent 
fibres to the central (T) cells. This gating mechanism in the dorsal horn modulates the T-
cell and influences the activity in large-diameter (A-delta nerve fibre) and small-diameter 
(C-fibres) fibres. Large-fibre activity tends to inhibit transmission (or closes the gate) 
whilst small-fibre activity tends to facilitate transmission (or opens the gate). Activity from 
descending tract fibres that initiate in supra-spinal regions and project to the dorsal horn 
coulGDOVRPRGXODWHWKLVJDWH2QFHQRFLFHSWLYHLQIRUPDWLRQUHDFKHVDFULWLFDO³WKUHVKROG´
WKDWVXUSDVVHVWKHLQKLELWLRQSURYRNHGLW³RSHQVWKHJDWH´DQGDFWLYDWHVSDWKZD\VWKDWOHDG






1.2.8 Pain Modulation and Mechanisms 
The localisation of allodynia and hyperalgesia at the muscle during exercise illustrated how 
the spinal cord (SC) and brain can exert a modulatory effect on how inputs from peripheral 
nociceptors are perceived (Mehler, 1962). In addition to receiving nociceptive input from 
ascending peripheral sites, nociceptive projection neurons in the dorsal horn (DH) in the 
SC receive nociceptive inputs from a host descending brain regions that play a crucial 
element in the modulation of pain (Suzuki, Rygh & Dickenson, 2004). This complex neural 
network of connections allows for the combination of signals from multiple tissues and 
can exert both inhibitory and excitatory effects on the signal of nociceptors and modulate 
perceptions of a noxious stimulus (Black, 2012).  
The original proposals in Melzack and Wall's µJDWH-FRQWUROWKHRU\RISDLQ¶ suggests that 
non-nociceptive input from afferent fibres activate interneurons at the SC level which 
inhibit the nociceptive projection neurons activity, thus blunting the nociceptive input from 
the peripheral tissues. This theoretical framework helped elucidate a variety of complex 
phenomena, such as why a balm that irritates the skin around a painful bruise or cut may 
provide temporary pain relief, and why thoughts and emotions influence pain perception 
(see Figure 1.8). The periaqueductal gray (PAG) is well-known to control nociceptive 
inputs and perception of pain through its interactions with both ascending and descending 
projections from numerous sites (Ossipov, Morimura & Porreca, 2014). Stimulation of the 
PAG has also been shown to result in analgesia without affecting attention, alertness, or 
motor control in response to non-nociceptive stimuli (Mayer & Price, 1976). The PAG 
integrates ascending nociceptive stimuli with descending nociceptive inputs from 
hypothalamus, amygdala, insula, and ACC (Brooks & Tracey, 2005). Between the PAG 
and the rostral ventromedial medulla (RVM), bidirectional connections also exist (Brooks 
& TracH\DQGIRUPZKDWLVWHUPHGµ3$*-390V\VWHP¶(OHFWULFDOVWLPXODWLRQRI
RVM or the PAG amygdala produces analgesia (Hosobuchi, Adams & Linchitz, 1977; 
2¶&RQQHU	&RRNDQGVRPHDQDOJHVLFVZRUNYLDQHUYHVLJQDOVIURPWKH590WR
the SC via the RVM. The RVM is a principal source of serotonin release, and serotonin 
has been shown to cause inhibition of nociceptive neurons in the DH (Jordan et al., 1978). 
In addition, the RVM has neurons that synapse on nociceptive projections of nerves in the 
spinothalamic tract and may attenuate nociceptive inputs by inhibiting excitatory 
interneurons or activating inhibitory interneurons. The PAG-PVM system and amygdala 
also contain high concentrations of receptors for endogenous opioids and exogenous 
opiates (Yaksh, Yeung & Rudy,  1976; Fields, Bry, Hentall & Zorman, 1983; Rossi et al., 
1994; Waters & Lumb, 1997; Heinricher, Tavares, Leith & Lumb, 1999). Consequently, 
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systemic administration of exogenous opiates in the PAG has been shown to induce 
analgesia (Fields, 2004) and endogenous opioids such as enkephalins, endomorphins, and 
beta-endorphins are likely to play a crucial element in pain modulation in the SC as well 
as the brain and afferent nociceptive fibres in the periphery (Stratton, 1982; Straneva, 
2002). During exercise, levels of endogenous opioids have been shown to increase, 
particularly in response to high intensity exercise (Goldfarb & Jamurtas, 1997), leading to 
the suggestion that endogenous opioids may play a role in exercise-induced analgesia 
(Janal, Colt, Clark & Glusman, 1984; Pertovaara, Huopaniemi, Virtanen & Johansson, 
1984). 
To summarise, the perception of pain starts with the sensitisation of peripheral nociceptors, 
central nociceptors, or both. Muscular nociceptors generally exist in and around the small 
arterioles, arteries and veins, and connective tissue found in skeletal muscular tissues. 
These nociceptive signals are conveyed to the DH of the SC through type III or IV afferent 
nerve fibres and respond to a host of noxious biochemicals, mechanical pressure, and 
thermal stimuli. Nociceptive signals are subsequently conveyed to the brain along several 
tracts where multiple regions are involved in its processing, including the thalamus, 
hypothalamus, reticular formation, PAG, ACC, and amygdala. Pain sensations may be 
modulated in these regions by endogenous and exogenous substances (e.g., opioids and 
other analgesic drugs) as well as by neural input from other tissue (e.g., afferent input from 
tissue deformation associated with muscular contractions). Thus, the perception of pain 
represents the end product of a complex and integrative sensation of both inhibitory and 
excitatory signals in which processing can occur in both ascending and descending 
pathways. 
In addition to physiological pain modulation, a number of studies have found that 
psychological manipulations are also capable of modulating pain perception by acting on 
processes within the nervous system, brain and spinal nociception (Fields, 1999, Rhudy et 
al., 2013). It has now been shown that a number of variables (including: emotional context, 
attentional state, empathy, attitudes and expectations, hypnotic suggestions, and the 
placebo response) can alter both pain processing in the brain and pain perception (Turner, 
Loeser, Deyo & Sanders, 1994; Rainville et al., 1999; Price, 2000; Villemure & Bushnell, 
2002; Linde et al., 2007). Several clinical and experimental studies demonstrate that 
individuals report significantly lower pain intensity when they are distracted from the 
noxious stimulation (Villemure & Bushnell, 2002; Apkarian, Bushnell, Treede & Zubieta, 
2005; Loggia, Mogil & Bushnell, 2008). At the cerebral cortex level, neuroimaging studies 
indicate that distraction from pain decreases noxious stimulus responses in both sensory 
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(including primary and secondary somatosensory cortices) and limbic cortical regions 
(including anterior cingulate cortex and insular cortex) (Apkarian et al., 2005). In 
experimental studies, mood and emotional state also alter pain perception, with a positive 
effect of mood or emotions following presentation of pleasant images, music, relaxing 
odours and humorous films, normally decreasing the perception of pain, whist negative 
mood or emotions, induced by unpleasant images increases the perception of pain (Price, 
2000; Villemure & Bushnell, 2002). It has also been shown that placebo analgesia is 
associated with reduced activity of certain regions of the brain, including anterior cingulate 
cortex, the thalamus and insula. Increased activity of brain regions associated with pain 
also occurs when there is an anticipation of pain, leading to an increased pain perception 
(Wager et al., 2004). In summary, variables such as mood, emotion, distraction and 
deception can alter pain perception irrespective of the size of the nociceptive stimulus. This 
helps demonstrate that pain is subjective and that there is an emotional element to pain. 
 
1.2.9 Assessment of Pain  
Pain perception is a complex, multifaceted experience that is subjective and relative to the 
individual. Therefore, the evaluation of pain perception is a challenge when it comes to 
KRZWRDVVHVVLW:KLOVWLWKDVEHHQVXJJHVWHGWKDWWKHUHLVQRVLQJOHµEHVW¶DVVHVVPHQWRI
SDLQGXULQJDQGIROORZLQJH[HUFLVH2¶&RQQRU	&RRNWKHUHDUHVHYHUDOFRPPRQO\
used methods for assessment of pain that have been shown to provide accurate, reliable, 
and valid information regarding certain dimensions of pain. These methods include 
subjective measures of pain or magnitude and objective measures of pain tolerance and 
pain threshold.  
 
1.2.9.1 Pain Threshold 
Pain threshold is defined as the minimum stimulus input required to be perceived as 
µSDLQIXO¶3UHVVXUH WKHUPDODQGHOHFWULFDOVWLPXOLDUHJHQHUDOO\XVHGWRLQYHVWLJDWHSDLQ
thresholds (Melchers & Andersson, 1973; Jensen, Karoly & Braver, 1986; Hargreaves et 
al., 1988; Droste et al., 1991). In an experimental trial, the intensity of noxious stimuli is 
GHFUHDVHGRULQFUHDVHGLQDVWHSZLVHLQFUHPHQWDOPDQQHU'XULQJ³GHVFHQGLQJ´WULDOVWKH
stimulus is initially set above the pain threshold and then gradually lowered until the 
stimulus LV QR ORQJHU SHUFHLYHG DV D SDLQIXO DQG GXULQJ ³DVFHQGLQJ´ WULDOV QR[LRXV
intensities below pain threshold are initially applied and then intensity is gradually 
increased until the stimulus is perceived as a painful (Black, 2012). This procedure has its 
roots in signal detection theory and scaling methods, and readers are referred to Gracely 
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and his colleagues (Gracely, Lota, Walter & Dubner, 1988; Gracely & Kwilosz, 1988) as 
well as Wall and Melzack (1999) for further complete explanations of the methodology 
underlining these techniques.  
In exercise-related research, the most common method used for determining the pain 
threshold is the use of manually applied pressure or force to numerous points on the muscle 
or another anatomical structure (e.g., finger) (Black, 2012). Delayed-onset muscle soreness 
has repetitively shown to lower the pain pressure threshold (Baker et al., 1997; Dannecker, 
Hausenblas, Kaminski & Robinson, 2005; 0DULGDNLV 2¶&Rnnor, Dudley & McCully, 
2007; Hedayatpour, Falla, Arendt-Nielsen & Farina, 2008). Whilst intra-individual and 
inter-individual differences can exist in threshold measures, the measurements can provide 
meaningful information regarding the peripheral and central sensation during and 
following exercise, and they can also be useful in determining the influences of various 
analgesic interventions (Black, 2012).  
 
1.2.9.2        Pain T ROHUDQFH  
Pain tolerance represents the maximal level (greatest) of noxious stimuli an individual is 
DEOHWRWROHUDWH2¶&RQQRU& Cook, 1999). Perhaps it is difficult and unethical to acquire 
a true assessment of pain tolerance in human subjects, as application of the largest noxious 
stimuli could result in substantial tissue damage (Black, 2012)$VVHVVPHQWRIDWUXHµSDLQ
WROHUDQFH¶FRXOGEHPHDVXUHGE\DSSOLFDWLRQRIDKRWFROGDQGHOHFWULFDOVWLPXOLDVZHOODV
application of mechanical pressure (2¶&Rnnor & Cook, 1999; Black, 2012). However, 
given the potential for tissue damage, applications more often involve examining the length 
of time an individual can or will tolerate a noxious stimulus, such as submersion of the 
hand in ice water (e.g., cold pressor test) and application of a mechanical stimulus (e.g., 
algometer). Measuring pain tolerance with this technique often imposes maximum 
exposure to the noxious stimulus, thus setting a maximum amount the possible length of 
tolerance time (O¶Connor & Cook, 1999). Pain tolerance is perhaps more relevant to 
endurance performance than pain threshold, as most endurance exercise occurs above the 
intensity at which pain threshold occurs. Therefore, the duration of pain, or level of pain, 
that someone is willing to engage in is the key aspect.  
 
1.2.9.3  Pain Intensity Ratings 
Subjective measures of  pain intensity can be assessed for any noxious stimulus that 
H[FHHGV DQ LQGLYLGXDO¶V SDLQ WKUHVKROG 0XOWLSOH TXHVWLRQQDLUHV DQG VFDOHV KDYH EHHQ
developed to assist in the quantification of pain intensity. Tools such as the Visual Analog 
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(VA) scales, Category Ratio (CR) scales, and magnitude estimation, at the level of groups 
and at the level of individuals are commonly used. VA scales comprise a line (typically 
50-PPLQOHQJWKZLWKYHUEDOSUHVHQWHUV³ZRUVWSDLQLPDJLQDEOH´DWWKHULJKWHQGDQG
³QR SDLQ´DWWKHOHIWHQG,QGLYLGXDOVDUHLQVWUXFWHGWRSRLQWDYHUWLFDOPDUNRQWKHOLQHVR
that the distance from the left edge anchors the pain being experienced in a given part of 
the body at that moment, as shown in Figure 1.9a. The distance in millimetres (mm) from 
the left edge of the line to the mark is used as the pain score. The VA scale is most popular 
in both research and clinical settings because of its ability to obtain a rapid rating and ease 
of use. VA scales possess inherent ratio properties, provide valid  and reliable assessment 
of intensity of pain (Revill, Robinson, Rosen & Hogg, 1976; Jensen et al., 1986; Cook et 
al., 1997), and have been shown to be sensitive to interventions that provide analgesia. 
Numerical or category ratio (CR) scales are also commonly used, especially to assess 
LQWHQVLW\RISDLQGXULQJWKHG\QDPLFH[HUFLVHSHUIRUPDQFH2¶&RQQRU& Cook, 1999). In 
study by Cook et al. (1997), a CR scale was established by combining the verbal presenters 
from the perception of pain profile (Tursky, Jamner & Friedman, 1982) with structures of 
the easily administered 0 - 10 CR Borg scale (Borg, 1990). The 0 - 10 CR pain intensity 
VFDOH LV³QXPEHUHG - 10. The verbal anchors and numerical vales for the scale are as 
follows; 0 no pain at all, ½ very faint pain, 1 weak pain, 2 mild pain, 3 moderate pain, 4 
somewhat strong pain, 5 strong pain, 7 very strong pain, 10 extremely intense pain (almost 
XQEHDUDEOH´&RRNHWDO7KHFDWHJRU\UDWLRVFDOHVDUHVKRZQLQ)LJXUH 1.9b. The 
administration of the category ratio (CR) scale in assessing pain, like the VA scales, have 
been shown to be both reliable and valid tools in assessing intensity of pain and values of 
peak pain during intense exercise (Cook et al., 1997).Despite the efficiency for assessing 
the intensity of pain, the nature of the numerical scales may introduce some bias. Because 
of their fixed-end-point these scales elicit difficulties for measuring the effect of treatment 
on pain conditions. An individual who rates the intensity of pain during exercise as higher 
than the plausible category scales will not be capable of providing the higher rating of pain 
during a subsequent condition, even when individual experiences greater intensity of pain. 
To resolve this issue, when it is necessary, the 0-10 CR scale allows individuals to choose 
a number above 10 and thus overcomes the fixed-end-point problem associated with 
typical category ratio scales. This scale has been shown to perform in a similar manner to 
VA ratio scales (Cook et al., 1997). 
 Generally, a limitation of the use of single VA, numerical, or category scales in the 
measurement of pain intensity is that these scales observe pain as a unidimensional 
experience missing qualities besides intensity. The experience of pain clearly involves 
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other dimensions, such as emotional and unpleasantness. Assessment tools beyond VA and 




1.2.9.4   Multidimensional Assessment of Pain 
In addition to intensity, assessing pain has an affective component (Singer et al., 2004). 
Intensity is measured via a sensory dimension (Duncan, Bushnell & Lavigne, 1989), whilst 
the affective dimension can provide information regarding the quality and location (e.g., 
aching, dull, sharp) of the pain regarding how unpleasant or bothersome the experienced 
pain may be (Price, 2000). Individual rating of both the affective and sensory dimensions 
can be acquired to provide a much more complete measurement of the pain an individual 
is experiencing (Price, 2002). Scales of the affective dimension have not been extensively 
used when evaluating pain perception during and following exercise, but the scales of this 
type could provide more detailed information about the efficiency of various treatments 
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for pain conditions. For instance, a pharmacological treatment with, for example ibuprofen, 
could attenuate the intensity of delayed-onset soreness but might not attenuate it sufficient 
to reduce how unpleasant or bothersome of pain was during a particular moment. Another 
instrument that has been established to measure pain in a multidimensional manner is the 
McGill Pain Questionnaire (MPQ) (Melzack, 1975). The MPQ is a multidimensional 
measure that has the ability to describe the diverse pain dimensions. It classifies pain into 
three unique dimensions: affective, evaluative, and sensory. It provides valuable 
information on the sensory and affective quality of pain experience as well as pain intensity 
and location, and is able to discriminate between various pain problems (Reading, 1984). 
The MPQ has been shown to be both valid and reliable (Reading, 1982; Wilkie et al., 
1990). The MPQ is commonly used in clinical and research tools and can provide useful 
information regarding the nature of the experience of pain during exercise (Black, 2012). 
However, obtaining repeated reporting on the MPQ during exercise can be difficult, 
because it requires participants complete multiple components and therefore requires 
significant attention over a prolonged period, which may not be practical during exercise.  
 
1.3 Pain: Psychological Perspectives 
The basis for categorising pain as a psychological phenomenon is provided by the 
distinction between pain and nociception (Baum, 1997). Nociception indicates the 
processing of neurophysiological events that activate nociceptors, which are then 
experienced as pain (Turk & Melzack, 2000). Initiation of the brain processing and 
nociceptive pathways contribute to the experience and awareness of the biological 
substrates, and in turn this suggests that pain should be described as psychological 
phenomenon (Hadjistavropoulos & Craig, 2004).  Motivational and emotional aspects are 
central to understanding the nature of pain (Price, 2000), and these are particularly 
important constructs in exercise too.  
 
1.3.1 The Influence of Emotion, Attention and Mood on Pain 
Mood, emotion and attentional state are probably the most significant psychological 
factors believed to influence pain modulation (Villemure & Bushnell, 2002). The 
hypothesis of motivational priming (Lang, 1995) suggests that a negatively or positively 
valence stimulus activates the defensive or the appetitive part of motivational system (MS) 
so that a new stimulus-response is increased if its valence is compatible with stimulated 
part of MS and diminished if it is incompatible (Kenntner-Mabiala et al., 2007). The 
International Affective Picture System (IAPS) provides a standardised set of images 
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stimuli, which systematically vary on the dimensions of valence and arousal and can be a 
useful methodological tool for affect induction (Lang, Bradley & Cuthbert, 1995). Indeed, 
much of the research supporting the psychological components of pain has used the IAPS 
to induce changes in mood. Kenntner-Mabiala and Pauli (2005) used the IAPS to assess 
pain response to electrical stimulation following the presentation of positive, neutral, and 
negative images.  They found that positive images were shown to associate with lower pain 
and lower N150 amplitudes recorded compared to negative images stimuli. This 
demonstrates that a psychological intervention, unrelated to the nociceptive stimuli, was 
capable of eliciting both a neurophysiological and perceptual change. Further evidence in 
support of motivational priming is provided by studies using the cold pressor test (CPT), 
where observing positive images compered to negative images caused an increase in pain 
threshold (Meagher, Arnau, & Rhudy, 2001) and in tolerance of pain (Meagher, Arnau, & 
Rhudy, 2001). Therefore, the observation that emotional image valence can modulate pain 
PD\EHXVHIXOWRROWRH[SORUHWKHQDWXUHRIµH[HUFLVH-LQGXFHGSDLQ¶(,3 
In addition to the effect of emotion on pain, attention is perhaps the most considered 
variable that influences pain and nociception (Villemure & Bushnell, 2002). Focusing an 
LQGLYLGXDOV¶ DWWHQWLRQRQ WKHSDLQ VWLPXOXVKDV JHQHUDOO\EHHQ VKRZQ WR H[DFHUEDWH WKH
perception of pain (Levine, Gordon, Smith & Fields, 1982), whereas distributing attention 
from pain stimulation decreases the perception of pain (Miltner, Johnson, Braun & Larbig, 
1989; Lautenbacher et al., 1998; Miron, Duncan & Bushnell, 1989). However, there is also 
evidence that the influence of attention on pain is based on whether the individual focuses 
on the affective or the sensory aspects of pain. Ahles et al. (1983) instructed individuals to 
attempt to express emotions or to focus on the sensory aspects of pain during the CPT task. 
The investigators observed that focusing attention on the sensory aspects, in comparison 
to affective aspects, was related to less distress. Moreover, focusing attention on emotional 
pain sensations results in more pain reports than when focussed on the sensory aspects 
during cold pressor test (Bishop, 1999).  
Mood state may also alter pain perception, as it is associated with motivation and 
performance. In experimental studies, enhancing mood by observing pleasant stimuli such 
as humorous films or music commonly decreases perception of pain (Cogan, Cogan, Waltz 
& McCue, 1987; Zelman, Howland, Nichols & Cleeland, 1991; Good, 1996; Weisenberg, 
Raz & Hener, 1998; de Wied & Verbaten, 2001; Meagher et al., 2001; Marchand & 
Arsenault, 2002). Contrariwise, decreased mood increases perception of pain (Zelman et 
al., 1991; Weisenberg et al., 1998; de Wied & Verbaten, 2001; Meagher et al., 2001). 
However, the interpretation of these studies is difficult, as they may not be able to control 
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the effect of focusing attention, a factor known to alter nociceptive transmission in spinal 
cord and affect the experience of pain (Villemure & Bushnell, 2002). Indeed, the pain 
modulation arising from mood changes be a result from the variation in attention, as an 
emotional response can be directly caused by level of attention (Öhman, Flykt & Esteves, 
2001).  
 
1.4 Exercise Induced Pain (EIP) 
Pain is a relatively common experience for people who exercise, and is often associated 
ZLWK WKH µEXUQLQJ¶ VHQVDWLRQ LQPXVFOHVRU WKHGXOO DFKHRIPXVFOH VRUHQHVVRU FUDPSV
(Friden, Sjöström & Ekblom, 1983; Schwane, Watrous, Johnson & Armstrong, 1983; 
Jones, Newham, Round & Tolfree, 1986; Newham, 1987; Clarkson & Sayers, 1992; Miles 
& Clarkson, 1994; Cook et al., 1997). Pain emanating from the muscle contractions during 
exercise is very common, and athletes can easily distinguish the sensation of dull ache of 
muscle soreness from that of exertion (Armstrong, 1984; Clarkson & Tremblay, 1988; 
&ODUNVRQ	+XEDO3DLQRIWKLVNLQGLVWHUPHGµH[HUFLVH-LQGXFHGSDLQ¶(,3DQG
has been shown to increase in-line with exercise intensity, expressed as either a percentage 
of peak oxygen consumption or peak power output during cycling exercise (Cook et al., 
1997). Following exercise cessation, muscular pain does not immediately cease, rather, it 
appears to decrease in an exponential manner over several minutes (Black, 2012). This 
decrease very closely imitates the decrease in oxygen consumption and rating perceived 
exertion (RPE) (Cook et al., 1997). Pain perception during high-intensity cycling 
performance has been described as intense, sharp, exhausting, burning, pulling, tiring, 
rasping, and cramping (Miles & Clarkson, 1994), and it appears likely that other types of 
aerobic exercise performance would elicit similar pain perception (Cook et al., 1997). This 
naturally occurring pain that is the consequence of intense and prolonged exercise has been 
shown to elicit a reproducible pain threshold of nearly 50% of peak oxygen consumption 
or peak power output, suggesting that high-force muscle contractions or high-intensity 
exercise are not necessary to provoke muscular pain (Weiser et al., 1973; Cook et al., 
1997). Muscular pain can be provoked during very short bouts of exercise, as brief as 8-
seconds (Cook et al., 1997), but tends to be likely more distinct during longer bouts of  
exercise (Black, 2012).  
 
1.4.1   The Aetiology of Exercise Induced Pain 
The experience of muscle pain tends to elicit large inter-subject variability with similar 
modes, relative exercise durations, and exercise intensities. This raises the question of what 
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nociceptive mechanisms are underlying or responsible for EIP. The exact mechanisms of 
muscle pain resulting from intense and prolonged exercise are still not yet known. 
However, the aetiology of EIP suggests that it may arise from either (or a combination of) 
accumulation of noxious biochemical, increased intramuscular pressure, or deformation of 
tissue due to muscular contractions (Mauger, 2014). Exercise, especially high-intensity 
exercise, leads to a build-up of metabolic by-products such as those discussed in Section 
2.4, which stimulate and sensitise type III and IV afferent nociceptive fibres (Mense, 
2009). However, muscular pain is generally related with work rate conditions where low-
force, repetitive, tonic muscular contractions are performed (Mense, 2009). The low-force 
PXVFXODUFRQWUDFWLRQVPD\JHQHUDWHHQRXJKIRUFHWRRYHUFRPHµV\VWROLFEORRGSUHVVXUH¶
and result in occlusion of the blood vessels that carry oxygen-rich blood to the working 
muscular and remove venous blood containing metabolic by-products such as lactic acid 
and other noxious biochemicals (Black, 2012). During exercise, some of those other 
noxious biochemicals may play a crucial element in the experience of pain (Cook et al., 
1997). Intense exercise has been shown to increase the release of histamine, potassium, 
and prostaglandin E2 (PGE2) (Rotto, Hill, Schultz, & Kaufman, 1990), and has also been 
shown to increase interstitial fluid or tissue fluid level of BKN and adenosine in skeletal 
muscular (Langberg et al., 2002). Increased serotonin levels in the brain have also been 
associated with exercise (Caperuto et al., 2009), and exercise has been shown to increase 
the level of substance P concentrations in the ventral horn of the spinal cord (Wilson et al., 
1993; Lind et al., 1996). Whilst none of these findings provides direct evidence for whether 
accumulation of these noxious biochemicals underpins the naturally occurring muscle pain 
experienced during exercise performance, at least they demonstrate a conceivable 
association. Additionally, the findings that EIP increases with longer durations of exercise 
and does not decrease immediately following exercise propose that muscular pain may 
build-up as accumulation of noxious biochemicals and drop as the biochemical levels are 
gradually removed during recovery (Cook et al., 1997). In short duration exercise that is 
of high intensity (e.g. HITT), there is likely a significant accumulation of these metabolites 
over a short period of time, and such exercise has been shown to cause significant amounts 
of pain (Foster et al., 2014). It may be that because this exercise is of shorter duration, a 
greater amount of pain is able to be tolerated by the athlete. Conversely, in moderate 
duration exercise, these noxious biochemicals still accumulate but at a slower rate and so 
cause a smaller level of pain but for a longer duration (Mauger et al., 2010). Because 
exercise of this sort goes on for longer, it is likely that only a lower magnitude of pain can 
be tolerated. However, in both this short and moderate duration exercise, interventions 
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which serve to reduce pain appear to improve performance (Foster et al., 2014; Mauger et 
al., 2010). In very long duration exercise (i.e. that takes place below the gas exchange 
threshold), it is likely that a minimal level of noxious metabolites will accumulate, and so 
the mechanism of EIP is less clear here. However, some evidence exists suggesting that 
noxious biochemicals are not solely responsible for naturally occurring EIP. For instance, 
administration of aspirin was not found to reduce EIP, which would reduce PGE2 levels 
during cycling exercise (Cook et al., 1997). Furthermore, exercise induced muscle leg pain 
has been shown to occur after only 8-seconds of cycling, which would potentially limit the 
biochemicals accumulated (Cook et al., 1997). These results propose that such 
accumulation is not a requirement for eliciting EIP. Another possible mechanism for EIP 
is increased intramuscular pressure associated with muscular contractions and force 
production. If force levels are sufficiently high, the rise in intramuscular pressure and the 
mechanical deformation of muscle could be enough to stimulate the HTM nociceptive 
afferent fibres (Black, 2012). Mechanically, stimulation of HTM muscle receptors by high-
force muscular contractions could be responsible for the experienced of pain during high-
intensity, short term exercise (Mense & Gerwin, 2010). These mechanisms, alongside a 
likely higher level of muscle damage, may provide the basis of EIP during longer duration 
exercise.   
 
1.4.2    Use of Exercise Induced Pain for Regulating Exercise 
Performance 
Exercise induced pain may play a key role in the maintenance of exercise intensity and 
consequently important for athletic performance (O'Connor & Cook, 2001; Bantick et al., 
2002; Eccleston & Crombez, 1999; Davis et al., 1997). A review of pain perception during 
exercise by Mauger (2013) suggested that muscular pain is a crucial factor in the work-
rate regulation (Mauger, 2013). This indicates that the different perceptions of pain that 
present among certain types of exercise should be studied further. Because understanding 
of the nociceptive mechanisms underpinning EIP may be a relatively limited, as a better 
understanding of the mechanisms and assessments of muscular pain that underpin EIP may 
lead to the development of more effective methods to improve endurance performance.  
While many bouts of exercise, especially moderate-high-intensity exercise, result in a 
noxious environment in the exercising muscles, certain components of pain, such as pain 
threshold, are altered during exercise. Numerous studies have shown a reduced pain 
response to noxious electrical stimuli of the arm (Feine et al., 1990), finger (Droste et al., 
1991), and dental pulp (Pertovaara, Huopaniemi, Virtanen & Johansson, 1984; 
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Kemppainen et al., 1985, 1986; Paddon-Jones & Abernethy, 2001) during exercise and 
that this attenuated sensitivity may occur in a dose-dependent manner with exercise 
intensity (i.e., greater stimulation is required to induce pain at higher exercise intensities). 
Furthermore, Kosek and Ekholm (1995) demonstrate the threshold of mechanical pressure 
required to induce muscular pain is reduced during isometric and static contractions. 
Several studies have demonstrated increases in pain threshold to heat, compression 
ischemia, mechanical pressure, and electrical stimulation of the dental pulp subsequent to 
exercise (Koltyn, 2000). The analgesic effects of exercise occur more often after high-
intensity exercise, are most commonly pronounced immediately succeeding exercise, after 
gradually dispersing with time (Koltyn, 2000, 2002). While the physiological mechanisms 
of the analgesic effects observed during exercise are not fully understood, numerous 
illuminations have been suggested. Exercise, especially vigorous and strenuous exercise 
(> 60% of VO2peak) lasting longer than 30-min, is known to result in the release of endogens 
opioids such as beta-endorphins, that could function to moderate pain intensity at a 
peripheral level and in central nervous system. Administration of opioids such as naloxone 
have yielded mixed results, some studies eliciting blunting or preventing of analgesia 
during exercise (Haier et al., 1981; Janal et al., 1984; Droste et al., ) and other finding 
no such effect (Janal et al., 1984; Olausson et al., 1986; Droste et al., 1991). These 
outcomes indicate that both non-opioid and opioid mechanisms may play a role exercise-
induced analgesia. A second possible explanation could be provided by Melzack and 
:DOO¶V  µJDWH-FRQWURO WKHRU\¶ZLWh the noxious stimuli (small fibres input) being 
blocked by other non-nociceptive input during exercise. When there is much more activity 
of large afferent fibres (non-nociceptors) in comparison to the activity of small afferent 
fibres (nociceptors), the gate blocks some level of the pain signals that pass through to the 
brain so that individuals tend to perceive less pain. Another possible mechanism could be 
that the distraction of exercise focuses attention away from noxious stimuli and can lead 
to exercise-induced analgesia (McCaul & Malott, 1984; Fillingim, Roth & Haley, 1989). 
The increase in heart rate and respiration has also been suggested to cause increases in pain 
threshold by drawing perceptual attention away from noxious stimuli (Fuller & Robison, 
1993). The key point to take from this, is that assessment of pain during exercise is 
complex, and methods of experimentally induced pain (e.g. algometry) do not necessarily 





1.4.3 Use of Exercise Induced Pain Tolerance for limiting Exercise 
Performance  
The concept that natural muscle pain limits exercise or athletic performance is fascinating 
but experimentally unclear and puzzling. It appears, perhaps, that exercising with intense 
pain could lessen motivation to exercise, leading an individual to reduce exercise intensity 
to reduce pain or prevent further increases in pain intensity. It has been suggested that pain 
sets ultimate limits on the performance of athletes during training and competition and 
consequently athletes with the greatest (largest) pain tolerances could perform at a higher 
percentage of their maximal capabilities and outperform athletes with lower pain 
WROHUDQFHV2¶&RQQRU	&RRN'HVSLWHWKHVHEHOLHIVUHODWLYHO\IHZVWXGLHVKDYH
attempted to explain the role of pain in exercise and performance.  
The majority of studies investigating exercise performance neglect to report pain 
perception during exercise, and this is despite the fact that EIP is a well-documented 
phenomenon. Cook et al. (1997) demonstrated an intensity of pain threshold for quadriceps 
muscle group during cycling performance of nearly 50% of VO2peak, and pain increased 
with exercise intensity until participants reached exhaustion. Although this study does not 
necessarily show that it was the lack of tolerance to the EIP that caused the cyclists to stop 
(for this was not the intention of the study), it does show a clear association between 
exercise intensity and pain perception. It is logical therefore, that athletes must be able to 
tolerate a lot of pain in order to maintain high work rates which are needed for a good 
exercise performance. However, many participants indicated that even though they 
experienced very strong muscle pain during the cycling task, muscular pain did not play a 
role in their exercise cessation. There is experimental evidence that proposes that 
competitive athletes may be considerably tolerant to some forms of pain than non-
competitive athletes, and that the stage of the season may dictate the level of painful 
training engaged in and consequently affect the perception of pain (Scott & Gijsbers, 
1981). A study by Anshel and Russell (1994) speculated that the capacity of an athlete to 
tolerate EIP is an important aspect in endurance exercise performance, and there is 
agreement between coaches, athletes and some researchers that EIP tolerance can limit 
different tySHV RI H[HUFLVH SHUIRUPDQFH 2¶&RQQRU  Cook et al., 1997; Kress & 





1.4.4   Manipulation of Exercise Induced Pain within Exercise 
Performance 
In experimental studies, the manipulation of EIP could also yield insight into its role in 
exercise performance. Ingestion of caffeine has been consistently shown to enhance 
exercise performance in the form of both increased work completed in a fixed period of 
time and increased exercise time to exhaustion (for example; Keisler & Armsey, 2006; 
Ganio et al., 2009). In addition, multiple studies have demonstrated reduced EIP following 
FDIIHLQHFRQVXPSWLRQ0ROWHWDO2¶&RQQRUHWDO0ROWHWDO*OLRWWRQL
& Molt, 2008; Gliottoni et al., 2009; Gonglach et al., 2015). A study by Jenkins et al. 
(2008) investigated the time trial performance (TT) in trained cyclists who were 
administrated a placebo or multiple low doses of caffeine and also measured EIP during 
the TT. The study found that EIP did not differ between the placebo and caffeine 
conditions, but that TT performance increased with caffeine. While these findings agree 
with those of Cook et al. (1997) that muscular pain may not be a primary limiting factor in 
exercise performance, a second elucidation may actually support a role for pain in 
determining exercise performance. Similar findings in a study by Mauger et al. (2010) 
showed that acetaminophen improves performance of a 10-mile cycle TT through an 
increased power output, but at the same level of the rating perceived exertion and muscle 
pain intensity. The study supports the notion that exercise is regulated by the perception of 
pain, and increased tolerance of pain can improve work rate during prolonged exercise. In 
DQRWKHUVWXG\E\2¶&RQQRUDQG&RRNSDUWLFLSDQWVDGDSWHd their work-rate during 
cycling exercise so that muscle pain intensities remained constant over a period of 20-30 
minutes. It is plausible that the cyclists in the studies by Mauger et al. (2010) and Jenkins 
et al. (2008) self-selected (self-paced) a work-rate during the TT that produced a muscle 
pain intensity that was near the maximum intensity they could tolerate or endure while 
continuing to exercise. Thus, the protocol of experiments could have masked the analgesic 
effects of acetaminophen or caffeine, but allowing work rate to vary.  
Numerous studies have also examined the impact of pain on exercise by attempting to 
increase the perception of pain during exercise through administration of opioid 
antagonists such as naloxone.  Administration of naloxone should increase perception of 
pain during exercise (Sgherza et al., 2002), which would be expected to reduce time to 
exhaustion. In an experimental study of administration of naloxone prior to exhaustive 
treadmill running, administration of naloxone led to increased pain as assessed via the 
McGill Pain Questionnaire (MPQ) (an increase of 30% in overall pain intensity) and 
reduced exercise time to exhaustion (Surbey et al., 1984). Another experimental study by 
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Paulev et al. (1989), found increased pain intensity during a 120-min running task, but 
exercise performance was not compromised. Additional experimental evidence 
considering the role of exercise-induced muscle pain can be assembled from studies 
examining performance in the presence of delayed-onset soreness or pain (DOMS). 
Decreased performance in short-duration exercise (20-30 s) (Sargeant & Dolan, 1987; 
Byrne & Eston, 2002), 5-min cycling exercise (Twist & Eston, 2009), and 30-min running 
TT (Marcora & Bosio, 2007) has been shown following the induction of DOMS. Whilst 
these studies reported a potential association between the presence of muscular pain and 
exercise performance, it is difficult to demonstrate conclusively whether pain is the 
primary cause of the decreased exercise performance in these studies, as damaged muscle 
can also lead to decreased joint range of motion and decreased capacity of muscles to 
generate force. Therefore, the use DOMS studies to explore the fatigue/pain relationship 
should be treated with caution. Other methods to induce pain during exercise include 
carrageenan (Diehl et al., 1988; Radhakrishnan, Moore & Sluka, 2003), hypertonic saline 
(Ro et al., 2007), acidic saline (Sluka et al., 2001), and mustard oil (Han et al., 2008). While 
these examples go some way to mimicking and exacerbating the sensation of EIP the 
methods of inducing EIP in these studies are limited and there still remains a need to seek 
a unique technique to apply the whole-body exercise. Thus, whist it appears perhaps that 
exercise-induced muscle pain may play some role in limiting exercise capacity, very few 
experimental studies have been able to determine the individual effects of pain sensation 
compared with other crucial factors on exercise performance. Given that exercise 
performance can be influenced not only by a host of physiological factors but also 
psychological factors, further studies attempting to determine the contribution of pain 
sensation to exercise  performance is necessary.   
 
1.4.5  Role of Exercise Induced Pain in Self-Pace Exercise Performance 
The role of exercise-induced pain in pacing strategies during endurance exercise 
performance is even less well established than its role on general performance. It is known 
that the sensation of pain accompanies intense exercise, and so it has been suggested that 
this sensation is utilised to moderate and judge the work rate (Mauger, 2014). In sport 
FRDFKHV DQG DWKOHWHV¶ GHVFULSWLRQ DERXW WKHLU SHUIRUPDQFH DQG WUaining, it appears that 
exercise pain tolerance is important for the regulation of pace, in which it contributes to 
the ultimate decision up or down regulate pace. The role of pain in these pacing decisions 
are not suggested to supersede the multitude of other factors known to contribute to pacing 
in endurance performance, but rather contributes to these. According to this proposition, 
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athletes change their work rate to moderate the level of pain perception (alongside a host 
of other sensations, such as RPE), with increases and/or decreases in work rate to manage 
the perception of pain to a level that the athlete is willing to tolerate (Mauger, 2014). These 
ideas are supported by investigations that have utilised analgesia during self-paced exercise 
to enhance performance (Mauger et al., 2010; Foster et al., 2014), and in these novel studies 
cyclists seem to be able to maintain a higher power output under conditions of analgesia. 
A key observation of these studies is that perception of pain remained the same (in 
comparison to the control condition) throughout the exercise, suggesting that the cyclists 
were willing to tolerate a given level of pain, and that changes in power output were made 
to achieve this. These findings are corroborated by recent studies that have used caffeine 
to induce an analgesic effect.  Indeed, Gonglach et al. (2015), showed that EIP is likely 
used as a regulator of exercise intensity when power output can be selected by the 
participant. But, caffeine is known to elicit a range of other ergogenic effects (Keisler & 
Armsey, 2006) which could conceivably explain the observed differences in power output, 
so the conclusions of this study need to be treated with some caution. However, ingestion 
of other analgesics, such as aspirin and codeine has not produced enhancements in athletic 
performance (Ray & Carter, 2007; Hudson et al., 2008). These studies used a fixed 
intensity exercise model, and this may have affected the impact of the analgesic effect 
during exercise. Alternatively, the different mechanism of action of aspirin and codeine 
may not be effective for EIP.   
Whilst several studies have investigated the relationship between pain perception and 
athletic potential, many of these have tended to use experimental pain, such as thermal pain 
(e.g. the cold pressor test) (for example; Janal et al., 1994; Ruble et al., 2005) and pressure 
pain (via algometry) (for example; Cook et al., 1997; Vaeter et al., 2015) to test their 
hypotheses. The importance of EIP may be misrepresented in these studies, as the 
interrelationship between nociception and pain perception pathways is a highly complex 
process, and follow different processing pathways by different types of painful stimuli and 
subsequently provoke very different responses (Olesen et al., 2012). Muscle pain arising 
from repetitive strain and intense exercise, which is associated with endurance 
performance, is likely induced through a combination of deformation of tissue, release of 
noxious metabolites and increased intramuscular pressure associated with muscle 
contractions (Ellingson et al., 2014), which is distinct from these traditional measures of 
pain induction. In order to appropriately understand the role of EIP on exercise 
performance, the experimental pain should emulate the variety of factors caused by EIP. 
For example, algometry may be a useful tool for assessing particular hyperalgesia of 
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muscles such as fibromyalgia (de Carvalho et al. 2012) and delayed onset muscle soreness 
(Close et al., 2006), but this does not sufficiently replicate EIP.  
 
 
2. Overview/General Conclusion of Literature Review 
Muscle fatigue is a very complex and multifactorial process (Fitts, 1994; Gandevia, 2001), 
and it is well-accepted that maximising power output or speed while limiting fatigue is the 
key determinant of success in endurance exercise (Joyner & Coyle, 2008). Substrate 
depletion, increased concentration of deleterious metabolites during prolonged strenuous 
exercise (Coyle et al., 1983; Kent-Braun, 1999), and reduced neural drive to the muscles 
(Gandevia, 2001) are all well-accepted models to explain this process of fatigue. However, 
they do not adequately explain how exercise intensity of regulated in self-paced exercise, 
or why performance is improved independently of any physiological manipulation. Indeed, 
where completion time is the measure of success, athletes are not required to produce 
maximal contractions and rarely cease exercising during or following the event (Mauger, 
2014). Rather, it is the athlete¶s ability regulate their own work-rate during the endurance 
event, that determines their success (Mauger et al., 2009). How this is achieved is a puzzle 
that still remains to be explained. Limitations and explanations of fatigue in previous 
literature suggests that endurance exercise performance may be limited by several 
physiological determinants, with maximal oxygen consumption VO2max, lactate threshold 
and efficiency interacting to produce race velocity (Lucia et al., 1999; Balmer, Davison & 
Bird, 2000; Jeukendrup, Craig & Hawley, 2000; Lucia, Joyos & Chicharro, 2000; Laursen, 
Shing & Jenkins, 2003; Joyner & Coyle, 2008). Whilst this is undoubtedly true, there are 
further unanswered questions that remain. New models of endurance performance, such as 
the CGM and Psychobiological Model attempt to answer these, and have gone some way 
to change the way we think about limitations of endurance performance. However, other 
markers such as pain, which are generated during prolonged exercise and are suggested to 
be important for performance, remain largely unexplored. The literature review has 
attempted to compile the most important studies on endurance performance in pain, to 
demonstrate current understanding and highlight areas that remain to be explored. 
Consequently, this thesis will seek to further knowledge in this area, by addressing the 






2.1 Purposes and Outline of the Thesis  
The overall purpose of this thesis is to examine and establish the importance of EIP on 
endurance performance. Through 5 novel studies, the thesis will explore the following aims 
and hypotheses.  
 
Chapter 3  Experimental 1st study: 
Tittle: Tolerance of exercise-induced pain at a fixed rating of perceived exertion 
predicts time trial cycling performance. 
Aim: To compare the predictive capacity of experimental pain and exercised-induced pain 
(EIP) on exercise performance. 
Hypothesis: Experimental induction of pain will be a poor predictor of time trial cycling 




Chapter 4  Experimental 2nd study: 
Tittle: Task deception using a Mirror Box can influence perceptual measures and 
the time-to-exhaustion of an isometric voluntary contraction 
Aim: To establish whether deception of exercise task difficulty will change pain 
response and affect endurance performance.  
Hypothesis: Increasing perception of task difficulty will increase EIP and decrease 
endurance performance. Decreasing perception of task difficulty will decrease EIP and 
increase endurance performance.  
 
 
Chapter 5  Experimental 3rd study: 
Tittle: Transcutaneous electrical nerve and interferential current stimulation reduce 
exercise-induced muscle pain and improve time to exhaustion performance 
Aims: To investigate whether reducing nociceptive afferent feedback at the spinal level 
during a sustained single limb, submaximal isometric contraction will reduce pain 
perception and improve time to exhaustion.  
Hypothesis: Reduced nociceptive afferent feedback will result in reduced perceived pain 




Chapter 6  Experimental 4th study: 
Tittle: Transcutaneous electrical nerve stimulation inhibits central pain 
transmission and limits the development of peripheral muscle pain during cycling 
time trial performance. 
Aims: To establish whether reducing nociceptive afferent feedback at the spinal level 
during cycling exercise will improve endurance performance.   
Hypothesis: Reduced nociceptive afferent feedback will result in improved endurance 
cycling performance.  
 
 
Chapter 7  Experimental 5th study: 
Tittle: The effect of compassional hyperalgesia on exercise-induced pain during 
endurance cycling performance. 
Aims: To examine whether changes in mood will affect pain perception and exercise 
performance.  
Hypothesis: Negative mood will increase pain perception and reduce endurance 






































The intention of this chapter is to define and describe the major and consistent 
methodologies used in the experimental studies reported in the following chapters. The 
particular protocols of the individual experiments are also detailed in the methods section 
of each chapter. All data collection for these experiments and all analyses which comprise 
this thesis were collected in the laboratories of the School of Sport and Exercise Sciences 
of the University of Kent. 
 
2.1 Recruitment and Ethical Approval 
Prior to the commencement of each study, ethics were approved by the University Ethics 
Committee (University of Kent).Before participating in each study, an information sheet 
(see example in Appendix A) was given to the participants, which explained and outlined 
the study details and scRSHRIWKHSDUWLFLSDQWV¶LQYROYHPHQWLQthe study. Participants who 
were interested in participating in the studies then contacted the researcher and further 
information was given if so required. Prior to use of any  equipment or measurements being 
taken, participants were required to complete a health questionnaire (see Appendix A). 
Those participants who were then interested in participating in the study filled out a written 
consent form (see example in Appendix A). The participants were informed that all data 
would be unidentifiable and that they had the right to withdraw from the experiment at any 
time. Prior to all experimental visits, participants were asked to abstain from the ingestion 
of alcohol (48 h prior), and asked to refrain from any vigorous exercise (24 h prior), 
caffeine (8 h prior) and analgesics (6 h prior) prior to any test visit (Lu, Lai & Chan, 2008). 
All visits were separated by 2-5 days. All data was collected at the School of Sport and 
Exercise Sciences University of Kent .  
 
2.2 Pre-test Measurement and Familiarisation 
All participants performed at least one familiarisation session of the experimental 
procedures performed in each study. This was to help reduce any learning effect and 
improve test reliability. In their first laboratory visit, all participants were measured for 
their height and weight. Height was measured using a stadiometer (Stadiometer, 
Holtain Ltd, Crosswell, Crymych, Dyfed, UK), with the participant being asked to remove 
their shoes and stand upright with heels and toes together and their back to the stand. 
Participants were encouraged to stand tall and look straight ahead. Height was then 
measured to the nearest millimetre. Body mass was assessed using a heavy-duty Seca 
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770 floor digital scale (Seca, Hamburg, Germany). Participants removed their shoes and 
stood on the scales. Body mass was measured to the nearest 100 g. All participants were 
fully familiarised with the rating of perceived exertion (RPE) using the Borg (6-20) (Borg, 
1998) scale and pain scale (Cook et al., 1997), that pain should be anchored to exercise-
induced pain (i.e. numeric values given relative to their experience of muscle pain). Details 
of scale familiarisation are given in Section   
 
2.3 The Validity and Reliability of Data Collection Tools 
In measurement and collection of data, the major pieces of equipment used throughout this 
thesis (including: Velotron, Lode Excalibur, The Metalyzer 3B, Biosen EFK and Polar 
RS400) have been shown to be valid and reliable (i.e. consistency and accuracy) in these 
sorts of tests (Sporer & McKenzie, 2007; Weber & Schneider, 2001; Meyer et al., 2001; 
Davison et al., 2000; Engström et al., 2012). This section will provide detail of these for 
the major pieces of equipment used throughout this thesis. 
 
2.3.1 Velotron 
The Velotron (Velotron, Racermate, Seattle, WA, USA) has been shown to be vaild and 
reliable in the sorts of tests used in the studies in this thesis (Sporer & McKenzie, 2007). 
The Velotron manufacturer reports the following specifications; generates variable load 
range from 5 to 2000 W, accuracy of ±1.5% and repeatability of ±0.2 % or better, smooth 
electronic shifting controlled from handlebar or remote gear-shift lever, set virtual gears to 
mimic the chain ring combinations on any bicycle. 
 
2.3.2 Lode Excalibur 
In experimental research, the reliability of the Lode Excalibur (Lode Excalibur, Lode 
Medical Technology, Groningen, The Netherlands) has been assessed by Weber and 
Schneider (2001). In the experimental studies in this thesis, the Lode Excalibur was used 
to deliver the maximal incremental test to determine VO2max and peak power output (PPO). 
The manufacturer reports the following specifications; workload range of 8-2500 W, 
maximum rpm independent constant load of 180 rpm, minimum rpm independent constant 
load of 25 rpm, workload accuracy below 100 W of 2 W, workload from 100 to 1500 W, 
accuracy of 2 %, and workload over 1500 W, accuracy of 5 %, maximum operational 
temperature 40 °C, minimum operational temperature 14 °C (minimum temperature at 




2.3.3 The Metalyzer 3B 
8VLQJ WKH 0HWDO\]HU % &RUWH[ %LRSK\VLN *PE+ /HLS]LJ *HUPDQ\ DQ DWKOHWH¶V
performance can be precisely assessed using parameters such as the maximum oxygen 
uptake (VO2max) at a maximum heart rate (HRpeak) and respiratory thresholds. The 
MetaLyzer 3B has been tested for validity and reliability by Meyer et al. (2001). This 
device has been reported to have the following specifications; volume transducer: range: 
0.1 ± 12 l/s, resolution: 7 mL, accuracy: 2%, O2 analyser: range: 0 ± 35 % O2, t90: 100 ms, 
accuracy: 0.1 Vol.%, CO2 analyser: range: 0 ± 13 % CO2, t90: 100 ms, accuracy: 0.1 
Vol.%, temperature sensor: range: -55 °C - +155 °C, accuracy: 1° C, and pressure sensor 
Type: range: 200 ± 1050 mbar, accuracy: 1.8%. 
 
2.3.4 Biosen EFK 
The Biosen (Biosen, EFK Diagnostics, London, England) has widely been used to test 
blood, plasma or serum to provide lactate and glucose values quickly and precisely in 
clinics. Test-retest reliability of the Biosen has been established by Davison et al. (2000), 
who showed a high level of reliability for this device (R2 = 0.995). This device has been 
reported to have following specifications by the manufacturer; multi-lingual touch screen 
display with step by stHSLQVWUXFWLRQVȝOEORRGSODVPDRUVHUXPVDPSOHUHTXLUHGIRU
analysis, results in 20-45 seconds, enzymatic-amperometric method using chip-sensor 
technology, measuring range, glucose 0.5±50 mmol/L (9±900 mg/dL); Lactate 0.5±40 
mmol/L (5±360 mg/dL), impUHFLVLRQ&9PPRO/DQGLQQRYDWLYHQHHGOHDQG
exchanger design eliminates cross contamination. 
 
2.3.5    Polar RS400 
The validity of HR measured by Polar RS400 has been assessed by Engström et al. (2012), 
with correlation coefficients ranging from 0.97 to 1.00. The Polar RS400 has been reported 
to have the following technical specifications by the manufacturer; operating temperature: 
-10 °C to +50 °C / 14 °F to 122 °F, accuracy of heart rate monitor: ± 1% or 1 bpm, 







2.4 Assessments of Test Performance  
2.4.1 The Graded Exercise Test (GXT) 
During the 1st, 3rd, and 5th studies, all participants visited the laboratory prior to the 
experimental visits to complete a maximal incremental test to determine their VO2peak or 
VO2max and peak power output (POpeak). On a cycle ergometer (Lode Excalibur, Lode 
Medical Technology, Groningen, The Netherlands), participants initially completed a 5-
10 min warm-up at 75 W, followed by an incremental ramp protocol which started at 100 
:DQGLQFUHDVHGE\:PLQ-1 until volitional exhaustion or when cadence dropped 5 
530EHORZWKHSDUWLFLSDQWV¶VHOI-selected cadence. Participants were given instructions to 
rate their perceived exertion (Borg, 1998) on the 6-20 scale, and to report perceived pain 
intensity (Cook et al. 1997) 15 s prior to the end of each stage. Oxygen consumption during 
the test was collected through online gas analysis (Cortex Metalyser 3B, Cortex GmbH, 
Lepzig, Germany), and heart rate was recorded through a telemetric device (Polar RS400, 
N2965, Finland). VO2max was determined by a visible plateau in oxygen consumption with 
a standard increment in exercise intensity, at or around the point of volitional exhaustion. 
$OO*;7¶VFRQGXFWHGGHPRQVWUDWHGVXFKDSODWHDX  
 
2.4.2 Assessments of VO2max 
During the 1st, 3rd, and 5th studies, using the cycle ergometer (Lode Excalibur, Lode 
Medical Technology, Groningen, The Netherlands), oxygen consumption and other 
ventilatory and gas exchange responses throughout the GXT (VE, VCO2 and RER) were 
collected through online gas analysis by the Cortex Metalyser (Cortex Metalyser 3B, 
Cortex GmbH, Lepzig, Germany). A volume transducer and sample line running from the 
Cortex Metalyser were attached to a turbine (Cortex Metalyser 3B, Cortex GmbH, Lepzig, 
Germany), which in turn was tightly secure to a face mask worn by the participants. The 
facemask covered the mouth and nose and was available in different sizes. To achieve a 
stable seal and ensure a tight-fitting mask seal around the face placed in right position, the 
experimenter temporarily positioned their hand over the turbine while asking the subject 
to expire, if the mask is properly fitted, it would be an airtight seal. The Cortex MetaLyzer 
was interfaced to a computer installed with Metasoft software (3B, Cortex GmbH, Lepzig, 
Germany). The Metalyzer automatically recorded ambient pressure and air temperature 
prior to each test. During a test, the software continuously captured ventilatory data, which 
were subsequently averaged over a 30 s time periods. The MetaLyzer- Metasoft interface 
also allowed the direct capture of HR data from a polar HR monitor (Polar RS400, Polar 
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Electro Oy, Kempele, Finland). All data captured by the Metasoft software were then 
exported and stored as an Excel spread sheet. 
Approximately one hour prior to testing, the Metalyzer was calibrated in accordance with 
the mDQXIDFWXUHUV¶UHFRPPHQGDWLRQV 
 
2.4.3 Assessment of Peak Power Output (PPO) 
During the 1st, 3rd, and 5th studies, power output was assessed using the cycle ergometer 
(Lode Excalibur, Lode Medical Technology, Groningen, The Netherlands) peak power 
output was defined as the highest PO averaged over 30 s in the GXT. For instance, as the 
GXT started at 100 W and increased by 30 W·min-2 a participant who terminate cycling 
after 10-min and 15 s would have POpeak of 265 W. Previous studies have been shown that 
POpeak is a stronger indicator of endurance cycling performance than VO2max (Lucia et al., 
2001a).  
 
2.5 Assessment of Endurance Performance  
2.5.1 Endurance Performance of a 10-Mile cycling Time Trial (TT)  
During the 1st, 3rd, and 5th studies, in order to provide a measure of endurance performance, 
on the cycle ergometer (Velotron, Racermate, Seattle, WA), participants were instructed 
to work at a self-selected intensity in order to complete the 10-mile (16.1-km) cycling time 
trial (TT) in the fastest possible time. Participants could change gear and cadence to vary 
their PO, and they could see the distance they had completed but were given no information 
on performance or physiological parameters (e.g. PO, HR, time elapsed). Participants were 
asked to report RPE and perceived pain every km. A fingertip sample of blood was 
acquired every 4-km for analysis for blood lactate concentration (B[La]). If participants 
required a fan, it was placed in a standardised position in front of the them during the entire 
duration of the endurance performance of a 16.1-km cycling time trial. Participants were 
given a 10-min cool-down following completion at a self-selected intensity. 
 
2.6 Assessment of Mood Questionnaire (MQ) 
During 3rd and 5th studies, The Brunel Mood Scale (BRUMS) was used in order to identify 
the particiSDQWV¶PRRGSULRUWRDQGIROORZWKHH[SHULPHQWDOWDVNV%5806GHYHORSHGE\
7HUU\HWDOWRPHDVXUHFXUUHQWPRRG³+RZGR\RXIHHOULJKWQRZ"´SULRUWRDQG
following the experimental tasks. This questionnaire has been adapted to create a shorter 
 LWHPV HJ ³DQJU\XQFHUWDLQPLVHUDEOH WLUHGQHUYRXVHQHUJHWLF´GLYLGHG LQWR VL[
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subscales: confusion, tension, anger, fatigue, vigour and depression. The items are 
answered on a 5-point scale (0 = not at all, 1 = a little, 2 = moderately, 3 = quite a bit, 4 = 
extremely), and each subscale, with four relevant items, can achieve a raw score in the 
range of 0 to 16.  
 
2.7 Assessment of Blood Lactate Concentrations [B(La)] 
 ȝO VDPSOHV RI FDSLOODU\ EORRG ZHUH WDNHQ IURP WKH WKXPE RI WKH SDUWLFLpants for 
measurement of blood lactate concentrations (Biosen, EFK Diagnostics, London, 
England). The site was first cleaned with an alcohol swap and allowed to dry. The thumb 
was then punctured using an automated instrument (Hemocue, Angelholm, Sweden), 
which inserted a sterile needle to a depth of 2.25 mm. Gentle pressure was then applied to 
the thumb tip, the initial blood wiped clear and a sample of arterialised whole blood (25 
ȝ/ZDVFROOHFWHGLQDKHSDULQLVHGWXEH0LFURYHWWH&%6DUVWHGW*HUPDQ\). Blood 
lactate concentration was measured during RPE clamp (1st study), fixed power (3rd study) 
every 2-minutes, and every kilometre during endurance performance of a 16.1-km cycling 
time trial (1st, 3rd, 5th studies). 
 
2.8 Assessment of Perceptual Parameters 
2.8.1 Assessment of Rating Perceived Exertion (RPE)  
Perceived exertion was measured during the incremental test (1st, 3rd, 5th studies), RPE 
clamp (1st study), fixed power (3rd study) every 2-minutes, for the time to exhaustion tests 
every 30 s (2nd study) and every 45 s (4th study) and for endurance performance of a 16.1-
km cycling time trial (1st, 3rd, 5th studies) every kilometre using the 15 points RPE scale 
(Borg, 1998), as shown in Figure 2.6. Standardised explanations of the scale were given to 
each participant in the first visit of each study prior to the warm-up. Briefly, participants 
were asked to rate how much effort was required to drive the limb/s. Standardised 
instructions for the RPE scale were given to each participant (see Appendix C).  
 
2.8.2 Assessment of Exercise-Induced Pain (EIP) 
Exercise-induced pain was measured during the incremental test (1st, 3rd, 5th studies), RPE 
clamp (1st study), fixed power (3rd study) every 2-minutes, for the time to exhaustion tests 
every 30 s (2nd study) and every 45 s (4th study) and for endurance performance of a 16.1-
km cycling time trial (1st, 3rd, 5th studies) every kilometre using the Cook scale (Cook et 
al., 1997), as shown in figure F.6. Standardised instructions for the scale were given to 
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each participant in the first visit of each study prior to the warm-up. Briefly, participants 
asked to rate the feelings of pain and discomfort, and not to report other pains they may 
have experienced (e.g., seat discomfort). Participants were also asked to not use this rating 
as an expression of perceived exertion. Standardised instructions for the scale were given 
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INTRODUCTION: Pain has long been linked to success in sport and it is well-recognised 
that intense and repetitive muscular contraction, which is consistent with endurance 
SHUIRUPDQFHFDXVHVµH[HUFLVH-LQGXFHGSDLQ¶ (Dannecker & Koltyn, 2014; Mauger et al. 
2010). Pain has an important role in protecting the body from damaging stimuli through 
avoidance behaviour, and so pain during exercise may contribute to task disengagement or 
UHGXFWLRQVLQZRUNUDWHWKDWDUHPDQLIHVWHGLQWKHDWKOHWH¶VSDFLQJVWUDWHJ\0DXJHU
Therefore, pain tolerance (the maximum level of perceived pain someone is able to 
tolerate) and threshold (the level at which a stimulus is initially perceived as pain) may be 
significant factors in successful endurance performance. Therefore, the purpose of this 
study is to compare the predictive capacity of experimental pain and exercised-induced 
pain (EIP) on exercise performance. METHODS: Thirty-two recreationally active male 
(n= 23) and female (n= 9) participants were recruited.  Participants completed measures of 
pain tolerance by cold pressor test (CPT), pain pressure threshold via algometry (PPT), 
and EIP tolerance using an RPE-clamp trial. A VO2max test provided traditional predictors 
of performance (VO2max, gas-exchange threshold (GET), peak power output (PPO)). 
Finally, participants completed a 16.1-km cycling time trial (TT). RESULTS: No 
correlation was found between experimental pain measures (CPT, PPT) and TT 
performance. However, there was a significant correlation between EIP tolerance and TT 
performance (R = -0.83, p < 0.01). Regression analysis for pain and physiological predictor 
variables (mean pain in CPT, PPT, EIP tolerance, VO2max, PPO, GET) revealed that a 
significant model (p < 0.01) emerged when only PPO (Adjusted R Square = 0.739) and 
(,3 WROHUDQFH ǻ5 6TXDUH    ZHUH used to predict TT performance. 
CONCLUSION: These findings suggest that EIP tolerance is an important factor in 
endurance performance. However, PPT and CPT have limited ability to assess this 
relationship, and so their use in EIP research should be treated with caution.  
 
 




The physiological determinants of endurance performance are well established, with 
maximal oxygen consumption (VO2max), the so-called µlactate threshold¶ and energetic 
exercise costs (economy) considered the most important (Joyner & Coyle, 2008). Whilst 
these factors are critical to a successful endurance athlete, the sole focus on physiological 
mechanisms ignores the fact that work rate regulation (pacing) is ultimately controlled by 
the brain (Ulmer, 1996). Consequently, perceptual markers, such as rating of perceived 
exertion (RPE), have been suggested to be equally important as traditional physiological 
components (Tucker, 2009), or even in some cases, the sole determinant (Marcora, 2010). 
However, whilst the recognition that effort perception is integral to endurance performance 
is an important step forward in providing a more holistic understanding of endurance 
performance, there are other perceptions generated during intense exercise that may also 
be involved. Pain has long been linked to success in sport and it is well-recognised that 
intense and repetitive muscular contraction, which is consistent with endurance 
SHUIRUPDQFHFDXVHVµH[HUFLVH-LQGXFHGSDLQ¶(,3'DQQHFNHU& Koltyn, 2014; Mauger 
et al., 2010). Pain has an important role in protecting the body from damaging stimuli 
through avoidance behaviour, and so pain during exercise may contribute to task 
GLVHQJDJHPHQW RU UHGXFWLRQV LQ ZRUN UDWH WKDW DUH PDQLIHVWHG LQ WKH DWKOHWH¶V SDFLQJ
strategy (Mauger, 2014). Therefore, pain tolerance (the maximum level of perceived pain 
someone is able to tolerate) and threshold (the level at which a stimulus is initially 
perceived as pain) may be significant factors in successful endurance performance.  
Although pain is a universally recognised perception, it is less well-known that different 
types of pain are sensed and processed very differently. Indeed, pain is now generally 
classified into three basic groups: neuropathic, inflammatory, and nociceptive (Dannecker 
& Koltyn, 2014; Ellingson et al., 2014), each of which may arise from different stimuli, 
may be perceived differently, and so exert a different response. This is important because 
the widely accepted definition of pain suggests that it is ultimately a subjective sensation, 
which is largely independent of the level of present or impending tissue damage (Olesen 
et al., 2012). Whilst several studies have investigated the relationship between pain and 
exercise, many of these have tended to use experimental pain, such as thermal pain (e.g. 
the cold pressor test) (for example; Janal et al., 1994; Ruble et al., 2005) and pressure pain 
(via algometry) (for example; Cook et al., 1997; Vaeter et al., 2015) to test their 
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hypotheses. Despite these techniques having excellent validity and reliability in studies of 
clinical pain, they inadequately represent the aetiology of EIP, and thus will likely be 
processed and reacted to very differently (Olesen et al., 2012). Exercise-induced pain likely 
arises from the build-up of a variety of noxious biochemicals (including; serotonin, 
bradykinin, histamine, potassium, hydrogen ions, adenosine, prostaglandins, and substance 
P FRPELQHG ZLWK LQFUHDVHG LQWUDPXVFXODU SUHVVXUH 2¶&RQQRU & Cook, 1999). 
Consequently, in order to test the relationship between the tolerance of pain during exercise 
and endurance performance, it is important to replicate the type of pain that is consistent 
with EIP. Because EIP might provide important perceptual information that informs the 
exerciser whether to elect to stop exercising or increase or decrease their work-rate 
(Mauger, 2013), valid data that establishes this relationship may be of use for exercise 
practitioners looking to improve adherence to exercise routines and for coaches looking to 
educate and improve the performance of their athletes. 
Therefore, the purpose of this study was to assess the relationship between traditional 
experimental measures of pain (the cold pressor test (CPT) and algometry), EIP tolerance 
DQGSDUWLFLSDQWV¶SHUIRUPDQFHRID-km cycling time trial. It was hypothesized that 
experimental induction of pain would be a poor predictor of time trial cycling performance, 
whereas EIP tolerance would be a strong predictor of time trial cycling performance. 
 
 
III. MATERIALS AND METHODS 
Participants 
Thirty-two recreationally active male (n= 23) and female (n= 9) participants who exercised 
regularly (3 h or more per week) were recruited for this study. None of the participants 
ZHUHWUDLQHGF\FOLVWV7KHSDUWLFLSDQWV¶PHDQDJHKHLJKWDQGERG\PDVVZHUH\UV
173.9 ± 10.1 cm and 73.2 ± 14.6 kg, respectively. Prior to participation in the study, an 
information sheet was given to the participants stipulating what they were asked to do. The 
participants were informed that all data would be unidentifiable and that they had the right 
to withdraw from the experiment at any time. Following this, they were asked to complete 
the inclusion/exclusion criteria checklist followed by an informed consent form. 
Participants ZHUHH[FOXGHGIURPWKHVWXG\LIWKH\KDG5H\QDXG¶VV\QGURPHGLDEHWHVW\SHV
I and II), cardiovascular disease, open cuts on their hands or any bleeding disorders. All 
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participants provided informed consent before volunteering for the study and the research 
was approved by the local Ethics Committee (University of Kent). Before all experimental 
visits, participants were asked to refrain from any vigorous exercise 24 hours prior to the 
laboratory visits, and asked to refrain from the ingestion of alcohol, caffeine and analgesics 
48 h, 8 h and 6 h prior to any visit (Lu, Lai & Chan, 2008). Participants reported to the 
laboratory on three separate visits, each separated by 2-5 days.  
 
Procedures 
After a separate familiarisation session of the experimental pain procedures and RPE-
clamp test, in their first visit participants completed an assessment of pain tolerance using 
the cold pressor test (CPT) and pain pressure threshold (PPT) via algometry. Following 
this, participants undertook an assessment of aerobic capacity by completing a cycle-based 
VO2max test. Finally, participants undertook a familiarisation of the endurance performance 
test by completing a self-paced 16.1-km cycling time trial (TT). Pain tests were separated 
by 30-min and exercise tests separated by 45-min to allow recovery.  During the second 
visit, participants performed a previously described RPE clamp trial (Tucker et al. 2006) 
on a cycle ergometer. During the final visit, participants completed a final performance 
16.1-km TT.  
 
VO2max Test (GXT) 
On a cycle ergometer (Lode Excalibur, Lode Medical Technology, Groningen, The 
Netherlands), participants initially completed a 5-min warm-up at 75 W, followed by an 
incremental ramp protocol which started at 100 W and increased by 30 W 2·min-1 until 
YROLWLRQDO H[KDXVWLRQ RU ZKHQ FDGHQFH GURSSHG  530 EHORZ WKH SDUWLFLSDQWV¶ VHOI-
selected cadence. Participants were given instructions to rate their perceived exertion 
(Borg, 1998) on the 6-20 scale and to report perceived pain intensity (Cook et al., 1997) 
15 s prior to the end of each stage. Oxygen consumption during the test was collected 
through online gas analysis (Cortex Metalyser 3B, Cortex GmbH, Lepzig, Germany), and 
heart rate was recorded through a telemetric device (Polar Electro, N2965, Finland). 
VO2max ZDVGHWHUPLQHGE\DYLVLEOHSODWHDXLQR[\JHQFRQVXPSWLRQRIP/āNJā-1·min-
1




 Cold Pressor Test (CPT) 
Participants were assessed for pain tolerance by using a CPT. This test involves the 
participant submerging their hand in iced water maintained between 0-2 °C, leading to the 
stimulation of the sympathetic nervous system and a high level of pain. Participants were 
asked to keep their hand in the iced water for as long as they could tolerate, although a cut-
off time of 7-min was imposed, which was unknown to the participant (Angius et al., 
2015). During the immersion, the participants reported their pain perception using the 
Cook numeric pain rating (0-10) scale (Cook et al., 1997). They remained seated 
throughout the test, which was conducted in a private room with no interference or 
interaction from the investigator. Before undergoing the CPT, hot/cold sensation tests were 
completed to ensure the participant could distinguish between hot and cold.  
 
Pain Pressure Threshold (PPT) Test 
Participants were assessed for PPT using a pressure algometer (Force Dial FDK, Wagner 
Instruments, CT, USA), three times, alternating between both thighs using a probe of 1 cm 
diameter.  For the assessment of PPT, participants lay in a supine position and were 
instructed to report a change in sensation from pressure to weak pain. Force was applied 
and gradually increased (3 N/cm2 per s) to the middle part of the rectus femoris on both 
legs. The rubber footplate of the algometer was held perpendicular to the muscle and the 
display turned away from the participant. This process was repeated three times for each 
leg. The average of the two nearest force values for each leg was recorded as the PPT for 
that limb. The mean of the PPT scores for the two legs was recorded as the SDUWLFLSDQWV¶
pain threshold.  
 
RPE Clamp 
Participants were instructed to exercise on the cycle ergometer (Veltron, Racermate, 
Seattle, WA) at a power output (PO) that was perceived by them to represent an RPE of 
ZKLFKFRUUHVSRQGHGWRWKHYHUEDOFXHRIEHWZHHQµKDUG¶DQGµYHU\KDUG¶DVGHVFULEHG
previously (Tucker et al., 2006). Participants were required to ride continually at an RPE 
of 16 and to adjust their PO so that this perceived effort was maintained. Pilot testing 
demonstrated this protocol to produce increases in perceived pain over time, despite the 
fixed rating of perceived exertion. The PO measured during the first 3-min of the trial was 
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averaged and SURYLGHG WKH µLQLWLDO 32¶ 7KH 53( FODPS WHVW ZDV WHUPLQDWHG ZKHQ
SDUWLFLSDQWV¶ 32 GURSSHG WR OHVV WKDQ  RI WKHLU LQLWLDO 32 7XFNHU HW DO., 2006). 
Participants provided a pain perception score (Cook et al., 1997), which was recorded 
every 2-minutes and at the end of the trial.  
 
Time Trial (TT) 
Participants completed a 16.1-km TT on the cycle ergometer (Veltron, Racermate, Seattle, 
WA), as previously described (Mauger et al., 2010). Briefly, participants were required to 
cycle 16.1-km as quickly as they could, and were not provided with any feedback other 
than distance completed. Participants were asked to provide their RPE and perceived pain 
after every km completed. After every 4 km, a fingertip sample of blood was taken to 
assess the concentration of blood lactate.  
 
Statistical Analysis 
All data are reported as means ± SD. Statistical assumptions were checked for linearity, 
multicollinearity, additivity, independence, homoscedasticity and normality, and accepted 
unless otherwise stated. The highest VO2 at the end of the VO2max test was recorded as 
VO2max and the highest sustained PO in the VO2max test was recorded at the peak power 
output (PPO). Gas-exchange threshold (GET) was calculated from the VO2max test gas data 
using the V-slope method (Wasserman et al. 1994). The pain reported on the termination 
of the RPE-FODPSWHVWZDVUHFRUGHGDVWKHSDUWLFLSDQWV¶(,3WROHUDQFHEnd-RPE was the 
highest RPE reported in the GXT. The relationship between the physiological parameters, 
experimental pain tests, EIP tolerance, End-RPE, and TT were established using a Pearson 
Bivariate two-tailed correlation. Hierarchical regression analysis was used to assess the 
predictive capacity of the physiological parameters (VO2max, PPO, GET) on TT 
performance, and following this, stepwise multiple linear regression was used to determine 
the predictive value of experimental pain (time lasted in CPT, mean pain in CPT, PPT) 
EIP tolerance and End-RPE on TT performance. Finally, the significant predictors from 
the pain and physiological parameters were entered into a hierarchical multiple linear 
regression analysis to assess their predictive capacity of TT performance. All data 
management and statistical analysis was performed using the statistical package SPSS for 
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Windows, PC software, version 22 (SPSS Inc., Chicago, IL, USA). The alpha value was 




All group mean values are reported in Table 3.3DUWLFLSDQWV¶SDFLQJSK\siological and 
perceptual responses during the TT are displayed in Figure 3.1,2,3,4,5. Correlation analysis 
revealed significant (p < 0.01) relationships between TT completion time and VO2max (R 
= -0.816, P < 0.001), PPO (R = -0.864, P < 0.001), GET (R = -0.454, P = 0.009), End-RPE 
(R = -0.736, P < 0.01) and EIP tolerance (R = -0.833, P < 0.01). There was no correlation 
(P > 0.05) between measures of experimental pain and TT performance (mean pain in CPT; 
R = 0.222; time lasted in the CPT; R = -0.292; PPT; R = -0.016), which are displayed in 
Figure 3.2. Correlation analysis demonstrated significant (P < 0.01) relationships between 
EIP tolerance and GET (R = 0.473, P < 0.01), VO2max (R = 0.770, P < 0.01) and PPO (R = 
0.757, P < 0.01).  
 
Figure 3.1  Correlation between time trial completion time and combined limb pain pressure 
threshold (R = 0.016, P > 0.05). 
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Time Lasted in Cold Pressor Test (min) 





















Figure 3.2  Correlation between time trial completion time and time lasted in cold pressor test 
(R = 0.292, P > 0.05). 
Mean Pain in Cold Pressor Test (a.u) 





















Figure 3.3  Correlation between time trial completion time and mean pain score in cold 
pressor test (R = 0.222, P > 0.05). 
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Exercise-Induced Pain Tolerance (a.u)





















Figure 3.4  Correlation between time trial completion time and exercise-induced pain 
tolerance (R = 0.833, P < 0.05) 
End-Rating Perceived Exertion (a.u)





















Figure 3.5  Correlation between time trial completion time and (e) end rating perceived 




Hierarchical multiple regression for physiological parameters (VO2max, GET and PPO) 
revealed that a significant model emerged (F (1,30) = 88.586, P < 0.01) when only PPO was 
used to predict TT completion time. PPO explained 74.7% variance (R Square = 0.747, 
$GMXVWHG56TXDUH ǻ5 Square = 0.747, F
 (1,30) = 88.586, P < 0.01, Beta = - 0.864).  
 
Stepwise regression for pain predictor variables (mean pain in CPT, time lasted in the CPT, 
PPT, EIP tolerance, and End-RPE) revealed that all variables with the exception of time 
lasted in CPT and End-RPE contributed to a predictive model. EIP tolerance predicted TT 
completion time and explained 69.4% variance (R Square = 0.694, Adjusted R Square = 
ǻ56TXDUH ) (1, 30) = 68.075, P < 0.01, Beta = - 0.833), PPT explained 
additionDOYDULDQFH56TXDUH $GMXVWHG56TXDUH ǻ56TXDUH 
ǻ) (1, 29) = 4.390, P = 0.045, Beta = - 0.886), and mean pain in CPT also explained 
DGGLWLRQDOYDULDQFH6TXDUH $GMXVWHG56TXDUH ǻ56TXDUH 
ǻ)(1, 28) = 5.543, P = 0.026, Beta = - 0.881). Therefore, EIP tolerance, PPT and mean pain 
in CPT explained 77.8% variance in TT completion time.  
 
Hierarchical multiple regression for PPO, EIP tolerance, PPT and CPT revealed that a 
significant model emerged only when PPO and EIP tolerance were used to predict TT 
completion time. PPO explained 74.7% variance (R Square = 0.747, Adjusted R Square = 
ǻ56TXDUH ) (1, 30) = 88.586, P < 0.01, Beta = - 0.547), and EIP tolerance 
contributed an additional 7.5 % variance (R Square = 0.075, Adjusted R Square = 0.810, 
ǻ56TXDUH ǻ) (1, 29) = 12.221, P = 0.002, Beta = - 0.419). Therefore, PPO and EIP 






























































Figure 3.6 Rating perceived exertion profile during the 16.1-km cycling time trial 
performance. 
Distance Completed (km)










































Figure 3.8 VO2 profile during the 16.1-km cycling time trial performance. 
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Figure 3.10  Power output profile during the 16.1-km cycling time trial performance. 
 
V. DISCUSSION   
The primary aim of this study was to examine the relationship between pain tolerance (CPT 
duration), pain threshold (PPT), EIP tolerance and cycling time trial performance. The 
primary and novel finding was that tolerance of EIP explained considerably more variance 
in cycling TT performance than pain threshold and tolerance assessed through algometry 
and a CPT (respectively). Therefore, participants who were willing to engage in greater 
amounts of pain during fixed effort exercise were generally able to produce faster 16.1-km 
times. This is an important finding, as traditional measures of pain tolerance and threshold 
(such as algometry and the CPT) are often used to inform discussion on the tolerance of 
the pain arising from intense exercise. As the results of the current study show that these 
traditional pain measures explain little variance in endurance performance (compared to 
tolerance of EIP), it suggests that the importance of a high pain tolerance to endurance 
performance may have been previously underestimated. This novel finding demonstrates 
the need to use experimental pain measures which replicate the aetiology of EIP when 
investigating the role of pain arising from intense exercise. This is further reinforced by 
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the observation that when combined with physiological predictors of endurance 
performance (VO2max, PPO, GET), only PPO and EIP tolerance could explain the variation 
in TT performance. This infers that both tolerance of EIP and physiological parameters 
need to be taken into account when explaining endurance performance. 
The current study is the first to directly use EIP tolerance as a predictor of endurance 
performance and to demonstrate the importance of using an appropriate method for pain 
induction in exercise/pain studies. Our data shows that pain tolerance (mean pain in CPT) 
during a CPT and pain threshold (pressure corresponding to weak pain) via algometry 
explain only limited variance in endurance performance (4.4% and 4% respectively), 
which is striking given the variance explained by EIP tolerance (69.4%). When combined 
with the physiological performance parameters, CPT and PPT had no predictive capacity, 
whereas EIP was still able to explain an additional 7.5% variance after PPO had explained 
74.7% variance in the model. This demonstrates that the method used to induce 
experimental pain should replicate the type of pain experienced as closely as possible, and 
may partly explain the lack of agreement in previous research that attempts to explain the 
relationship between pain and exercise performance. Although the method of inducing EIP 
in the current study is a step-forward in quantifying its role in endurance performance, 
developing an experimental pain model which replicates EIP in resting conditions is still 
important. Although some studies have achieved this through the use of intramuscular 
saline injection (Khan et al., 2011) or biochemicals (Pollak et al., 2014), these studies are 
limited and there still remains a need to apply this technique to whole-body exercise. 
Perception of pain is generally assessed in research through the use of thermal, pressure 
and electrical stimuli to promote an algesic response. Consequently, it is these methods 
which have usually been applied to studies that examine the relationship between exercise 
and pain (Ellingson et al., 2012; Janal et al., 1994; Ruble et al., 2005; Vaegter et al., 2015). 
This may have misrepresented the importance of EIP, as the pathway between nociception 
to pain perception is a hugely complex process, and different types of painful stimuli 
follow different processing pathways and consequently evoke very different responses 
(Olesen et al., 2012), as our data supports. This is one of the key reasons why particular 
analgesics are more effective in treating different types of pain. Pain arising from intense, 
repetitive and rhythmical movement, which is consentient with endurance exercise, is 
likely produced through a combination of increased intramuscular pressure, release of 
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noxious metabolites and deformation of tissue associated with muscular contractions 
(Ellingson et al., 2014). Thus, in order to adequately examine the role of EIP in exercise 
performance, the experimental pain used should try to emulate the environment and 
aetiology of EIP as closely as possible. Therefore, whilst algometry may be a useful means 
to assess specific hyperalgesia of muscles (for example in delayed onset muscle soreness 
(Close et al., 2006) and fibromyalgia (de Carvalho et al., 2012)), it does not adequately 
represent EIP, and thus, we recommend that its use in the assessment of this phenomenon 
should be avoided. The mechanisms causing the perception of pain during a CPT are so 
far removed from the sensation of EIP (Olesen et al. 2012), that its use is also questionable 
when assessing the role of pain in exercise performance.  
It has previously been suggested that the tolerance of EIP is an important prerequisite for 
endurance performance (Mauger, 2013, 2104). Whilst this notion is well-supported 
through interviews with athletes and coaches (Kress & Statler, 2007), given the emphasis 
placed on this parameter there is comparatively little empirical evidence to convincingly 
substantiate these beliefs. Whilst studies have been able to demonstrate that EIP is 
proportional to exercise-intensity (Cook et al., 1997), and that using an intervention to 
reduce pain (such as caffeine or paracetamol) can improve exercise performance (Astorino 
et al., 2011; Astorino et al., 2012; Foster et al., 2014; Hudson et al., 2008; Jenkins et al., 
2008; Mauger et al., 2010, 2014), the design of these studies generally mean that whilst 
performance can be improved, differences in pain between conditions are masked (i.e. not 
different). This may be because participants regulate their intensity based on their pain 
perception (Mauger, 2014), but therein lies an assumption that the intervention has elicited 
analgesia, and that it is this analgesia which has allowed an improved performance. This 
inference is further questioned by studies which employ an analgesic intervention which 
elicits no change in pain or performance ± a common finding when aspirin and dietary 
ginger are used (Black & 2¶&RQQRU; Cook et al., 1997; Hudson et al., 2008). 
However, studies which increase pain during exercise through intramuscular saline 
injections (Graven-Nielsen et al. 2002; Khan et al. 2011) and muscle damage (for example; 
Black & Dobson, 2013) have shown that performance is decreased, thus providing further 
support for the notion that pain perception influences exercise performance. A recent study 
(Gonglach et al., XVHGDQRYHOµSDLQ-FODPS¶H[HUFLVHWULDOWRH[DPLQHWKHDQDOJHsic 
effect of caffeine on exercise performance, and further substantiates this view. The use of 
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the pain-clamp in this study (Gonglach et al., 2015) provides more direct evidence that a 
reduction in pain can lead to an improved endurance performance. Thus, despite the 
methodological constraints of previous studies, the majority of the literature is supportive 
of the concept that pain tolerance is an important pre-requisite to endurance performance. 
To our knowledge, the data from the current study is the first to meaningfully quantify this 
relationship, and shows that the recreationally active in this study participants who were 
willing to engage in greater amounts of pain in a separate exercise trial exhibited better 
performances in the TT. The linear relationship between perceived pain and work-rate 
(Cook et al., 1997) likely underpin this observation ± if higher work rates produce greater 
levels of pain, then for a faster completion time an athlete must be willing to endure 
significant amounts of pain in order to maintain competitive work rates. For the athlete 
who will not or cannot endure higher levels of pain, they must adhere to lower work rates 
in order to prevent pain from progressing to intolerable levels - in the current study, 
participants with worse TT completion times were apparently unwilling to maintain 
sufficiently high PO in the RPE-clamp because they could not tolerate the pain that this 
would induce. Although changes in work rate during self-paced exercise may be partly 
regulated by pain perception (and therefore performance predicted by pain tolerance), the 
relationship between pain and performance is likely more complex than this. Indeed, it 
appears that analgesia may only be effective during less painful exercise (Gonglach et al., 
2015), and that complete analgesia negatively affects the pacing response (Amann et al., 
2009).  Therefore, it may be that pain is used to help regulate pacing during exercise (in 
addition to a host of other variables), but that this regulation is overly conservative so that 
higher levels of peripheral fatigue could be tolerated (if pain were reduced). 
When traditional predictors of endurance performance (VO2max, GET, PPO) were 
combined with the significant pain threshold/tolerance predictors (EIP tolerance, PPT and 
time lasted in CPT) in the regression analysis, only PPO and EIP tolerance
 
arose as 
significant contributors to predicting TT performance. This observation supports the notion 
that both physiological and psychological components should be accounted for in 
endurance performance. The factors affecting endurance performance have been well-
argued (Joyner & Coyle, 2008; Marcora, 2010; Tucker, 2009), but perhaps the most widely 
DFFHSWHGLVWKDWRI-R\QHUDQG&R\OH¶VPRGHORIHQGXUDQFHSHUIRUPDQFHZKLFKuses 




explain day-to-day variation between performances, variation between individuals with 
similar values, and changes in velocity within a race (when even pacing is the optimal 
strategy). Tolerance of EIP and pain perception during exercise may help explain these 
issues, because these traditional performance parameters (VO2max, GET, PPO) will partly 
determine the size of the nociceptive signal for a given velocity. Indeed, EIP arises as a 
result of the build-XSRIQR[LRXVELRFKHPLFDOV2¶&RQQRU& Cook, 1999) combined with 
increased intramuscular pressure, and the point at which this increases significantly is 
partly dependent on the transition from steady-state to non-steady-state exercise. This is 
because many of these noxious biochemicals are produced when energy is derived from 
anaerobic sources. However, it is well-known that perceived pain is ultimately a subjective 
experience, which is not always dependent on the size of the nociceptive signal. Therefore, 
whilst the physiological parameters of endurance performance may dictate the peripheral 
conditions for pain, how this is perceived and acted on by the athlete will depend on a 
multitude of other psychological and perceptual factors (Kress & Statler, 2007). This 
suggests that endurance performance is not solely a product of the peripheral factors of the 
Joyner and Coyle (2008) model (which may dictate the state of the peripheral muscle for 
a given velocity), and that the pain and discomfort arising from the interpretation of the 
intramuscular environment (and its effect on decision making) should be recognised. 
However, it should be stated that in the current study, peak power output still explained 
the greatest variance in TT performance (~75%), with tolerance on EIP pain explaining an 
additional 7.5%. Therefore, the contribution of EIP tolerance to the endurance performance 
model (for the participant group for this study) is 10% of that explained by traditional 
physiological factors. Consequently, physiological capacity is still of primary importance 
in explaining endurance performance, although the current data suggests a smaller, but 
nonetheless important role for EIP tolerance. Indeed, in the current study, for a participant 
in the upper part of the third quartile for TT completion time, performance variation 
explained by EIP tolerance could be sufficient to move them into the upper second quartile.  
It is important to note that the participants in the current study, whilst recreationally active, 
were not trained cyclists. It has previously been suggested that physical activity (Ellingson 
et al., 2012) and regular, specific endurance training (Scott & Gijsbers, 1981) decrease 
pain perception. Therefore, the variance in endurance performance explained by EIP 
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tolerance in this study is likely specific to the participant population and should not be 
assumed to be similar in trained or highly trained individuals. However, none of the 
previous studies investigating the differences in pain perception between untrained and 
trained individuals have used EIP as a measure of experimental pain, and as previously 
discussed, this limits the understanding of this pain/exercise relationship. Indeed, the 
relationship between pain threshold/tolerance and training appears complex, with exercise 
training appearing to improve pain tolerance in some tests (e.g. CPT) but not others (Janal 
et al., 1994). Therefore, future research should seek to further explore the influence of 
training on pain perception, using an experimental pain model that replicates EIP.    
The lack of previous research discussing the role of pain in exercise performance may be 
due to the type of exercise task traditionally used in exercise science. In addition, sensation 
of pain is often measured and discussed as part of perception of effort and fatigue (Sgherza 
et al., 2002), and this may have affected wider understanding of the specific role of pain. 
Until relatively recently, research investigating fatigue and perception of effort has tended 
to rely on time to exhaustion and fixed intensity tests (Mauger, 2013). However, 
contemporary research has started to use self-paced exercise models, which can elicit a 
different response and is more applicable to exercise performance (than fixed work rate 
models). In the current study, it is interesting to note that the end pain scores reached in 
the RPE clamp trial (where PO was free to vary), and the self-paced TT were very similar 
(7.23 ± 2.02 and 7.25 ± 2.24 respectively), and that the end pain in the VO2max test (where 
PO was externally controlled) was much lower (6.31 ± 2.70). This is a similar observation 
to previous pain studies (Cook et al. 1997), where relatively low pain responses were 
reported for fixed intensity exercise of moderate intensity and for a maximal incremental 
test. Therefore, it may be that the nature of self-paced exercise provides conditions where 
the athlete is able and/or willing to reach considerably higher levels of EIP in comparison 
to fixed intensity exercise. Therefore, the importance of EIP with respect to performance 
in fixed intensity exercise may be different to that of self-paced performance, and thus its 
importance may have been previously underestimated. Future research should seek to use 







This study demonstrates that EIP plays an important role in moderate duration endurance 
performance for recreationally active participants, and that a high tolerance for EIP 
provides an important performance advantage. Because the magnitude of perceived pain 
depends on a host of factors, not always related to the size of the nociceptive stimulus, it 
is important that psychological performance parameters (in this case pain), are considered 
alongside the physiological. When assessing pain threshold and tolerance, it is important 
to account for the aetiology of the pain type, as this has consequences for its perception. 
Therefore, when examining the pain-exercise relationship, induction of experimental pain 
through the CPT and algometry should be avoided, as this bear little relevance to EIP.  
Consequently, future studies looking to investigate the role of EIP should try to replicate 
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INTRODUCTION: Ramachandran's mirror box technique has previously been used to 
treat pain arising from clinical conditions, by creating an illusion of a hidden limb. We 
sought to use this technique to deceive participants about the difficulty of an exercise task, 
to examine whether this deception would moderate exercise-induced pain (EIP) and rating 
of perceived exertion (RPE), and whether this would influence endurance performance. 
METHODS: 42 participants were allocated into a Control (No Mirror) and Experimental 
(Mirror) group. In the first experimental visit, all participants performed three separate 
isometric elbow flexion tasks of 20% of their one repetition maximum (1RM) until 
exhaustion in both arms simultaneously. In the second visit, participants in the Control 
group repeated the same task as visit 1. Participants in Experimental group performed the 
same task but with their arms in a mirror box, and unbeknown to the participant, on two of 
the tests the hidden arm lifted 15%1RM and 25%1RM. Time to exhaustion, RPE and EIP 
was recorded for each of the tests. RESULTS: The deception of task difficulty in the 
Experimental group led participants to produce significantly longer times to exhaustion 
when they thought the task was easier than it was, and significantly shorter times to 
exhaustion when they thought it was harder than it was (F (1,40) = 4.293, P = 0.045). The 
ANOVA revealed a significant main effect of condition for EIP during the TTE test (F (1, 
40) = 8.736, P = 0.005), and a significant interaction effect of EIP between groups for each 
time condition were observed (F (1,40) = 7.163, P = 0.011). The ANOVA revealed a 
significant main effect of condition for RPE during the TTE test (F (1, 40) = 33.403, P < 
0.001), and a significant interaction effect of RPE between groups for each time condition 
(F (1,40) = 13.367, P < 0.001). This was accompanied by significantly higher EIP and RPE 
when they thought the task was harder than it was, and significantly lower EIP and RPE 
when they thought the task was easier than it was. CONCLUSION: This study 
demonstrates that expectations about task difficulty and its associated perceptions 
influence subsequent performance. These findings show that EIP and RPE were partly 
based on the expected task, and exercise performance was positively or negatively 







Ramachandran's mirror box technique (Ramachandran and Rogers-Ramachandran and 
Cobb, 1996) is a promising intervention that is commonly used to treat hemiparesis 
following stroke, phantom-limb pain, and complex regional pain syndrome. It can also lead 
to better motor outcomes, and it is reported to have analgesic benefits on intractable pain 
conditions (Ramachandran & Altschuler, 2009). The technique involves participants 
viewing one limb (for example; the left arm) and a reflection of it in the mirror, thus 
creating the illusion of viewing both arms, despite the fact the participants only see the 
reflection of their left arm in the mirror. How the mirror box is capable of treating both 
acute and chronic pain conditions is the matter of debate, largely because the processing 
of pain throughout the brain is complex and involves multiple primary and secondary 
regions. Indeed, brain functional imaging of neuronal activity has identified that multiple 
brain regions are modulated and activated by nociceptive stimuli (Price, 2000). However, 
some nociceptive regions remain unknown and often processing involves several non-
nociceptive activations which reflect secondary processes, such as anticipation, attention, 
affect, and cognitive aspects of pain perception (Buchel et al., 2002; Coghill et al., 1999; 
Derbyshire et al., 1997; Rainville et al., 1997). One area of primary importance is the 
insular cortex, which sustains many connections throughout the brain network, including 
the primary and secondary somatosensory areas: auditory, visual, motor cortical areas, 
several thalamic nuclei, amygdalae, basal ganglia (BG), anterior cingulate, prefrontal 
cortex, and hypothalamus (Black, 2012; Augustine, 1996; Mesulam & Mufson, 1982). 
This demonstrates the complex nature of pain processing and the different conscious and 
subconscious components involved in the ultimately subjective experience of pain 
perception. It is likely that the mirror box is capable of attenuating pain through its effect 
on the mirror neurons, which are present in cerebral cortical areas of the human brain, and 
form a section of a complex network that is required for visual information (Rizzolatti & 
Craighero, 2004). The neurons in the temporal, occipital, frontal, and parietal areas (that 
contribute to the mirror neurons) in the premotor cortex (Iacoboni et al., 2005) are 
responsible for the assembly of visual and motor sensory system information and thus may 
play a vital role in pain as a perceptual and affective phenomenon. It is suggested that in 
amputees, phantom limb pain can be caused because after amputation the motor output 
still perceives the limb to be present, but proprioceptive and visual input is absent from the 
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amputated area. This incongruent information processing may lead directly to pain, and 
indeed, even in healthy LQGLYLGXDOV¶ limb pain can be induced when incongruent 
information is presented (McCabe et al., 2005). The mirror box essentially works by 
rectifying the incongruence of the visual and sensory input by creating an illusion of the 
missing limb. These studies demonstrate that a mirror box is capable of creating (or 
rectifying) an incongruent environment between expectation and reality.  
Intense and repetitive or prolonged muscular contraction produces a metabolic 
environment in and around the muscle that sensitises and stimulates peripheral nociceptors. 
The consequence of this is that prolonged exercise causes a level of discomfort and pain 
that is proportional to exercise intensity and/or exercise duration (Cook et al., 1997). 
However, in most exercise scenarios there is a host of external factors, independent of the 
metabolic environment in the muscle (i.e. the size of the nociceptive signal), which have 
the potential to moderate the overall pain perceptioQ RU LQWHQVLW\ ,QGHHG SDUWLFLSDQW¶V
mood, a different level of motivation, or task distraction have all been shown to reduce 
pain perception in experimental studies (Atlas & Wager, 2012), and these factors are 
changeable in most forms of exercise. This is important because it is suggested that 
exercise-induced pain (EIP) can limit or predict endurance performance (Astokorki & 
Mauger, 2016) and may pose a barrier to engaging in physical activity. Whilst it is difficult 
to repeatedly and safely reduce the size of the nociceptive signal during exercise (although 
this has been shown to improve exercise performance using analgesic drugs, it is not 
recommended as a strategy ± Mauger et al., 2010, Foster et al., 2014), there may be scoped 
to moderate the psychological processing of pain during exercise. However, this possibility 
has not yet been investigated. 
The purpose of the current study was to use the mirror box technique to investigate whether 
pain arising from exercise could be attenuated by changing particLSDQW¶VSHUFHSWLRQRIWKH
exercise task. The mirror box was used to create the illusion that participants were lifting 
either a heavier, or lighter mass than they actually were. It was hypothesised that when 
participants thought they were lifting a heavier mass, pain would be increased and time to 
exhaustion would be reduced. Whereas when they thought they were lifting a lighter mass, 





III. MATERIALS AND METHODS 
Participants: 
Forty-two recreationally active, male (n=29) and female (n=13) participants were recruited 
IRUWKLVVWXG\3DUWLFLSDQWV¶PHDQDJHKHLJKWDQGERG\PDVVZHUH± 4 years, 176 ± 10 
cm and 70.73 ± 12.5 kg respectively. Individuals suffering from the following conditions 
were excluded from the study; a history of mental or brain disorders, cardiovascular 
disorders, types I and II diabetes, and those taking chronic medications that affect the 
central nervous system. Participants were informed that all data would be unidentifiable 
and that they had the right to withdraw from the experiment at any time. Following this, 
they were asked to complete a health questionnaire followed by an informed consent form. 
The study was approved by the local Ethics Committee of the University of Kent. 
Participants reported to the laboratory on two separate experimental visits. For 24 h before 
each visit, participants refrained from any vigorous exercise, and asked to refrain from the 
ingestion of alcohol, caffeine and analgesics 48 h, 8 h and 6 h prior to any visit (Lu, Lai & 
Chan, 2008). The time interval between the two experiments was 2-7 days. Following Visit 
1, participants were allocated to either a control group (No Mirror) or an experimental 
group (Mirror). Group allocation was made according to paUWLFLSDQWV¶WLPHWRH[KDXVWLRQ
(TTE) time achieved during Visit 1 so that TTE times were evenly balanced between 
groups (Mirror = 570 ± 265 s; No Mirror = 571 ± 148 s). This resulted in 21 participants 
(male = 15, female = 6) in the control group and 21 participants (male = 14, female = 7) in 
the experimental group.  
 
Procedures  
Following a separate familiarisation session of the procedures, in this first visit, 
participants performed a one repetition maximum (1RM) contraction of the bicep muscle 
to familiarise them with the isometric time to exhaustion (TTE) exercise task. In a seated 
position, with their elbow rested on a pad on a table in front of them, participants lifted a 
series of increasingly heavier dumbbell weights through 90 degrees of elbow flexion 
(forearm resting on table at 0° followed by elbow flexion to forearm to 90°). Starting 
weight and weight increments were estimated by experimenter and participant to minimise 
the number of lifts required to reach 1RM. One to 3-min rest were provided between each 
contraction so that the participant was adequately rested for each attempt. This process was 
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repeated for both dominant and non-dominant arms and all participants received strong 
verbal encouragement throughout each contraction. Following a 20-min period of rest, 
participants then performed an isometric TTE bicep contraction of both arms at 20% 1RM. 
Participants held the dumbbells in the required position (elbow joint at 90° with elbow 
rested on table, with forearm and upper arm each at 45° to table surface) with both arms 
until they could no longer maintain the contraction. Every 45 s during the TTE, participants 
were asked to report their muscle pain using a numeric pain rating scale (Cook et al., 1997) 
and their rating of perceived exertion (RPE) using the Borg (6-20) scale (Borg, 1998). 
Participants were instructed to report RPE solely as effort to drive the limb (Pageaux et al., 
2015) (i.e. independent of pain and discomfort) and that pain should be anchored to 
exercise-induced pain (i.e. numeric values given relative to their experience of muscle 
pain).In the second visit, participants were asked to perform a similar TTE task as 
described above, however participants were required to complete three TTE tests holding 
20% of their 1RM in the non-dominant hand and 20%, 25% and 15% of their 1RM in the 
dominant hand, in a randomised order and with 20-min recovery between each TTE. The 
No Mirror (Control) group could see both arms, however, the Mirror (Experimental) group 
performed the task with their arms inside a mirror-box (Ramachandran et al, 1995). The 
mirror-box consisted of a mirror placed in the sagittal plane between two arm holes. One 
side of the box was covered allowing participants to only see their non-dominant hand, 
however due to the mirror placement, the image of the non-dominant hand was 
superimposed onto the dominant hand so the participants believed they could see both 
hands. To facilitate this illusion, participants in the Mirror group were given a period of 
10-min before the TTE tasks to move their hands simultaneously until they perceived their 
non-dominant hand as the dominant (i.e. participants only saw their non-dominant hand 
and its reflection, but perceived the reflection to be their dominant hand). The result of the 
illusion was that participants in the Mirror Group believed that they were always lifting 
20%MVC in both hands, whereas they were actually lifting; 20% and 20%, 20% in the 
non-dominant hand and 15%, and 20% and 25% in the dominant hand (see Figure 4.1). 
This illusion was reinforced by the investigator telling the participant that they were 
replicating the task from Visit 1 three times (i.e. always lifting 20%1RM in both hands). 
In the same manner as Visit 1, RPE and pain were recorded every 45 seconds. Both groups 
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were asked to focus on both arms throughout the TTE, however no other verbal 








All data are presented as mean ± SD. Data were checked for standard assumptions 
(Kruskal-Wallis test and Shapiro-Wilk test) for each statistical test prior to analysis, and 
none of these were violated. To control for the inter-individual variability of baseline 
values in TTE that occurred between the two groups (Mirror and No Mirror), comparisons 
were made according to the percentage change from baseline TTE (20%1RM) to the mass 
change conditions (15%1RM (Light) and 25%1RM (Heavy)), thus creating two conditions 
IRU WKH DQDO\VLV RI 77( ¨+HDY\ DQG ¨/LJKW (Tstutsumi et al., 2011). Therefore, to 
compare TTE time, mean exercise-induced pain and mean RPE between groups for each 
FRQGLWLRQD[$129$JURXSPLUURUDQGQRPLUURU[FRQGLWLRQ¨+HDY\DQG¨/LJKW
was employed. To compare perceptual measures (exercise-induced pain and RPE) between 
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conditions over time, the slope method was used to create a single value for pain and RPE 
to represent a change over time, as described previously (Angius et al. 2016). To do this, 
individual values of RPE and pain obtained during the TTE were plotted against the 
absolute TTE time for each condition, the curve for each variable was mathematically fitted 
by a linear equation to then obtain the slope. Consequently, perceptual values were 
analysed using a 2x2 ANOVA. All data management and statistical analysis was 
performed using the statistical package SPSS for Windows, version 22 (SPSS Inc., 




























Time to Exhaustion (TTE): The percentage change from baseline TTE to the Light and 
Heavy conditions is shown in Figure 4.2. The ANOVA revealed a significant main effect 
of condition for the TTE test (F (1,40) = 44.113, P < 0.01). A significant interaction effect of 
TTE between grouSV0LUURUDQG1R0LUURUIRUHDFKWLPHFRQGLWLRQ¨/LJKWDQG¨ +HDY\
was observed (F (1,40) = 4.293, P = 0.045). This demonstrates that participants in the Mirror 
































Figure 4.2  TTE elicited a significant difference between conditions. *significantly different 











Exercise-induced pain (EIP): The ANOVA revealed a significant main effect of condition 
for EIP during the TTE test (F (1, 40) = 8.736, P = 0.005), as shown in Figure 4.3. A 
significant interaction effect of EIP between groups for each time condition were observed 
(F (1,40) = 7.163, P = 0.011). This shows that the perceived EIP for participants in the 
Experimental group was attenuated by the illusion that all masses lifted were the same, as 





























Figure 4.3  Difference in EIP slope from the Control condition to the two mass change 




































































Figure 4.4  The progression of the perceived EIP over time was more similar between 
conditions in the Mirror group (a) then in the No Mirror group (b). This suggests that the visual 




Rating perceived exertion (RPE): The ANOVA revealed a significant main effect of 
condition for RPE during the TTE test (F (1, 40) = 33.403, P < 0.001), and a significant 
interaction effect of RPE between groups for each time condition (F (1,40) = 13.367, P < 
0.001), as shown in Figure 4.5. This shows that the perceived RPE for participants in the 
Experimental group was attenuated by the illusion that all masses lifted were the same, as 































Figure 4.5  Difference in RPE slope from the Control condition to the two mass change 








































































Figure 4.6  The progression of the RPE over time was more similar between conditions in the 
Mirror group (a) then in the No Mirror group (b). This suggests that the visual dimensions of the 




The purpose of this study was to investigate whether deceiving participants about the 
difficulty of an exercise task using an optical illusion, would be able to moderate perceptual 
response and change endurance performance. The primary finding was that despite the 
exercise task being made harder or easier (via increasing or decreasing the mass lifted), an 
optical illusion which made participants oblivious to this change blunted the effect of the 
task difficulty on the perceptual measures (EIP and RPE) and resulted in less dramatic 
changes in endurance performance. To our knowledge, this is the first study demonstrating 
that deception of task difficulty, via the use of a mirror box, can moderate perceptual 
response and endurance performance.   
In the current study, participants in the Mirror (Experimental) Group believed they were 
always lifting 20%1RM in both hands, whereas they were actually lifting 5% more or 5% 
less than this (i.e. 25% 1RM and 15%1RM) in their dominant hand. This created a scenario 
where participants were completing a task that was significantly harder (25% 1RM) or 
easier (15%1RM) but were deceived to believe that it was always the same task. 
Participants in the No Mirror (Control) Group who were aware of the changes in mass (i.e. 
that the tasks were easier or harder) showed that when a lighter weight was lifted, RPE and 
EIP rose less steeply and TTE was longer. When a heavier mass was lifted, RPE and EIP 
rose more steeply and TTE was shorter. Whilst the participants in the Mirror 
(Experimental) Group showed a similar response, the degree to which the perceptual and 
performance measures differed between conditions was significantly attenuated. That is, 
lifting a heavier mass did not increase EIP and RPE, and did not reduce TTE by as great a 
degree as in the Control group. However, lifting a lighter mass did not reduce EIP and 
RPE, and did not increase TTE by as great a degree as in the Control group. This suggests 
that the perception of task difficulty exerts an important influence on perceived effort of 
lifting a mass, and the EIP arising from muscular contraction. It is likely that the changes 
WRWKHVHSHUFHSWXDOPHDVXUHVWKHQFDXVHGFKDQJHVWRSDUWLFLSDQWV¶HQGXUDQFHSHUIRUPDQFH
(Marcora & Staniano, 2010; Mauger, 2014). 
Whilst it is widely acknowledged that endurance performance is primarily dictated by 
physiological parameters (Joyner & Coyle, 2008), there is growing understanding that the 
perceptual response to exercise also forms an important basis for success. Indeed, the 
psychobiological model argues that endurance performance can be explained solely by 
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psychological constructs (Marcora, 2010). According to this model, during a time-to-
exhaustion test, RPE gradually increases over time so that the task feels increasingly 
strenuous. The model predicts that people will consciously disengage from the task when 
their perception of effort has increased to the critical level set by their potential motivation, 
or, they believe they have attained maximal effort and perceive continuing as being beyond 
their capability (Marcora & Staiano, 2010; Smirmaul, Dantas, Nakamura, & Pereira, 
2013). Therefore, according to this model, any intervention which serves to moderate RPE 
will have a direct effect on endurance performance. The results of the current study support 
this, as deceiving participants about the mass lifted attenuated RPE and a consequent 
change in time to exhaustion was observed. However, the psychobiological model is 
extreme in that it states that perception of effort (and changes to it) is the sole driver for 
determining endurance performance. However, it has been proposed that the pain arising 
from repeated muscle contraction (exercise-induced pain) also forms an important 
psychophysiological determinant of endurance performance (Mauger, 2014). This concept 
is directly refuted by the psychobiological model (Marcora, 2010), yet numerous studies 
demonstrate that changing pain response during exercise has a direct effect on performance 
(Gonglach et al., 2015; Graven-Nielsen et al., 2002; Mauger et al., 2010; Foster et al., 
2014). In the current study, deception of task difficulty moderated the EIP that participants 
felt, and differences in time to exhaustion were observed between these conditions. 
Therefore, the results of this study also support the notion that EIP plays an important role 
in endurance performance, and this can be moderated independently of the magnitude of 
the nociceptive signal. There was also a similar response for changes in perception of effort 
however, and so the importance of effort perception alongside pain should also be 
recognised.  
The observation that perceived pain can be influenced by psychological interventions is 
not new. Indeed, expectation and arousal factors, such as placebo effects and the 
requirement to focus on an ongoing task, are examples of variables that modulate pain 
(Wiech, Ploner, & Tracey, 2008). Simple perceptual factors can also influence pain. For 
example, both reported intensity of pain and neural responses to painful stimuli are reduced 
when participants look at their own body, compared with when they view a neutral object 
(Longo, Betti, Aglioti, & Haggard, 2009). This visually induced analgesia demonstrates 
that acute pain can be modulated by specific visual contexts. The effect of the 
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psychological intervention in the current study on EIP however, is a new finding, and this 
may have been due to the anticipation or expectation of pain that participants thought may 
arise as a result of the mass lifted in the time to exhaustion task.  Indeed, when pain is 
anticipated, patients often report the worsening of pain (Turner et al., 1994), whereas 
expectation of pain relief usually induces placebo analgesia (Wager et al., 2004). 
Furthermore, the level of expected pain intensity significantly alters perceived pain when 
comparisons between two noxious thermal stimuli of almost equal intensity are made 
(Keltner et al., 2006). In the current study, the participants were well conditioned from 
Visit 1 to know the expected rate of EIP increase during the 20%1RM TTE task, and so 
these expectations may have served to influence the actual pain experienced when 
unbeknown to them the task was made easier or harder in Visit 2. Studies in pain 
neuroscience suggest that nociceptive brain regions are modulated by stimulus 
expectancies and even short-term expectations that vary as a function of cue have strong 
effects on pain perception and pain-evoked responses (Atlas, Bolger, Lindquist & Wager, 
2010). These conditioned expectations of pain appear to result in real changes in pain-
related processing in the brain, with regions affected including the cingulate, insula, 
thalamus, lateral prefrontal cortex, orbitofrontal cortex, parahippocampus, and caudate 
(Atlas & Wager, 2012). Thus, in the current study, despite the nociceptive signal being 
increased (or decreased) by changing to the mass lifted, an expectation that the EIP would 
not be different likely resulted in changes to pain-related processing in the brain that caused 
EIP to change little.  
The Mirror Box technique has been shown to be a successful method in treating conditions 
where movement is impaired or significant pain is experienced with relatively little limb 
movement (Ramachandran & Altschuler, 2009). The current study also suggests, for the 
first time, that it is successful in reducing the non-clinical pain related to strenuous physical 
exercise and that this can improve exercise capacity/performance. However, the 
practicality of using the Mirror Box to improve physical activity or performance outside 
of the laboratory in fully mobile populations is perhaps questionable. However, doing so 
would be advantageous because even moderate levels of exercise elicit some level of pain 
(Borg, 1998), and symptoms of diseases such as pain and fear of pain may present barriers 
to physical exercise (Hays & Clark, 1999) in some clinical populations where exercise 
would be beneficial to their condition. Indeed, regular exercise provides a range of health 
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benefits, which significantly reduce all-cause mortality (Lee & Skerrett, 2001) and 
consequently exercise is often prescribed to treat a range of clinical conditions to improve 
patient outcome (Naci & Ioannidis, 2013).  If pain could be reduced during exercise, then 
this may improve motivation to exercise (Wiech & Tracey, 2013) and help improve rates 
of adherence to exercise prescription programmes. The results of the current study provide 
a proof of principle that visual expectations of exercise can influence pain, perception of 
effort and exercise performance/capacity and so similar interventions that have more real-
world practicality may provide an avenue for future study. The rapid development of new 
technology and the increased affordability of virtual reality (VR) devices may provide this, 





This study used the well-established Mirror Box technique to deceive participants about 
the expected difficulty of an isometric, single-limb TTE task. The Mirror Box created an 
illusion that deceived participants into believing that the task was the same as previously 
completed, when in fact it was easier or harder. This purely psychological intervention 
resulted in reduced EIP and RPE (when participants thought the task was easier), and 
increased EIP and RPE (when participants thought the task was harder). These 
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INTRODUCTION: Exercise-induced muscle pain (EIP) is believed to arise from a bult-
up of endogenous algesic substances, with an increased intramuscular pressure in and 
around the muscle. Transcutaneous electrical nerve stimulation (TENS) and interferential 
current (IFC) have been shown to elicit analgesic effects in a variety of conditions. 
However, the relative effectiveness of these two modulations on EIP has not been 
considered. Therefore, the aim of this study was to investigate whether TENS or IFC elicit 
an analgesic effect during single limb, submaximal isometric contraction, and whether this 
improves time to exhaustion. METHODS: 18 recreationally active male (n= 11) and 
female (n= 7) participants were recruited. A single-blind, crossover, randomised design 
with TENS, IFC, and sham conditions was used (on separate visits). The TENS and IFC 
were administered on the bicep of the dominant arm, whereas in the sham condition a 
dummy simulator produced no current. In each condition, participants initially performed 
3x5 second maximal voluntary contractions (MVCs) against a load cell. The maximum of 
the values was used to establish the 20% MVC for the TTE task. The TTE task involved 
the participant maintaining a 20% isometric MVC of the bicep until task withdrawal. 
RESULTS: The ANOVA revealed a significant difference in the time to exhaustion 
between conditions (F (2, 34) = 10.554, P < 0.001). The ANOVA also revealed a significant 
main effect of condition for exercise-induced pain during the TTE test (F (2, 34) = 3.690, P 
= 0.035). No significant changes in rating of perceived exertion (RPE) were found between 
the three conditions (P > 0.05). A 3 x 8 (condition x iso-time) ANOVA revealed a 
significant interaction effect for exercise-induced pain over time between conditions 
during the TTE test with lower pain intensity in the TENS and IFC conditions (F (3.4, 58.4) = 
3.671, P = 0.013). No interaction effects for RPE were found between the three conditions 
(P > 0.05). For the MVC, paired-sample t-tests demonstrated that MVC was significantly 
reduced following the TTE in the Sham (t (17) = 9.069, P < 0.001), TENS (t (17) = 7.037, P 
< 0.001) and IFC conditions (t (17) = 8.558, P < 0.001). No significant differences between 
conditions were found for the pre-MVC (F (1.4, 23.4) = 1.758, P = 0.188) or the post-MVC 
(F (2, 34) = 1.499, P = 0.238). CONCLUSION: The findings of the study suggest that TENS 
and IFC elicit an analgesic effect for EIP, and that this intervention elicited a significant 




II. INTRODUCTION  
Exercise-induced muscle pain is believed to arise from an accumulation of endogenous 
algesic substances (including: hydrogen ions, potassium, histamine, serotonin, bradykinin, 
acetylcholine, adenosine and substance P), with an increased intramuscular pressure in and 
around the muscle (Mense, 1993). These endogenous algesics are released from cells when 
homoeostasis is disturbed, which is a consequence of intense exercise (Mauger et al., 
2010). Therefore, exercise-induced muscle pain is closely bound to both the intensity and 
duration of the exercise task (Cook et al., 1997). The accumulated algesic substances 
sensitise, activate, or increase the firing rate of group III and IV afferent muscle fibres, 
which then convey nociceptive signals regarding actual or potential tissue damage to the 
brain via the spinal cord (O'Connor & Cook, 1999). It is suggested that the perceived pain 
arising from this afferent fibre activation, along with increased intramuscular pressure, heat 
accumulation, and skeletal muscle fatigue, may play a combined role in the regulation of 
the level of exercise intensity and preservation of a metabolic reserve by the central 
nervous system (Tucker, 2009). Indeed, the activity of afferent fibres can moderate sensory 
receptor input, reflex and inhibitory circuit neurons in the spinal cord, neurotransmitters 
involved in synaptic modulation, and central nervous system efferent output (Bentley, 
1996). Consequently, muscle pain may increase afferent neuron inhibition and decrease 
the ability of the brain to recruit muscles ability to produce force (Graven-Nielsen et al, 
2002). Furthermore, as a consequence of the pain, the exercise may also reduce mood 
(Karsdorp et al., 2013) and make the task psychologically more demanding and less 
desirable, which may decrease motivation and performance. Therefore, there is likely both 
a psychological and physiological benefit to reducing muscle pain during exercise.  
Transcutaneous electrical nerve stimulation (TENS) and interferential current (IFC) have 
been shown to elicit analgesic effects in a variety of conditions (Marchand et al., 1993; 
Robinson, 1996; Schmitz et al., 1997). How this analgesia is achieved is debated, but 
DeDomenico (1987) and Savage (1992) suggest that the electrical principles of TENS and 
IFC differ, and so the techniques operate through different mechanisms of action. The 
neurophysiological basis of muscle pain relief from TENS is believed to derive directly 
from the gate control theory of pain. Accordingly, TENS is proposed to selectively activate 
$ȕ ODUJH-diameter afferent fibres by high frequency stimulation, inhibiting constant 
transmission of nociceptive neurons by generating an afferent barrage of nerve impulses 
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within the spinal cord (Melzack, 1965; Garrison & Foreman, 1994; Walsh, 1997). 
However, it is also suggested that the application of TENS burst mode can effectively 
DFWLYDWH*URXS,,,$įDQG&VPDOO-diameter afferent fibres by both high frequency and 
low frequency bursts applied together. This is suggested to lead to the release of 
endogenous opioids (Resende et al., 2004; Sabino et al., 2008), and serotonin (Chen, 2010) 
and a subsequent decrease in pain. IFC utilises a medium frequency alternating current 
with a various beat frequency (Low & Reed, 1994; Cramp et al., 2000), and combined with 
a kilohertz cycle duration delivers current to overcome skin impedance and penetrate deep 
into the muscle. This is believed to reduce pain transmission through gate control 
mechanisms, release endorphins and increase circulation of opioids (Melzack, 1965; 
Dounavi, Chesterton & Sim, 2012).  
Muscle stimulation using therapeutic current has previously been used in combination with 
exercise to achieve several aims, including pain relief, facilitated recovery, treatment for 
urinary incontinence in female athletes and delayed onset muscle soreness (Bolin, 2003; 
Heyman, De Geus, Mertens & Meeusen, 2009; Rivata et al., 2010; Rocha et al., 2012; 
Vanderthommen et al., 2012). Given that exercise-induced muscle pain may be a factor 
affecting exercise capacity and performance, and that therapeutic muscle stimulation has 
shown promise in the treatment of muscle pain (Tourville, Connolly & Reed, 2006), there 
may be scoped to use this technique to reduce muscle pain during exercise.  
To our knowledge, no studies have considered the effectiveness of TENS and IFC on 
exercise-induced muscle pain during fatiguing exercise. Therefore, the aim of this study 
was to investigate whether TENS or IFC elicit an analgesic effect during single limb, 
submaximal isometric contraction, and whether this improves time to exhaustion.  
 
 
III. MATERIALS AND METHODS 
Subjects 
Eighteen recreationally active male (n= 11) and female (n= 7) participants were recruited 
IRUWKLVVWXG\7KHSDUWLFLSDQWV¶PHDQDJHKHLJKWDQGERG\PDVVZHUH\Us, 176 ± 11 
cm and 73.5 ± 16.6 kg, respectively. Prior to participation, an information sheet detailing 
the study was given to participants, which included an inclusion/exclusion criteria 
checklist. Participants were excluded from the study if they had history of cardiovascular 
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disorders (e.g. angina, heart attack, high blood pressure etc.), chronic medications that 
affect the central nervous system, current pregnancy, bleeding disorders (e.g. 
haemophilia), deep vein thrombosis, impaired sensation, acute/chronic infection (e.g. 
tuberculosis), malignancy, recently radiated tissue, skin diseases or severely damaged skin, 
types I or II diabetes, were using a cochlear implant hearing device or pacemakers, or any 
other condition that may be a danger to their participation (e.g. muscle injury). Following 
satisfactory completion of the inclusion/exclusion criteria checklist, all participants 
provided written informed consent and the research was approved by the University of 
Kent Ethics Committee. Prior to all experimental occasions, participants were asked to 
refrain from the ingestion of alcohol 48 h before the laboratory occasions, and asked to 
refrain from any vigorous exercise (24 h prior), caffeine (8 h prior) and analgesics (6 h 
prior) prior to any test occasion (Lu, Lai & Chan, 2008). Following a full familiarisation 
visit, in a single-blind, crossover, and randomised design, all participants completed a 
TENS, IFC, and sham condition, which were separated by 2-5 days. 
 
TENS and IFC Stimulation 
Using a Vectra Genisys multi-waveform stimulator (Chattanooga Group, Hixon, TN, 
USA), as shown in Figure 5.1, the parameters of biphasic IFC pulses were delivered in a 
continuous mode with a pulse frequency of 100Hz. For the biphasic TENS pulses, a 
continuous pattern of sWLPXODWLRQZDVXVHGZLWKDSXOVHZLGWKRIȝVDQGDIUHTXHQF\
of 100 Hz. A bipolar IFC set-up was used in the current study in order to maintain blinding 
of conditions. Both bipolar and quadripolar IFC have been shown to be equally successful 
when used to manage pain conditions (Johnson & Tabasam, 1998). The current intensity 
was adjusted for the TENS and IFC conditions so that participants reached a strong but 
appropriate intensity without causing any noticeable muscle contraction, whereas in the 
sham condition a dummy simulator produced no current. The two electrodes were 
administered on the bicep of the dominant arm that they were at least 2.5 cm apart (this 
was kept consistent between participants). This location was then recorded and re-used for 





Figure 5.1  Elicit a participant performing a TTE by applying TENS intervention on their 
bicep. 
 
Sham Stimulation  
A sham stimulation was used as a placebo-controlled condition. During the sham 
condition, electrodes were placed in the same locations as the IFC and TENS conditions, 
EXWSDUWLFLSDQWVUHFHLYHGQRFXUUHQWDQGZHUHWROG³7KLVW\SHRIVWLPXODWLRQLVVXSSRVHGWR
reduce pain by using a subthreshold stimulus WKDW \RX ZLOO QRW DEOH WRSHUFHLYH´ 7KLV




During the familiarisation visit, a general health screening was conducted which included 
a series of tests to ensure that it was safe to administer TENS and IFC to participants. 
Before undertaking stimulation, participants were tested for sensory discrimination using 
a sharp and blunt patella hammer, and a skin integrity test to ensure normal skin sensation. 
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For application of TENS and IFC, the skin of the dominant bicep was cleaned thoroughly 
prior to electrode placement in order to reduce electrical resistance. Following this, 
bipolar surface TENS and IFC electrodes were attached to the bicep of the dominant arm. 
Subsequently, TENS and IFC were applied in order to find the appropriate stimulation 
intensity for the subsequent test occasions. The current intensity was adjusted until 
participants reported feeling a tingling sensation without visible muscle contraction and/or 
muscle pain (i.e. non-painful paraesthesia). During stimulation, and after testing, 
participants were monitored for signs of skin irritation, nausea, swelling and pain. On 
completion of stimulation, the current was ramped down before turning off the machine.  
On each test occasion, participants were given standard instructions for the numeric pain 
rating scale (Cook et al. 1997) and rating of perceived exertion (RPE) using the Borg (6-
20) scale (Borg, 1998). Pain was anchored according to minimum and maximum pain felt 
due to exercise-induced pain (EIP). All tests were preceded by a standardized warm-up 
where participants performed three unilateral (dominant arm) maximal voluntary 
contractions (MVC) of the elbow flexors against a load cell (Globus Ergo Meter, Globus, 
Codogne, Italy), which were separated by a 3-min rest. To do this, participants were in a 
seated position with the forearm resting on a bench and the elbow angle at 90º and the wrist 
angle at 180º. Each MVC test was performed for 5 s with a rapid increase in force over 1 
s, a sustained maximum for 3 s, and a gradual release over the final second. Maximal force 
was recorded for each MVC. Participants were strongly encouraged to perform maximally 
throughout each contraction. The maximum of the three values was used to establish the 
20% MVC for the time to exhaustion task (TTE) performed in that visit. Following a rest 
period of 10-min, participants undertook the TTE in the same seated position described for 
the MVC tests. The TTE task required the participant to maintain a 20% isometric MVC 
of the bicep until force dropped below the force required for more than 2 s, or when the 
participant withdrew from the task. During the TTE task, participants were asked to rate 
their perceived pain and RPE every 30 s. On completion of the TTE task, participants 
immediately performed a further MVC for assessment of fatigue.   
Following the familiarisation visit, all participants returned to the laboratory on three more 
occasions to perform the experimental sessions using the same protocol described above. 
In these experimental tests, TENS, IFC or Sham were administered during the TTE tests. 




Prior to statistical analysis, standard assumptions (Kruskal-Wallis test and Shapiro-Wilk 
test) were checked for each statistical test, and none of these were violated. Time to 
exhaustion (TTE) was analysed using a repeated measures ANOVA and Bonferroni 
Pairwise Comparisons. Mean RPE and mean EIP were assessed using an ANOVA with 
repeated measures and appropriate follow-up paired-sample t-tests. Changes in RPE and 
EIP during each condition were performed using a three-way ANOVA with repeated 
measures, with follow-up paired samples t-tests used to detect differences between 
conditions when an interaction effect had been observed. All statistical analysis was 
performed using the statistical package SPSS version 22 for Windows (SPSS Inc., 
Chicago, IL, USA). Descriptive data are reported as means ± SD. Statistical significance 
























Time to Exhaustion (TTE): The ANOVA revealed a significant difference in the time to 
exhaustion between conditions (F (2, 34) = 6.763, P = 0.003), as shown in Figure 5.2. 
Pairwise comparisons revealed a significantly different TTE time between TENS (10 min 
49 s ± 6 min 16 s) and SHAM conditions (7 min 52 s ± 2 min 51 s) (P = 0. 031) and between 
IFC (11 min 17 s ± 6 min 23 s) and SHAM conditions (P = 0.02). No significant difference 


























Figure 5.2  TTE elicited a significant difference between conditions. Sham = placebo-
controlled, TENS = transcutaneous electrical nerve stimulation, IFC = interferential current. 











Exercise-Induced Pain (EIP): The ANOVA revealed a significant main effect of 
condition for perceived exercise-induced pain during the TTE test (F (2, 34) = 3.690, P = 
0.035), as shown in Figure 5.3. Follow up paired-sample t-tests showed a significant 
difference in mean exercise-induced pain during the TTE tests between the TENS and 
sham conditions (t (17) = 2.322, P = 0.033), but no significant differences between the IFC 
and sham conditions (t (17) = 1.919, P = 0.072), or the TENS and IFC conditions (t (17) = - 


























Figure 5.3  Pain scores elicited a significant difference between conditions. Sham = placebo-
controlled, TENS = transcutaneous electrical nerve stimulation, IFC = interferential current. 
*significantly different from Sham condition (P < 0.05). 
 
 
A 3 x 8 (condition x iso time) ANOVA revealed a significant main effect of condition for 
perceived exercise-induced pain (F (1.24, 19.13) = 8.39, P = 0.006). There was also a 




for exercise-induced pain over time between conditions during the TTE test (F (3.73, 63.4) = 
4.95, P = 0.002), as shown in Figure 5.4. Follow-up paired-sample t-tests showed a 
significantly different pain perception between TENS and SHAM conditions at 120 s (t (17) 
= 2.482, P = 0.024), 180 s (t (17) = 2.319, P = 0.033), 210 s (t (17) = 3.402, P = 0.003) and 
240 s (t (17) = 3.589, P = 0.002. Significant differences were also shown between IFC and 
SHAM conditions at 120 s (t (17) = 2.482, P = 0.024), 150 s (t (17) = 2.388, P = 0.029), 180 
s (t (17) = 2.997, P = 0.008), 210 s (t (17) = 3.298, P = 0.004) and 240 s (t (17) = 2.858, P = 

































Figure 5.4  Pain scores over time elicited a significant interaction between conditions from 
60 - 240 s during the TTE test. ** denotes a significant interaction between sham and TENS. # 
denotes a significant interaction between sham and IFC. # denotes a significant interaction between 
TENS and IFC in perceived pain. 
 










Rating Perceived Exertion (RPE): There was no significant main effect of condition (F (2, 




A 3 x 8 (condition x iso time) ANOVA revealed a significant main effect of condition for 
time (P < 0.001), but no main effects (F (2.34) = 2.706, P = 0.081) or interaction effects for 

































Figure 5.5  RPE scores elicited no significant difference between conditions. Sham = placebo-



































Figure 5.6  RPE scores over time elicited no significant difference between conditions. Sham 















Maximal Voluntary Contraction (MVC): No significant differences between conditions 
were found for the pre-MVC (F (1.4, 23.4) = 1.758, P = 0.188) or the post-MVC (F (2, 34) = 
1.499, P = 0.238). MVC was significantly reduced following the TTE in the SHAM (t (17) 
= 9.069, P < 0.001), TENS (t (17) = 7.037, P < 0.001) and IFC conditions (t (17) = 8.558, P 
< 0.001), as shown in Figure 5.7, suggesting that significant fatigue and performance 





Figure 5.7  MVC pre-and post elicited between conditions. In the sham condition displayed 
a significantly reduced in MVC pre-and post. TENS condition displayed a significantly reduced in 
MVC pre-and post. IFC condition displayed a significantly reduced in MVC pre-and post. 
However, there was no significant difference between conditions for pre-MVC, and no significant 
difference between conditions for post-MVC.  
 
   




The purpose of this study was to investigate whether TENS and IFC can elicit an analgesic 
effect during a sustained single limb, submaximal isometric contraction in healthy 
participants. The primary finding of this study was that both TENS and IFC were able to 
significantly reduce exercise-induced pain, and that this intervention elicited a significant 
improvement in time to exhaustion performance. To our knowledge, this is the first study 
utilising a randomised, crossover and placebo controlled design, which shows an ergogenic 
effect for TENS and IFC. This data also provides support for the notion that exercise-
induced pain is a limiter of endurance performance in single limb exhaustive exercise.  
It has previously been suggested that the perceived pain arising from prolonged or 
repetitive muscular contraction may be an important sensation which is used to regulate 
work rate and influence endurance performance (Mauger, 2014). This exercise-induced 
pain is caused by one, or a combination of, algesic metabolic by-products, an increased 
intramuscular pressure and muscular distortion (Dannecker & Koltyn, 2014; Mense, 1993). 
This noxious environment serves to both sensitise and stimulate both Type III (A-delta 
fibres) and Type IV (C fibres) small afferents, which convey the nociceptive signal and 
synapse in lamina I, II and V (Mense, 1993). If a stimulation threshold is met, a 
postsynaptic output will be produced and transmitted to the supraspinal regions of the 
brain, where it is processed and interpreted as perceived pain. The type of sustained sub-
maximal contraction used in the current study has been shown to produce such a noxious 
environment, which both inhibits the excitation-contraction coupling process (Kent-Braun, 
1999) and elicits a nociceptive signal, as described above. Although pain tolerance has 
long been linked to athletic potential (Scott & Gijsbers, 1981), it is only relatively recently 
that a growing body of empirical evidence has provided strong support this notion. EIP 
may exacerbate fatigue by reducing voluntary activation of the muscle (Kennedy et al. 
2013) or by contributing to a host of unpleasant sensations (Kress and Stratler, 2007) that 
either leads to a decision to reduce work rate or disengage with the task (Mauger, 2014). 
Whilst the current study cannot identify whether psychological or physiological 
determinants led to the apparent ergogenic effect of therapeutic muscle stimulation, it does 
provide further evidence that analgesic interventions during exercise are able to increase 
time to exhaustion performance. Exercise-induced pain increased as function of time and 
reached its most intense at the end of the exercise, where near maximal values were 
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observed. To moderate this pain, without changing the metabolic environment at the 
muscle, TENS and IFC were used to inhibit the transmission of the nociceptive signal at 
the spinal level. The TENS intervention appeared to reduce perceived pain, which resulted 
in a longer time to exhaustion of the sustained isometric contraction and a faster TT time. 
The analgesic mechanism of TENS and IFC are suggested to be underpinned by the gate-
control theory of pain (Sluka & Walsh, 2003). Indeed, when TENS and IFC are applied to 
produce a strong comfortable and non-painful paraesthesia, large diameter afferents (A-
beta fibres) are selectively activated (Sluka & Walsh, 2003). The activation of these large 
diameter low threshold mechano-receptive nerve fibres could inhibit the nociceptive 
transmission from small diameter higher threshold nociceptive (A-delta and C) fibres 
through pre- and post synaptic inhibition in the dorsal horn of the spinal cord (Melzack & 
Wall, 1967). This would reduce the number of nociceptive signals reaching the higher 
brain centres and consequently reduce the perceived pain for a given stimulus at the 
nociceptor. A reduction in the afferent barrage from Type III and IV fibres could also offset 
the reduction in voluntary activation that is observed during painful exercise (Kennedy et 
al. 2013), which would likely allow for an improved exercise performance. 
Accordingly, in the current study exercise-induced pain increased as function of time and 
reached its most intense at the end of the exercise, where near maximal values were 
observed. To moderate this pain, without changing the metabolic environment, TENS and 
IFC were used to inhibit the transmission of the nociceptive signal. This intervention 
appeared to induce analgesia which resulted in a longer time to exhaustion of the sustained 
isometric contraction. The mechanism of analgesia by TENS and IFC are posited to operate 
lie in the gate-control theory of pain (Sluka & Walsh, 2003). When TENS and IFC are 
applied at high frequency (~100 Hz), with pulse durations between 300 ȝVDQGDSXOVH
amplitude titrated to produce a strong comfortable and non-painful paraesthesia, large 
diameter afferents (A-beta fibres) are selectively activated (Sluka & Walsh, 2003). 
According to Gate Control Theory of Pain (Melzack & Wall, 1965), the activation of large 
diameter low threshold mechano-receptive nerve fibres could inhibit the nociceptive 
transmission from small diameter higher threshold nociceptive (A-delta and C) fibres 
through pre-and post synaptic inhibition in the dorsal horn of the spinal cord. This would 
reduce the number of nociceptive signals reaching the higher brain centres and 
consequently reduce the perceived pain for a given stimulus at the nociceptor. Whilst, the 
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mechanism of reduced pain perception observed in the TENS and IFC conditions is 
perhaps best supported by the gate control mechanisms discussed above, it has also been 
suggested that analgesia through TENS and IFC may also be explained by the release 
endogenous opioids (Kalra et al. 2001). Whilst evidence for this mechanism is stronger for 
low frequency TENS (Sjölund & Eriksson, 1979), more recent studies on animal models 
also suggest that analgesia by high frequency TENS is reduced by systemic naloxone in 
KLJKHQRXJKGRHVWREORFNȝįDQGțRSLRLGUHFHSWRUV+DQHWDO, 1991; Woolf et al., 1980), 
thus supporting a role for endogenous opioids for both high and low frequency TENS.  
The mean reduction in pain (compared to the SHAM condition) elicited by TENS and IFC 
was approximately 12%, with a stronger effect evident later in the exercise (>30% after 
180 s ± see Figure 5.3).  The greater reductions in pain with TENS and IFC towards the 
end of exercise are paralleled by the increasingly noxious environment in the muscle and 
the consequential increased pain. Therefore, the apparent analgesic effect of the 
stimulation was most noticeable during a noxious environment that elicited a pain intensity 
of ~4.3 (µVRPHZKDW VWURQJSDLQ¶DQGDERYHRQWKH&RRN6FDOH&RRNHWDO, 1997). It is 
important to note, that in the familiarisation visits, this scale was anchored specifically 
according to previously experienced maximum and minimum levels of muscle pain during 
exercise, rather than a general pain sensation (e.g. dental pain), so as to provide a measure 
specific to the experiences of EIP. The effectiveness of the analgesia observed in the 
current study is supported by some studies which have used TENS to reduce pain. Indeed, 
in a cross-over study investigating neuropathic pain in patients with spinal cord injury, 
analgesic TENS was shown to elicit a 29-38% improvement on a global relief scale. 
Furthermore, Bjordal et al. (2003) demonstrated a 26.5% mean reduction in analgesic 
consumption for post-operative patients following a well-controlled TENS intervention. 
Salisbury and Johnson (1995) have also shown that TENS increased the cold pain threshold 
and that IFC decreased cold pain intensity. However, whilst several studies have 
demonstrated positive analgesic effects of TENS, there are a number of studies that show 
no such effect (Johnson & Tabasam, 1999; Tabasam & Johnson, 1999; Alves-Guerreiro, 
2001; Claydon et al., 2008; Gomes et al., 2014). The numerous systematic reviews and 
meta-analysis (for example; Hurlow et al., 2012; Simpson et al., 2014; Zeng et al., 2015) 
on this area suggest that different TENS parameters, SDWLHQW¶V groups, outcome measures 
and a lack of placebo controls and randomisation are the reason for the equivocal findings 
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for the effectiveness of TENS. Therefore, in the current study the use of a placebo 
controlled condition, the randomisation of conditions and the controlled exercise intensity 
between conditions and participants presents a robust experimental design that supports 
the effectiveness of TENS as an analgesic intervention, and a role for EIP on endurance 
performance.  
The apparent analgesic effect of TENS on EIP observed in the current study, coupled with 
TENS being a safe, non-invasive and cheap intervention, may have potential implications 
for improving physical activity behaviour in certain individuals. Exercise and physical 
activity is known to induce a range of health benefits, which significantly reduce all-cause 
mortality (Lee & Skerrett, 2001). Exercise is also prescribed to treat a range of disease and 
clinical conditions to improve patient outcome and increase quality of life (Naci & 
Ioannidis, 2013; Thomson et al., 2003). Despite this, there are universally low rates of 
regular exercise participation and low levels of adherence to prescribed exercise protocols 
(Findorff et al., 2009; Linke et al., 2011). The reasons and risk factors which underpin low 
activity levels (particularly for at risk populations) are multifactorial, and likely depend 
personal attributes (demographics, cognitive variables, behaviours) and environmental 
factors (social environment, physical environment, and characteristics of the physical 
activity) (Woodward & Berry, 2001). Indeed, obstacles to physical activity for obese and 
normal weight individuals include low motivational status, self-efficacy, negative learning 
history with exercising, lack of coping skills, and aversive environmental characteristics 
such as reduced access to physical activity facilities, high costs of training programs, low 
social and cultural support, and time barriers (Sherwood & Jeffery, 2000). However, as 
pain inherently motivates decisions and action (Wiech & Tracey, 2013), and exercise is 
known to elicit pain (Cook et al., 1997), pain avoidance may contribute to lower physical 
activity and adherence. This is supported by some studies which demonstrate that 
symptoms of diseases such as pain and fear of pain present the biggest barriers to physical 
exercise (Clark; Hays & Clark, 1999). Indeed, Cohen-Mansfield et al. (2003) showed that 
health problems and pain were the main obstacles to physical exercise in a nondisabled 
population aged 75±85 years. The reduced EIP elicited by TENS in the current study 
provides some provisional support for its use as a cheap intervention with the potential to 
reduce pain for those who find it a barrier to exercise.   
 110 
 
A notable observation in the current study is that TTE increased following a reduction in 
pain, but with no change in RPE between conditions. It has been suggested that RPE is the 
conscious manifestation of afferent information from a host of afferent physiological 
systems and external cues, and that this perception of effort is an important determinant of 
endurance performance (Tucker, 2009). However, the balance of evidence suggests that 
the primary generator for perception of effort is the collorary discharge (i.e. an internal 
signal that arises from centifugal motor commands) associated with central motor 
command (McCloskey, 1981), and that this is independent from afferent feedback 
(including pain) from the working muscles and other interoceptors (Marcora, 2009; de 
Morree et al, 2012, 2014). Indeed, feelings of pain and discomfort have often been assessed 
as part of the perception of effort (Noble & Robertson, 1996), however, numerous studies 
have shown that pain and effort can be dissociated (Angius et al., 2015; Cook, 1997; 
2¶&RQQRU & Cook, 2001; Pageaux et al., 2015; Astokorki & Mauger, 2016) and are 
therefore distinct entities. By dissociating perception of effort and EIP in the current study 
by using separate scales and proving detailed instructions, we were able to observe the 
individual effects of therapeutic muscle stimulation on EIP and RPE, and the consequent 
impact on endurance performance. In-line with our hypothesis, a reduction in EIP 
paralleled an improvement in TTE and TT performance. This finding supports the view 
that EIP is a contributing factor to task cessation and self-paced performance (Mauger, 
2014), but is contrary to the view that endurance performance is primarily determined by 
perception of effort, as stated by the Psychobiological Model (Marcora, 2010). The view 
that the generation of RPE from central command underpins the psychobiological model 
of performance, which postulates that endurance performance is primarily determined by 
perception of effort (Marcora & Staniano, 2010), (Marcora 2010). Although this model 
acknowledges that severe pain (from a muscle strain for example) would affect motivation 
(and therefore inhibit performance), it suggests that muscle pain normally experienced 
during high-intensity aerobic exercise does not limit performance in healthy humans 
(Marcora 2010). The results of the current study suggest WKDWµQRUPDO¶(,3H[SHULHQFHG
during exhaustive exercise does affect performance and that it can be moderated 
independently of perception of effort. These findings support other studies which 
demonstrate that an analgesic intervention can improve exercise performance in a variety 
of exercise models (Astorino et al., 2011; Astorino et al., 2012; Foster et al., 2014; 
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Gonglach et al., 2015; Mauger et al., 2010; Mauger et al., 2014) and strengthens the belief 
(Kress & Statler, 2007) that tolerance of EIP is an important prerequisite for endurance 




The findings of the study suggest that TENS and IFC elicit an analgesic effect on EIP 
during single limb, submaximal isometric contraction performance, and that this reduction 
in muscle pain can improve time to exhaustion performance in the absence of changes to 
perceived exertion. Further studies are needed to identify how TENS or IFC elicits an 
analgesic effect for EIP, and the psychophysiological underpinning the subsequent 
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INTRODUCTION: Muscle pain is a natural consequence of intense and prolonged 
exercise and has been suggested to be a limiter of performance and barrier to physical 
activity. Transcutaneous electrical nerve stimulation (TENS) and interferential current 
(IFC) have been shown to reduce both chronic and acute pain in a variety of conditions. 
This study was sought to ascertain whether TENS and IFC could reduce exercise-induced 
pain and whether this would affect endurance exercise performance. It was hypothesised 
that TENS and IFC would reduce exercise-induced muscle pain and result in an improved 
endurance exercise performance during whole-body dynamic exercise. METHODS: 
Twenty-tow healthy male and female participants completed a 16.1-km cycle time trial as 
quickly as they could whilst receiving TENS, IFC and a Sham placebo in a repeated 
measures, a cross-over, randomized, and placebo controlled design. RESULTS: The 
ANOVA revealed a significant difference in completion time between conditions (F (2, 42) 
= 6.597, P = 0.003). Pairwise comparisons revealed that participants performed a 
significantly faster TT (P = 0.001) in the TENS condition (29 min 6 s ± 3 min 20 s) 
compared to the SHAM (29 min 39 s ± 3 min 34 s) condition. There were no significant 
differences (P = 0.872) between the IFC condition (29 min 28 s ± 3 min 34 s) and the 
SHAM, or the TENS and IFC conditions (P = 0.116). The ANOVA also revealed a 
significant main effect of condition for power output (F (2, 38) = 3.48, P = 0.041), mean HR 
(F (1.38, 29.06) = 4.016, P = 0.042) and mean B[La] (F (1.49, 31.37) = 7.54, P = 0.004). There was 
a significant difference in the mean EIP between conditions during the TT (F (2, 44) = 4.210, 
P = 0.022). Paired t-tests revealed that participants perceived significantly less pain during 
the TENS condition (3.5 ± 1.8) than in the sham condition (4.0 ± 2.0) (t (21) = 3.037, P = 
0.006). No differences were observed between the TENS and the IFC condition (3.8 ± 1.9) 
or the IFC and Sham condition (P > 0.05). No significant differences in mean RPE were 
found between conditions during the TT (P > 0.05). CONCLUSION: These findings 
demonstrate that TENS can attenuate exercise-induced muscle pain in healthy volunteers 
and that consequently significantly improves endurance performance in whole-body 
dynamic exercise. 
 






The perception of muscle pain involves a complex neurobiological integrated network of 
peripheral and central mechanisms that are dependent on interactions between top-down 
and bottom-up information. Of primary importance however, is the nociceptive signal, 
which arises when A-delta (group III) and C fibres (group IV) are sensitised and stimulated 
by variety of noxious mechanical, thermal and chemical stimuli (Marchettini et al., 1996). 
Intense and prolonged muscular contraction elicits such an environment, through the 
production of bradykinin, hydrogen ions, potassium, prostaglandins and an increased 
intramuscular pressure (Mense, 1993), and results in what has been termed exercise-
induced pain. Consequently, intense and prolonged exercise is often accompanied by 
sensations of pain and discomfort, which may contribute to a negative affect (Babel, 2015) 
and present barriers to regular physical exercise (Cohen-Mansfield et al., 2003). 
Additionally, because the magnitude of exercise-induced pain is proportional to exercise 
intensity (Cook et al., 1997), and pain represents a powerful stimulus to disengage from 
the pain-causing behaviour, successful endurance exercise performance may require a high 
tolerance to pain (Mauger, 2014). Indeed, Astokorki and Mauger (2016) have recently 
shown that tolerance to exercise-induced pain (but not pressure or thermal pain) predicted 
cycling performance in untrained men and women. This finding is supported by studies 
that have sought to reduce pain during exercise and observed an improved endurance 
performance as a consequence (Astorino et al., 2011; Astorino et al., 2012; Foster et al., 
2014; Hudson et al., 2008; Jenkins et al., 2008; Mauger et al., 2010, 2014). 
If reducing pain during exercise allows an improved endurance performance, or reduces 
the unpleasantness of the experience, then an intervention which can achieve this could be 
of interest to populations where regular exercise would impart a health or performance 
benefit. Whilst some studies have achieved this through pharmacological intervention, 
such as paracetamol or caffeine ingestion (Astorino et al., 2011; Astorino et al., 2012; 
Foster et al., 2014; Hudson et al., 2008; Jenkins et al., 2008; Mauger et al., 2010, 2014), 
there are negative side-effects associated with this that may offset the benefit of any 
increased exercise performance or adherence. Furthermore, it should be noted that some 
evidence exists investigating that the ingestion of other analgesics (aspirin and codeine) 
has not reduced exercise-induced pain or produced improvements in performance (Roi et 
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al., 1994; Cook et al., 1997; Ray & Carter, 2007; Hudson, Green, Bishop & Richardson, 
2008). Thus, there is a need for alternative methods of analgesia, that can be used during 
exercise and elicit little or no side-effect and show an improved performance. According 
to the Gate Control Theory of pain (Wall & Melzack, 1965), perception of pain is not solely 
due to activation of nociceptors, but is the outcome of modulation of both nociceptive and 
non-nociceptive inputs. Inhibitory interneurons regulate the transmission of ascending 
nociceptive information at the substantia gelatinosa, allowing modulation of the 
nociceptive signal before it has reached the brain level (Melzack & Wall, 1965). Thus, 
selectively stimulating $ȕODUJH-diameter afferent fibres in the presence of a nociceptive 
stimulus may serve to reduce the subsequent perception of pain ± this is the premise of 
µUXEELQJDEUXLVHGVKLQUHGXFHVWKHSDLQ¶,QDFFRUGDQFHZLWKWKLVDSSOLFDWLRQRIDKLJK
frequency electrical stimulation with a pulse amplitude titrated to produce a strong 
comfortable and non-painful paraesthesia is suggested to activate large diameter afferents 
(A-beta fibres) (Sluka & Walsh, 2003) and induce mild analgesia (Melzack, 1965; Garrison 
& Foreman, 1994; Walsh, 1997). This technique is called transcutaneous electrical nerve 
stimulation (TENS), and when adapted to produce both high-low frequency impulses, 
interferential current stimulation (IFC). When administered correctly, these techniques are 
safe, produce no dangerous side-effects and whilst not widely used, have been shown to 
elicit pain relief, facilitate recovery, treatment for urinary incontinence in female athletes 
and delayed onset muscle soreness (Bolin, 2003; Heyman, De Geus, Mertens & Meeusen, 
2009; Rivata et al., 2010; Rocha et al., 2012; Vanderthommen et al., 2012).  
However, no studies have administered TENS or IFC during exercise with the aim of 
reducing exercise-induced pain. Therefore, the purpose of this study was to establish 
whether the analgesic effect of TENS and IFC using equal stimulus parameters of 
frequency, and current amplitude would reduce perceived pain and improve performance 
of a 10-mile (16.1 km) cycling time trial. It was hypothesised that the TENS and IFC would 








III. MATERIALS AND METHODS 
Subjects 
Twenty-two participants (male n=14, female n=8), trained in cycling and triathlon and 
exercising regularly (> 3 KSHUZHHNZHUHUHFUXLWHGIRUWKLVVWXG\7KHSDUWLFLSDQWV¶PHDQ
age, height and body mass were 33 ± 8 yrs, 173 ± 7 cm and 71.8 ± 13.3 kg, respectively. 
Prior to participation, participants were given an information sheet of the study describing 
what they were asked to do. All data were anonymised and participants were told that they 
had the right to withdraw from the experiment at any time. Following this, they were asked 
to complete the inclusion/exclusion criteria checklist and medical health questionnaire. 
The participants were excluded from the study if they had history of any cardiovascular 
disorder (e.g. angina, heart attack, high blood pressure etc), chronic medications that affect 
the central nervous system, pregnancy, bleeding disorders (e.g. haemophilia), deep vein 
thrombosis, impaired sensation, acute/chronic infection (e.g. tuberculosis), malignancy, 
recently radiated tissue, skin diseases or severely damaged skin, types I or II diabetes, or 
were using cochlear implants or pacemakers, or any other condition that may be a danger 
to their participating in a test (e.g. injury). Following this, all participants were asked to 
read and sign an informed consent form. The research was approved by Local Ethics 
Committee at the University of Kent. task. Participants were asked to refrain from the 
ingestion of alcohol 48 hours, caffeine 8 hours and analgesics 6 hours, and asked to refrain 
from any vigorous exercise 48 hours, prior to experimental visits (Lu, Lai & Chan, 2008). 
Participants were also asked to maintain their normal diets and keep regular sleeping hours.  
 
Table 6.1.  Group mean values across all perceptual and exercise tests 
Variable Male Female Total (Fe & M)   
Age (yrs) 33 ± 4 31 ± 6 32 ± 7   
Height (cm) 176 ± 4 167 ± 5 173 ± 7   
Body mass (kg) 74.36 ± 12.23 60.50 ± 5.05 71.86 ± 13.40   
VO2max (mL/kg/min) 55.3 ± 5.3 47.9 ± 8.8 52.5 ± 7.5   
Anaerobic Threshold (mL/kg/min) 29.7 ± 6.5 25.5 ± 3.7 28.2 ± 5.9   
Peak Power Output (W) 322.4 ± 53.6 207.1± 40.2 280.5 ± 74.4   
GXT end pain 7.4 ± 2.7 4.9 ± 1.7 6.5 ± 2.7   
GXT end RPE 18.8 ± 1.5 16.3 ± 2.1 18.0 ± 2.0   
GXT HR 
max 
(beat. min-1) 178.2 ± 11.4 177.4 ± 11.4 177.9 ± 11.4  
  




Participants attended the laboratory on four separate occasions, each separated by 2-5 days. 
Visit one involved full familiarisations of the stimulations, perceptual scales, 
questionnaires and exercise tests. In visits 2-4, participants completed the exercise test (10-
mile cycling time trial) in the presence of either TENS, IFC or sham in a counter-balanced 
and single-blind experimental design.  
 
Familiarisation 
On the first visit to the laboratory, participants underwent a general health screening in 
addition to a test for skin integrity and sensory discrimination using a sharp and blunt 
patella hammer. All the participants completed the test satisfactorily and agreed to proceed 
with experiment. To be familiarised with the TENS and IFC stimulation, and to ensure the 
stimulation induced a strong comfortable and non-painful paraesthesia, participants were 
briefly administered TENS and IFC. In order to reduce resistance to the electrical current, 
the skin of the vastus lateralis of both thighs was shaved and cleaned thoroughly before the 
electrodes were placed on it. Bipolar surface electrodes were placed over the vastus 
lateralis and the TENS and IFC were applied at high frequency, but low intensity 
stimulation. To ensure the appropriate intensity for the subsequent test occasions, 
amplitude was steadily increased until the participant perceived a comfortable tingling 
sensation but did not experience any muscle pain. The intensity of TENS or IFC was 
gradually increased in a similar manner, but limited so as to produce no muscle contraction. 
6WLPXODWLRQIUHTXHQF\ZDVLQFUHDVHGXSWR+]ZLWKDSXOVHZLGWKRIȝV± these 
parameters induced a comfortable tingling sensation, with no muscle pain or contraction 
in all participants. Throughout all test occasions, participants were monitored for signs of 
skin irritation, nausea, swelling and pain. Following familiarisation to TENS and IFC, 
participants were introduced to the numeric pain rating scale (0-10) (Cook et al., 1997) and 
%RUJ¶V -20) rating of perceived exertion (RPE) scale (Borg, 1998). Participants were 
instructed to report RPE solely as effort to drive the limb (Pageaux et al., 2015) (i.e. 
independent of pain and discomfort) and that pain should be anchored to exercise-induced 
pain (i.e. numeric values given relative to their experience of muscle pain). After 
participants confirmed their understanding of the pain and RPE scales, they completed a 
VO2max test (GXT) after a standardized 10-min warm-up at a self-selected intensity on the 
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cycle ergometer (Velotron, Racermate, Seattle, WA). An incremental step protocol was 
utilised, starting at a power output (PO) of 100 W with increases of 30 W. min-1. 
Participants maintained a self-selected cadence until volitional exhaustion or when they 
could no longer maintain the required cadence. During the test, gas exchange (Cortex 
Metalyser 3B, Cortex GmbH, Lepzig, Germany) and heart rate (HR) (Polar Electro, 
N2965, Finland) were recorded continuously, with RPE and perceived pain recorded at the 
end of each stage. Throughout the test verbal encouragement was given by the researcher. 
On completion of the test, participants received a 30-min rest period during which they 
were familiarised to, and completed, a mood questionnaire (Brunel Universal Mood States 
(BRUMS) (Terry & Fogarty, 2003). Finally, after the 30-min rest period, participants 
completed a familiarisation of the self-paced 10 mile (16.1-km) cycling time trial (TT). 
Participants could change gear and cadence to complete the TT in the fastest time they 
could, and they could see the distance they had completed but were given no information 
on performance or physiological parameters (e.g. PO, HR, time elapsed). Participants were 
asked to report RPE and perceived pain every km. On completion of the TT, participants 
completed a further BRUMS.  
 
Experimental Visits 2-4 
Participants initially completed a BRUMS before performing the TT in the same manner 
as described above, with the addition of a fingertip sample of blood acquired every 4-km 
for analysis for blood lactate concentration (B[La]). Throughout the TT participants either 
received TENS, IFC or sham (placebo-controlled) on the vastus lateralis of both thighs, as 
shown in Figure 6.1. Prior to the TT, the stimulation electrodes were placed (in the manner 
described in the familiarisation visit) and current was applied for 5-min, followed by a 10-
min warm-up on the cycle ergometer at a self-selected intensity. The parameters of the IFC 
pulses were delivered in a continuous mode with a pulse frequency of 100Hz (ascertained 
in the familiarisation visit). For the TENS pulses, a continuous pattern of stimulation was 
XVHGZLWKDSXOVHZLGWKRIȝVDQGIUHTXHQF\DW+]$V7(16LVFDUULHGRXWYLD
two electrodes, bipolar IFC was used to maintain blinding of conditions. Previous studies 
have shown that bipolar and quadripolar techniques work equally well when used to 
manage pain conditions (Johnson & Tabasam, 1998). Stimulation was delivered using a 
Vectra Genisys multi-waveform stimulator (Chattanooga Group, Hixon, TN, USA). In the 
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sham stimulation, the electrodes were placed on the same muscle site as the TENS and IFC 
conditions and the machine was turned on but with no stimulation applied. Participants 
ZHUH WROG ³7KLV W\SH RI VWLPXODWLRQ LV VXSSRVHG WR UHGXFH SDLQ XVLQJ D VXEWKUHVKROG
stimulXVWKDW\RXZLOOQRWEHDEOHWRSHUFHLYH´ZKLFKZDVVWUHQJWKHQHGYLDDYLVXDOGLVSOD\
of the electrical current on an oscilloscope. On completion of the TT, participants 
completed a BRUMS.  
 
Statistical Analysis 
Descriptive data are reported as means ± SD. Standard assumptions (Kruskal-Wallis test 
and Shapiro-Wilk test) were checked for each statistical test prior to analysis, and none of 
these were violated. Power output and HR were averaged for every km completed. TT 
completion time was analysed using a repeated measures ANOVA and Bonferroni 
Pairwise Comparisons. BRUMS score, PO, B[La], HR, RPE and pain were assessed using 
an ANOVA with repeated measures and appropriate paired-sample t-tests Bonferroni 
Pairwise Comparisons. Changes in PO, B[La], HR, RPE and pain over time between 
conditions was examined using a three-way ANOVA with repeated measures and 
appropriate follow-up paired-sample t-tests. All statistical analysis was performed using 
the statistical package SPSS for Windows, PC software, version 22 (SPSS Inc., Chicago, 

















Time Trial (TT) Completion Time: The ANOVA revealed a significant difference in 
completion time between conditions (F (2, 42) = 6.597, P = 0.003). Pairwise comparisons 
revealed that participants performed a significantly faster TT (P = 0.001) in the TENS 
condition (29 min 6 s ± 3 min 20 s) compared to the SHAM (29 min 39 s ± 3 min 34 s) 
condition. There were no significant differences (P = 0.872) between the IFC condition 
(29 min 28 s ± 3 min 34 s) and the SHAM, or the TENS and IFC conditions (P = 0.116).  
 
 
Power Output (PO): The ANOVA revealed a significant main effect of condition for 
power output (F (2, 38) = 3.48, P = 0.041). There was also a main effect for distance 























Figure 6.1 Shows the power output differences between conditions. * A significant main 





























Figure 6.2  Power output profiles during the time trials for TENS, IFC and Sham conditions. 















Rating Perceived Exertion (RPE): No significant main effects for condition were 
observed (P > 0.05). There was a main effect for distance completed (P < 0.001), but no 














































Exercise-induced pain (EIP): There was no main effect of condition for EIP (F (1.41, 29.62) 
= 3.60, P = 0.054). There was a significant main effect for distance completed (P < 0.001) 
and a significant interaction effect (F (30, 630) = 2.04, P = 0.001). Follow-up paired t-tests 
revealed that participants perceived significantly less EIP in the TENS condition compared 
to the SHAM at the 4th, 6th, 9th, 11th, 12th, 13th and 15th km (P < 0.05), as shown in 































Figure 6.4  Exercise-induced pain profiles during the time trials for TENS, IFC and Sham 
conditions. ** denotes a significant interaction between sham and TENS. * denotes a significant 




















Heart Rate (HR): The ANOVA revealed a significant difference in the mean HR between 
conditions during the TT (F (1.38, 29.06) = 4.016, P = 0.042). There was a significant main 
effect for distance completed (P < 0.05), and a significant interaction effect was observed 
(F (1.3, 27.8) = 3.171, P = 0.008). Follow-up paired-sample t-tests showed a significant 
difference in HR between TENS and SHAM conditions between the 8th-16th km (P < 0.05). 
Additionally, significant differences in HR between IFC and SHAM conditions were 
observed between the 11th-16th km (P < 0.05). There were also significant differences in 
HR between TENS and IFC conditions during the 9th, 14th, 15th and 16th km (P < 0.05). 






























Figure 6.5  Heart rate profiles during the time trials for TENS, IFC and Sham conditions. ** 
denotes a significant interaction between sham and TENS. # denotes a significant interaction 































Blood lactate (B[La]): The ANOVA revealed a significant main effect of condition (F (1.49, 
31.37) = 7.54, P = 0.004), a main effect for distance completed (P < 0.05) and a significant 
interaction effect F (3.68, 77.63) = 3.51, P = 0.013). Follow up paired-sample t-tests showed a 
significantly different B[La] between TENS and SHAM conditions at the 12th km (t (21) = 
- 2.850, P = 0.01), and the 16th km (t (21) = - 4.370, P < 0.001). There was also a difference 
in B[La] between IFC and SHAM conditions at the 16th km (t (21) = - 3.632, P = 0.002), 
and a significant difference in B[La] between TENS and IFC conditions at the 12th km (t 






































Figure 6.6  Blood lactate profiles during the time trials for TENS, IFC and Sham conditions. 
** denotes a significant interaction between sham and TENS. # denotes a significant interaction 










BRUMS: No differences in mood states were found between conditions pre- or post TT. 
Paired-sample t-tests showed only a significant difference in pre- and post TT for vigour 
during the TENS condition (t (21) = - 2.114, P = 0.047). No other differences in pre- post 
mood states were observed.  
 
 
V. DISCUSSION  
The purpose of the study was to determine whether TENS and IFC would improve the 
performance of a 10-mile cycling TT by reducing exercise-induced pain in trained cyclists. 
The principal and novel finding of this study was that TENS significantly improved 
completion time of the cycling TT, and that this was achieved by maintaining a higher PO, 
HR and B[La]. Despite the increased physiological strain and metabolic challenge induced 
by the higher PO, participants felt less exercise-induced pain in the TENS condition 
alongside no change in perception of effort. These findings support previous research 
which demonstrates that mild analgesia can induce an ergogenic effect in self-paced 
exercise, but is the first study to show that a TENS intervention can be used to elicit this 
analgesia to exercise-induced pain.    
The TENS intervention in the current study conferred a ~2% average improvement in TT 
completion time compared to the placebo condition. This was the result of a significantly 
higher PO (mean of 216 W) that was sustained throughout the TT (see Figure 6.2), which 
likely led to the observed higher HR and B[La] concentration in the TENS condition. The 
higher metabolic demand in the TENS condition would have created a greater noxious 
environment in and around the muscle (evidenced by the higher B[La]), which would have 
been expected to increase perceived pain. However, the striking finding of this study was 
that despite the increased nociceptive conditions, participants perceived less pain in the 
TENS condition. TENS is hypothesised to reduce pain by selectively activating the large-
diameter primary afferent fibres (A-beta fibres) (Sluka & Walsh, 2003), which inhibits the 
nociceptive transmission from small diameter higher threshold nociceptive (A-delta and 
C) fibres through pre-and post synaptic inhibition in the dorsal horn of the spinal cord 
(Melzack & Wall, 1965). Additionally, activation of small-diameter afferent fibres through 
TENS and/or IFC may modulate the transmission of pain through the release of 
endogenous opioids (Resende et al., 2004; Sabino et al., 2008), and serotonin (Chen, 2010). 
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Therefore, despite the likely higher stimulation of the nociceptive fibres experienced in the 
TENS condition of the current study, TENS stimulation may have been able to attenuate 
the noxious input of nociceptors at the spinal cord level, thereby reducing the overall 
experience of pain in this condition. 
Classically, endurance performance has been explained through a performance model that 
focusses solely on the physiological mechanisms underpinning maximal oxygen uptake, 
lactate threshold and exercise efficiency (Joyner & Coyle, 2008). Whilst there is no doubt 
that these parameters set the basis of performance velocity, they are not capable of 
explaining differences between race performance, or how work rate is regulated during 
exercise. Furthermore, the model is not capable of explaining improvements in 
performance via interventions that have no effect of the maximal oxygen uptake, lactate 
threshold, and exercise efficiency parameters. A clear example of this is the study of Swart 
et al. (2009), who showed that highly trained cyclists were capable of sustaining 
significantly higher work rates under increased levels of metabolic and cardiorespiratory 
stress for longer when given the amphetamine methylphenidate. This study demonstrates 
that the exercising body is capable of tolerating a significantly greater physiological strain 
than is usually achievable is normal conditions, and that this tolerance is likely set by the 
central nervous system. The Central Governor Model (Noakes 2000, 2011) suggests that 
endurance performance is regulated through a complex comparison between perceived 
demands of the exercise (knowledge of end-point, environmental conditions, course 
topography), knowledge of own physiological capability and current demands of the 
exercise (via afferent feedback). This internal calculation is set with the primary aim of 
avoiding a disturbance to homeostasis to a level that would result in damage to the body. 
Support for this model is underpinned by studies which have shown that changes to factors 
influencing the internal calculation (e.g. distance knowledge (Mauger et al., 2009), 
competition (Corbett et al., 2012), central processing (Swart et al., 2009)) can improve 
endurance performance. However, Amann et al. (2009) suggest that a difference in 
endurance performance is primarily dependent on afferent feedback from the periphery. In 
this Afferent Feedback Model, metabolic changes in the muscle results in a reduced or 
impeded central motor drive that elicits central fatigue. This system is suggested to act as 
a safety mechanism, so that central motor drive restricts the development of peripheral 
locomotor fatigue to an individual critical threshold, and that this level of restriction is at 
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least partly based on muscle afferent feedback. The studies by Amann and colleagues 
(2009) using fentanyl and epidurals support this notion, although there are some inherent 
methodological flaws arising from complete blockade of afferent feedback in these study 
design (e.g. migration of fentanyl above the site of blockade, effect on exercise pressor 
reflex). The Psychobiological Model of endurance performance (Marcora, 2009) suggests 
that motivation and perception of effort (RPE) are the sole determinants of endurance 
performance. In this model, RPE is the product of central command (via the collorary 
discharge) and completely independent of afferent feedback. Increased central drive is 
required in the presence of muscle fatigue, and so RPE increases with task duration. 
Disengagement from the task occurs when the RPE is greater than the motivation for the 
task. This model is supported by studies that show that changes to RPE are able to change 
endurance performance, and that RPE is a product of the central motor drive (Pageaux et 
al., 2015). The results from the current study show an improvement in performance via an 
intervention that likely reduced nociceptive signal past the spinal level. This allowed a 
higher PO to be sustained, alongside a reduced level of pain but no change in RPE. Central 
command would likely have been higher in the TENS condition (increased PO and a higher 
level of muscle fatigue) compared to the sham condition, and according to the 
psychobiological model, this should have resulted in an increased RPE. As this was not 
the case, the results of this study cannot be explained by the psychobiological model. 
However, the reduced afferent feedback experienced in the TENS condition may have 
either reduced the conscious awareness of the demands of the task, and/or moderated the 
debilitative cortico-spinal effects that a sustained higher PO would usually elicit. 
Consequently, the findings of the current study are best explained by the central governor 
model or the afferent feedback model.  
The 30 s improvement in completion time (~2% faster than sham) observed in the TENS 
condition, whilst small, is likely meaningful. Indeed, for riders of similar ability competing 
in amateur 10-mile TT races, a 30 s improvement in completion time would usually result 
in several places higher in the rider rankings. As there are no known side-effects with 
TENS that may affect exercise, the change in performance observed in the current study 
can be exclusively attributed to the analgesic effect. This finding provides support for the 
notion that tolerance of exercise-induced pain is a determinant of endurance performance 
(Astokorki & Mauger, 2016), and that moderation of it confers a performance advantage 
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(Mauger, 2014). Astokorki and Mauger (2016) have recently shown that when combined 
with physiological performance parameters, tolerance of exercise-induced pain was able 
to explain an additional 7.5% variance after PPO had explained 74.7% variance in 
endurance performance. Mauger et al. (2010) have also shown that mild analgesia using 
paracetamol improves 10-mile TT performance to a similar degree observed in the current 
study. Whilst the current study supports the theoretical importance of exercise-induced 
pain to endurance performance, the practicality (and ethical implications) of using TENS 
as an ergogenic aid is perhaps less impactful. However, even moderate levels of exercise 
elicit some level of pain (Cook et al., 1999), and symptoms of diseases such as pain and 
fear of pain present the biggest barriers to physical exercise (Clark; Hays & Clark, 1999) 
in some clinical populations where exercise would be beneficial to their condition. Indeed, 
regular exercise provides a range of health benefits, which significantly reduce all-cause 
mortality (Lee & Skerrett, 2001) and consequently exercise is often prescribed to treat a 
range of clinical conditions to improve patient outcome (Naci & Ioannidis, 2013; Thomson 
et al., 2003). If pain could be reduced during exercise, then this may improve motivation 
to exercise (Wiech & Tracey, 2013) and help improve rates of adherence to exercise 
prescription programmes. Therefore, the results of the current study have particular 
relevance to populations who engage in exercise for health benefit (rather than endurance 
performance), because TENS could provide a cheap, safe and non-invasive means of 




 This study demonstrates that electrical nerve stimulation through TENS can elicit an 
analgesic effect during exercise and improve the performance of a 10-mile cycling TT. 
Despite a higher PO, B[La] and HR, TENS reduced perception of pain during exercise, in 
the absence of a difference in RPE between conditions. These findings provide some 
insight into the pain pathways involved in the transmission of exercise-induced pain, and 
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INTRODUCTION: Pain is an unpleasant, subjective experience that includes sensory and 
HPRWLRQDO FRPSRQHQWV 6HYHUDO VWXGLHV KDYH VKRZQ WKDW REVHUYLQJ RWKHU¶V SDLQ FDQ
enhance the intensity of painful stimuli (compassional hyperalgesia), likely through 
changes in mood. This phenomenon was used in the current study to investigate the degree 
to which negative mood may affect exercise-induced pain and endurance performance. 
METHODS:Twenty-one participants, trained in cycling, completed 5 laboratory visits. 
The first two visits assessed  aerobic capacity (VO2max test) and fully familiarised 
participants with the fixed power (FP) and time trial (TT) tests. In the subsequent three 
visits, in a counter-balanced manner, participants performed a FP and TT. Immediately 
prior to these, participants viewed a collection of images from the International Affective 
Picture System database that were either pleasant, unpleasant (painful) or neutral. 
Participants were asked to rate each image with respect to affective valence and their level 
of emotion. During the TT and FP, participants were asked their EIP, RPE and had 
measures of HR and B[La] recorded. RESULTS: Rated the subset of painful images with 
significantly higher values for emotional pain compared to the pleasant images and neutral 
images (P<0.05), and also rated each subset of images as different from one another for 
affectice valence (P<0.05). The ANOVA revealed a significant main effect of condition 
for TT performance (F (2, 40) = 8.480, P = 0.001), PO (F (2, 40) = 6.318, P = 0.004), HR (F (2, 
40) = 4.502, P = 0.017), and B[La] (F (2, 40) = 5.724, P = 0.007) during the TT cycling 
performance, but no significant effect of condition for mean RPE or EIP (P > 0.05). The 
FP, a significant main effect of condition for EIP (F (2, 40) = 4.363, P = 0.019), but no 
difference for RPE, HR or B[La] was found. The mood states, a significant effect of 
condition for depression, tension, anger, and confusion following viewing the images (P < 
0.05), but no differences for fatigue and vigour were observed. CONCLUSION: The 
results of this study demonstrate that viewing painful images prior to exercise decreased 
TT performance. This study demonstrates that there is an emotional element to the 








Pain is an unpleasant, subjective experience that includes sensory and emotional 
components (Rainville, 2002). The sensory components of pain involve the transmission 
of signals from peripheral receptors through somatosensory to thalamic nuclei (VPL, 
VPM, S1, S2, and the posterior parietal regions) and, consequently, from these regions to 
cortical limbic pathways including the anterior cingulate cortex (ACC) and the anterior 
insular (AI) (Price, 2002). The emotional components of pain relate to perceptions of the 
unpleasantness of pain and primarily comprise of a complex system of neurophysiological 
networks in the brain, and involve several regions near the edge of the cortex which are 
associated with mood and instinct (Price, 2000; Boggio, Zaghi & Fregni, 2009), this region 
also controls the basic core of emotions (fear, pleasure, anger) which influence 
observation, memory, movement, and cognition which are combined to yield insights into 
the thoughts and feelings of others (Ickes, 1997). These basic emotions primarily involve 
the limbic system (Boggio et al., 2009). The cortical limbic pathway is known to integrate 
nociceptive input with information about the overall body status, and in turn regulates the 
affect attributed to pain (Price, 2002). Indeed, this affective component of pain depends 
upon neurophysiological systems that are anatomically distinct, at least partially, from 
those involved in the sensory perception of pain (Duquette, Roy, Lepore, Peretz & 
Rainville, 2007). In this regard, emotions and mood form an important element of pain, 
and changes in these have been shown to result in a different experience of perceived pain 
(De Wied & Verbaten 2001; Meagher et al., 2001).  
At the neural level, several studies have described the sensation of pain without apparent 
QR[LRXVVWLPXODWLRQDQGKDYHVKRZQWKDWREVHUYLQJRWKHU¶VSDLQHPRWLRQDOO\FDQHQKDQFH
the intensity reports to painful stimuli ± an effect termed compassional hyperalgesia (de 
Wied & Verbaten, 2001; Wunsch et al., 2003; Godinho et al., 2006; Loggia et al., 2008; 
Godinho et al., 2012). The International Affective Picture System (IAPS) suggests using 
hyperalgesia as a comprehensive term for all cases of increased pain sensitivity, since it is 
so often difficult to distinguish whether it is capable of activating nociceptors (Loeser & 
Treede, 2008). It is believed that the dorsolateral prefrontal cortex (DLPFC) plays a crucial 
role in physical, somatosensory pain perception, and its role in emotional pain, through 
exertion control on the perception of pain by modulating cortical and subcortical pathways 
(Lorenz, Minoshima & Casey, 2003; Godinho et al., 2006; Freund, Stuber, Wunderlich, & 
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Schmitz, 2007; Bar et al., 2007; Borckardt et al., 2007). Besides these regions, however, 
the neural activity of midbrain and ventral inferior frontal gyrus is also believed to be 
involved in the processing of pain and negative emotions, and is associated with the neural 
basis of empathy for pain response (Kober et al., 2008; Fan et al., 2011; Buhle et al., 2013).  
,QWHQVH H[HUFLVH FDXVHV D QR[LRXV HQYLURQPHQW LQ WKH PXVFOH ZKLFK HOLFLWV µH[HUFLVH-
LQGXFHGSDLQ¶(,3DQGWROHUDQFHRIWKLVVHQVDWLRQKDVEHHQDVVRFLDWHGZLWKHQGXUDQFH
performance (Dannecker & Koltyn, 2014; Mauger et al. 2010). The athlete¶VµJULPDFH¶FDQ
be frequently observed in a variety of events, and partly represents the obvious pain and 
effort that the athlete is going through (Kress & Stratley, 2007). Indeed, there have been 
cited incidents where athletes have appeared to exaggerate or hide their facial expressions 
during an event in an attempt to deceive their opponents about how they are faring 
(Fotheringham, 2001). However, it has perhaps not been considered how observing 
VRPHRQHHOVH¶VSDLQGXULQJH[HUFLVHPD\DIIHFWRQH¶VRZQSHUFHSWLRQV,IWKHLQWHQVLW\RI
the pain stimuli observed from others changes our own pain processing of pain and the 
way we experience it (Lamm et al., 2007), then this may affect decisions to alter work-rate 
due to a different pain perception (Mauger, 2014).  
Therefore, the purpose of this study was to examine whether a moderation of the emotional 
response to pain via the use emotional pain evoking images, effects pain perception during 
endurance performance. It was hypothesised that painful images would induce 
hyperalgesia and reduce endurance cycling performance.  
 
 
III. MATERIALS AND METHODS 
Participants 
Twenty-one male (n = 13) and female (n = 8) participants, trained in cycling (>3 h exercise 
per week) were recruited for this study, with characteristics detailed in Table 1. Before 
participating in this study, participants  were given a brief of the study (information sheet) 
describing exactly what they were asked to do. Participants were informed that a series of 
potentially distressing images would be viewed in this study. Ten images (4 painful, 3 
neutral, 3 pleasant) were presented to participants before taking part in the study so that 
they were aware of the type of image that would be viewed if they decided to participate. 
The participants were aware that all data would be unidentifiable and that they had the 
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right to withdraw from the study at any time without being required to provide a reason or 
an explanation. Following this, they were asked to complete the inclusion/exclusion 
criteria checklist and then asked to sign an informed consent form. Individuals suffering 
from the following conditions were excluded from the study: pregnancy, psychological 
disorders, history of fainting, bleeding disorders (e.g. haemophilia), types I or II diabetes, 
history of brain disorders, clinically significant or unstable medical, neuropsychiatric, or 
chronic pain disorder, history of substance abuse or dependence, history of brain surgery, 
tumour, or intracranial metal implantation, or be taking chronic medications that affect the 
central nervous, and history of heart disorders. All participants provided informed consent 
prior to volunteering for the study. Before all experimental visits, participants were asked 
to refrain from any vigorous exercise 24 hours before the laboratory visits, and asked to 
refrain from the ingestion of alcohol, caffeine and analgesics 48 h, 8 h and 6 h before any 
experimental visit (Lu, Lai & Chan, 2008). The experimental protocol was approved by 
the local Ethics Committee (University of Kent). Participants reported to the laboratory on 
five separate visits, each separated by 2-5 days. 
 
Table 7.1  Participant mean values for anthropometric characteristics, cardiovascular and 
performance parameters, and mean ratings for image subsets for Affective Valance and Emotional 
Pain.  
9DULDEOH 0DOH )HPDOH 7RWDO)	0 
$JH\UV    
+HLJKWFP    
%RG\PDVVNJ ц ц  
92PD[P/NJPLQ    
$QDHURELF7KUHVKROG:    
3HDN3RZHU2XWSXW:    
*;7HQGSDLQ    
*;7HQG53(      
*;7+5PD[EHDWPLQ
     
 
    
,PDJHZLWKUHVSHFWVFRUH 3OHDVDQW 1HXWUDO 3DLQIXO 
$IIHFWLYH9DOHQFH    
(PRWLRQDOSDLQQRSDLQ    
RPE, rating of perceived exertion; GXT, graded exercise test; HR, heart rate; * Rating image based 
on emotional pain perceived and not feelings of disgust/unease 
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Table 7.2  Participants mean values for multidimensional assessment of interoceptive 
awareness questionnaire 
Variables values 
Noticing 3.46 ± 0.85 
Not-Distracting 3.31 ± 1.21 
Not-Worrying 2.32 ± 0.83 
Attention Regulation 3.33 ± 0.58 
Emotional Awareness 3.22 ± 0.89 
Self-Regulation 3.36  ± 2.43 
Body Listening 1.59 ± 1.34 




Seventy-five images categorised into three subsets (painful, pleasant, and neutral), were 
shown via a PowerPoint Presentation on three separate experimental conditions (visits 3-
5). Both painful and pleasant images had somatosensory content (i.e. illustrated athletes in 
painful or pleasant situations). The painful images (n = 25) presented emotionally 
disturbing images demonstrating athletes in pain (e.g. a severe injury). Pleasant images (n 
= 25) presented athletes enjoying cycling, exercising or joyful situations. The neutral 
subset (n = 25) presented a photo that included complex visual stimuli with no particular 
emotional content (e.g. a photo of a garden). Where appropriate, images (40%) were taken 
from the International Affective Picture System (IAPS) (Lang et al., 2001) according to 
IAPS criteria in terms of valence and arousal, which have previously been validated for 
their valence score (Boggio et al., 2006, 2008). As a limited number of relevant images 
(i.e. pain occurring in sporting situations) were present on the IAPS database, the 
remaining images were obtained from the internet. In this study, the image stimulus was 
presented sequentially within a slide show over the course of the exercise tasks, in an 
analogous manner to numerous pain studies which utilise the same technique (e.g. Boggio 
et al., 2009; Godinho et al., 2011; Godinho et al., 2011). Briefly, participants viewed a 
computer screen at a comfortable distance of approximately 60 cm. A standardised set of 
instructions were utilised to explain the procedure of the study, and they were informed 
that a series of images would be viewed. It was highlighted that participants should rate 
each image based on the emotional pain felt and not feelings of disgust or unease. The 
 138 
 
three subsets of images were presented on separate visits in a counterbalanced and 
randomised order. Each subset presented a total of 25 images (15 images were viewed 
before the fixed power test and 10 images before the time trial). Each image was viewed 
for 30 s, as shown in the schematic in Figure 7.1. Immediately after viewing each image, 
participants were asked to rate each image with respect to affective valence (1 = pleasant, 
9 = unpleasant) (Avery et al., 2007) and their level of emotional pain while viewing the 







Figure 7.1 Overview of study design. Participants completed 5 visits to the laboratory (Each 





In their first laboratory visit, participants completed a familiarisation of viewing images 
and providing a rating for these, and were then were given a Multidimensional Assessment 
of Interoceptive Awareness questionnaire (MAIA) created by Mehling et al. (2012). This 
TXHVWLRQQDLUHZDVXVHGLQRUGHUWRLGHQWLI\WKHSDUWLFLSDQWV¶DZDUHQHVVRIXQFRPIRUWDEOH
comfortable, and neutral body sensations, tendency not to ignore or distract oneself from 
sensations of pain or discomfort, tendency not to worry or experience emotional distress 
with sensations of pain or discomfort, ability to sustain and control attention to body 
sensations, awareness of the connection between body sensations and emotional states, 
ability to regulate distress by attention to body sensations, active listening to the body for 
LQVLJKW H[SHULHQFHRIRQH¶VERG\ DV VDIH DQG WUXVWZRUWK\7KLVTXHVWLRQQDLUHKDVEHHQ
divided into eight subscales (including: noticing, not-distracting, not-worrying, attention 
regulation, emotional awareness, self-regulation, body listening and trusting. The items are 
answered on a 0 to 5-point scale (0 = never and 5 = always). Following this they were 
given standard instructions for the numeric pain rating scale (0-10, Cook et al. 1997) and 
rating of perceived exertion (RPE) using the Borg (6-20) scale (Borg, 1998) and a mood 
questionnaire (Brunel Universal Mood States; MQ) (Terry & Fogarty, 2003). Following 
this, participants commenced an assessment of aerobic capacity by performing a cycling-
based VO2max test. Power output was assessed using the cycle ergometer. Heart rate was 
continuously displayed using a Polar Vantage XL heart rate monitor (Polar Electro Oy, 
Kempele, Finland). Prior to the test, the ergometer was adjusted for each participant and 
the setting was recorded to allow reproduction at each subsequent visit. Expired gases were 
assessed using an online gas analyser (Cortex Biophysik GmbH, Leipzig, Germany) 
throughout the test. Following a rest period of 30-min, participants then performed a 
familiarisation of the exercise performance task described in Visit 2. 
During the second visit, participants completed a second familiarisation MQ, followed by 
a second familiarisation of the exercise performance tasks. These involved a fixed power 
test (FP) where participants cycled against a fixed power equivalent to 70% of the maximal 
aerobic power (determined from GXT) for 10-min, maintaining a self-selected cadence 
throughout. The cadence was recorded to allow reproduction at each subsequent visit. The 
FP test was designed to be non-exhaustive, so that participants could report RPE and 
perceived pain every 2-minutes to allow an analysis of the perceptual effect of the 
experimental intervention, and to allow them to be able to complete the subsequent 
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performance trial. 5-min following the completion of the FP, participants completed the 
endurance performance test - a self-paced 16.1-km cycling time trial (TT) (Velotron, 
Racermate). Participants were instructed to complete the distance as quickly as possible, 
and to report RPE and perceived pain every km. After the TT, participants were given a 
10-min cool-down at a self-selected intensity, and then completed a further MQ.  
Visits 3-5 formed the experimental data collection. In these visits, participants initially 
completed a MQ followed by the FP and the TT (as described in Visit 2). During these 
exercise tasks, the computer screen was placed at eye level 60-cm away from participants, 
and then an image subset group (i.e. neutral/pain/pleasant) was presented. The presented 
image subset was randomised and counter-balanced across visits 3-5. Fifteen images from 
the subset were presented prior to FP task for a period of 7-min and 30 s, and 10 images 
were presented during the rest period between the FP and TT for 5-min (each image was 
viewed for 30 s). After viewing each image, participants were immediately asked to rate 
each image and their level of emotional pain while viewing the images. After the TT test, 
participants completed a final MQ.  
 
Statistical analysis 
Prior to statistical analysis, standard assumptions were checked for each statistical test, and 
none of these were violated, with the exception of completion time for the TT. The 
reciprocal translocation was used to normalise the distribution of TT completion time, 
which was then analysed using a repeated measures ANOVA and Bonferroni Pairwise 
Comparisons. Analysis of mean PO, mean HR, mean B[La], RPE and mean exercise-
induced pain were performed using an ANOVA with repeated measures and appropriate 
follow-up paired-sample t-tests or pairwise comparisons. Changes in PO, HR, B[La], RPE 
and exercise-induced pain during each TT and FP condition were assessed using a three-
way ANOVA with repeated measures and appropriate follow-up paired-sample t-tests. All 
statistical analysis was performed using the statistical package SPSS version 22 for 
Windows programs (SPSS Inc., Chicago, IL, USA). Descriptive data are reported as means 







Image Ratings: Participants rated the subset of painful images with significantly higher 
values for emotional pain compared to the pleasant images and neutral images (P<0.05). 
Participants also rated each subset of images as different from one another for affective 
























Pain / No-Pain 
 
 
Figure 7.2  Shows differences between conditions for rating of affective valence and 
emotional pain perceived. * denotes significant difference between conditions for affective valence 
(P<0.05). # denotes significant difference between conditions for pain/no-pain. 
 
 
Time Trial Task (TT) 
Completion Time: The ANOVA revealed a significant difference in completion time 









participants performed a significantly faster TT (P = 0.003) in the pleasant condition (29 
min 38 s ± 4 min 35 s) and the neutral condition (29 min 39 s ± 3 min 34 s) compared to 
the painful condition (30 min 19 s ± 5 min 7 s). There were no significant differences 
between the neutral condition and the pleasant (P = 1.000).  
 
Power Output (PO): The ANOVA revealed a significant main effect of condition for PO 
during the TT cycling performance (F (2, 40) = 6.318, P = 0.004), as shown in Figure 7.3. 
Follow-up tests showed a significant difference in mean PO between pleasant and painful 
image conditions (t(20) = 3.493, P = 0.002) and between neutral and painful image 
conditions (t(20) = 2.939, P = 0.008), but no significant differences between pleasant and 
neutral image conditions was found (t(20) = 0.560, P = 0.581). There was also a main effect 
for distance completed (P < 0.001), but no interaction effect (F (30, 600) = 0.847, P = 0.702), 





















Figure 7.3  Shows the power output differences between conditions. * A significant main 





























Figure 7.4  Power output differences between conditions over time. Although there was a 
significant difference in mean PO between conditions, no significant interaction effects for PO over 
time between conditions during the TT were observed (P > 0.05), indicating that the intervention 














Heart Rate (HR): The ANOVA revealed a significant difference in the mean HR between 
conditions during the TT (F (2, 40) = 4.502, P = 0.017). There was a significant main effect 
for distance completed (P < 0.05), but no significant interaction effect was found (P > 
































Figure 7.5  Heart rate differences between conditions over time. Although there was a 
significant difference in mean HR between conditions, no significant interaction effects for HR 
over time between conditions during the TT were observed (P > 0.05). *significantly different 








Blood lactate (B[La]):The ANOVA revealed a significant main effect of condition for 
mean B[La] during the TT (F (2, 40) = 5.724, P = 0.007), a main effect for distance completed 


































Figure 7.6  Blood lactate differences between conditions over time. # denotes a significant 
difference between pleasant and unpleasant image conditions, and a significant difference between 











Perceived Exertion: No significant main effects for condition were observed (P > 0.05). 
There was a main effect for distance completed (P < 0.001), but no significant interaction 
















































Exercise-induced pain (EIP): No significant main effects for condition were observed (P 
> 0.05). There was a main effect for distance completed (P < 0.001), but no significant 










































Fixed Power Task (FP) 
Heart Rate (HR): No significant main effects for condition were observed (P > 0.05). 
There was a main effect for time completed (P < 0.001), but no significant interaction 






































Exercise-induced pain (EIP): There was main effect of condition for EIP (F (2, 40) = 4.363, 
P = 0.019). There was a significant main effect for time completed (P < 0.001). Following-
up tests showed a significant difference in EIP between pleasant and painful image 
conditions (P = 0.015). No significant difference between pleasant and neutral image 
conditions (P = 0.308), or between neutral and painful image conditions was found (P = 
0.098). The ANOVA revealed no significant interaction effects for EIP (P > 0.05), as 






























Figure 7.10  EIP differences between conditions during the FP test. # denotes a significant 






Percieved Exertion (RPE): No significant main effects for condition were observed (P > 
0.05). There was a main effect for time completed (P < 0.001), but no significant 














































Blood Lactate (B[La]). No significant main effect of condition or interaction effects for 





























Figure 7.12  No differences between conditions for blood lactate during the FP test.  
 
 
Mood States (BRUMS):  
 
Table 7.3  Participant mean values for mood states (depression, tension, anger and 
confusion).  
 Pleasant       Neutral Painful 
 Pre Post Pre Post Pre Post 
Depression 1.10 ± 2.28 0.71± 1.55 1.14 ± 2.43 1.43± 2.68 1.57 ± 2.36 2.43± 2.82* 
Tension 1.86 ± 2.85 0.90 ± 1.34 1.33 ± 2.18 1.48 ± 2.54 1.38 ± 2.27 3.29± 3.85* 
Anger 1.29 ± 2.39 1.14 ± 2.85 1.67 ± 2.31 1.38 ± 2.91 1.81 ± 3.08 2.38±3.63* 
Confusion 0.95 ± 1.80 0.86 ± 1.82 1.00 ± 1.82 0.71 ± 1.95 2.19 ± 2.42 2.24±3.02* 
* A significant different between pre-and post. 
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V. DISCUSSION  
The primary finding of this study was that viewing a set of images that elicited a significant 
degree of emotional pain prior to exercise, exacerbated the level of perceived pain 
experienced for a given exercise intensity, and this resulted in endurance performance 
being negatively impacted. When a set of images were presented that depicted painful 
sporting situations (in comparison to neutral or pleasant images), participants rated cycling 
at 70% of their peak PO as significantly more painful, despite no change in any 
physiological response or perception of effort. This increased pain then likely resulted in 
a longer time trial performance, arising from a self-selected power output that was 
significantly lower and a consequently lower mean HR and B[La]. These findings suggest 
that there is a significant emotional element to EIP, which if exacerbated can lead to an 
increased perception of pain despite no change in the nociceptive signal.  
Pain sensation can be separated into a sensory-discriminative and an affective-motivational 
component (Treede, Kenshalo, Gracely & Jones, 1999). The sensory-discriminative 
component (i.e. nociception or sensory pain) informs the individual about the location, 
modality, and intensity of stimuli. The affective-motivational component (i.e. pain 
unpleasantness or emotional pain) refers to the emotional responses to a painful stimulus, 
or accompanying feelings of fear, disgust, exhaustion, sadness, and anxiety. These 
sensations motivate the individual to escape or reduce the source of pain, and thus provide 
an important protective function. Numerous studies have previously demonstrated that the 
sensation of pain can be present without any apparent noxious stimulation, and that pain 
perception and the intensity of the noxious stimuli are not necessarily directly proportional 
(Keltner et al., 2006). This observation is consistently demonstrated where observing 
RWKHUV¶ SDLQ FDQ HQKDQFH WKH LQWHQVLW\ UHSRUWLQJ RI SDLQIXO VWLPXOL ± an effect termed 
compassional hyperalgesia (Godinho et al., 2006). Importantly, this shows that changes to 
the affective-motivational component of pain can moderate the sensory-discriminative 
component. It is suggested that the unpleasant emotional mood states elicited by viewing 
RWKHUV¶SDLQDXJPHQWWKH sensory experience of pain, whereas pleasant emotional states 
diminish it (Meaghar et al. 2001). Therefore, for compassional hyperalgesia to be elicited, 
changes in mood relevant to unpleasant emotional states need to be elicited. The 
manipulation check data in the current study (i.e. differences in response to the pre/post 
MQ) indicate that the targeted emotional states were stimulated by the image subsets (i.e. 
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depression, tension, anger and confusion all significantly increased following viewing the 
Painful images), which is a consistent response to this type of intervention (Meaghar et al., 
2001). Indeed, De Wied and Verbaten (2001) and Meagher et al. (2001) both found that 
exposing subjects to painful images negatively affected emotional state, and this reduced 
the tolerance of a cold pressor test. Wunsch et al. (2003) further showed that unpleasant 
images depicting painful scenes, led to increased intensity and unpleasantness judgement 
of thermal stimuli. These effects were subsequently suggested to be specifically related to 
the particular observation of painful scenes, as non-painful images that were equally 
unpleasant did not induce hyperalgesia (Godinho et al., 2006). The results of the current 
study replicate these previous findings, and demonstrate that a negative emotional state, 
induced by emotionally painful images, can increase intensity of EIP. This is an important 
observation, because it has previously been suggested that EIP is processed and perceived 
very differently to traditional models of experimental pain (Angius et al., 2015), and 
therefore it is not necessarily expected that the same interventions bring about the same 
effects with these different types of pain. Indeed, transcranial direct current stimulation of 
the motor cortex has previously been shown to reduce the intensity of pain associated with 
a cold pressor test, but did not have any analgesic effect on exercise induced pain (Angius 
et al., 2015). As the motor cortex is more associated with the sensory-discriminative aspect 
of pain (Boggio et al, 2008, 2009), combined with the current findings this may also 
suggest that EIP is strongly influenced by the affective-motivational component.  
The experience of pain is represented in memory through learning and life experiences, as 
with other affective states, and this association between pain experience and particular 
situations is perhaps one of the most important systems to promote survival (Gendolla, 
2012). Pain-priming results in increased pain intensity for a given painful stimuli and an 
activation of the memory network, suggesting an activation of the mental representations 
about past experience of pain (Silvestrini, 2015). Viewing painful images prior to exercise 
performance may therefore activate the memory networks regarding previously painful 
exercise situations, and therefore create expectancy that the imminent task will be painful. 
An alternative explanation is that focus on painful images prior to exercise may change 
attention during exercise so that more focus is put on the painful aspects of it, resulting in 
a higher pain rating for a given nociceptive stimuli (Meagher et al., 2001).  
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In the current study, the FP test was designed to assess whether the intervention resulted 
in a change in perceptual response (i.e. pain and RPE) for a given exercise intensity. The 
subsequent TT was then performed to assess whether the predicted change in perceptual 
response would elicit a change in endurance performance. This experimental design was 
necessary to fully explore the research question, because it has previously been shown that 
whilst changes in perceptual responses to an intervention can be observed in fixed intensity 
exercise, in self-paced exercise (such as a TT), participants tend to maintain a fixed 
progression in perceptual parameters at the expense of changes to work rate (Mauger et 
al., 2010, Mauger, 2014; Tucker, 2009). Thus, the TT provided a true measure of self-
paced endurance performance, whilst the FP task helped demonstrate that the intervention 
elicited the predicted perceptual response. It is noteworthy that the intervention resulted in 
no changes to RPE, and a significant change to EIP in the FP task. This provides further 
evidence that EIP and RPE can be partitioned, provided participants are given adequate 
instructions and familiarisation with the two scales (Pageaux, 2016). Of further note, is 
that despite no apparent effect of the intervention on RPE, performance of the TT was 
affected by the intervention. This supports the findings from Chapters 5 and 6, that 
endurance performance can be moderated by changes in pain perception, independently to 
any change in RPE. This further question the validity of the psycho-biological model of 
endurance performance, which suggests that RPE is the sole determinant of endurance 





VI. CONCLUSION  
In conclusion, this study has shown that there is a strong emotional element to EIP, and 
that this can be moderated by manipulating mood. In the current study, this was achieved 
be presenting participants with a series of emotionally painful images, and this caused an 
effect called compassional hyperalgesia. In support of the previous experimental chapters, 
perception of pain proved to be a determinant of endurance performance, as when more 
pain was felt for a given exercise intensity (due to compassional hyperalgesia), cycling 






























8.1 General discussion 
Exercise-induced pain is a naturally experienced phenomenon and arises as consequence 
of intense and prolonged exercise. However, it has been suggested to have a negative effect 
on endurance performance. Despite this, the study of exercise-induced muscle pain during 
athletic performance has received limited attention. Therefore, the main purpose of the 
thesis was to provide further empirical evidence to advance scientific knowledge and 
understanding of the phenomenon of EIP; primarily by comparing experimental pain 
measures (CPT, PPT) to the sensation of and tolerance to EIP (Chapter 3), and to consider 
strategies to mitigate the impact of EIP as means of understanding its mechanisms. These 
interventions included those which have both a top-down (mirror visual feedback (Chapter 
4), compassional hyperalgesia (Chapter 7)) and bottom-up effect (TENS and IFC (Chapter 
5 and 6)). As a result, this thesis demonstrates that:  
I) EIP plays a crucial factor in endurance performance and can even predict 
performance in time trial cycling (1st study in Chapter 3);  
II) A high tolerance of EIP provides an important pre-requisite for successful 
endurance performance (1st study in Chapter 3);  
III) Top-down control and psychological factors linked to task expectation have a 
large influence on the magnitude and impact of EIP during endurance 
performance (2nd study in Chapter 4);  
IV) Decreasing the magnitude of the nociceptive signal, independently to any 
change in RPE, provides an analgesic effect on EIP and results in an improved 
endurance performance in both single limb and whole-body exercise (3rd study 
in Chapter 5, 4th study in Chapter 6);  
V) The impact of pain during exercise can be affected by mood, with a decreased 
mood resulting in an increased pain sensation (induced via compassional 
hyperalgesia) and decreased endurance performance (5th study, Chapter 7).   
VI)  
Overall, this thesis represents original work, which makes a significant contribution to 





The primary purpose of the 1st experimental study performed in Chapter 3 was to examine 
the relationship between pain threshold/tolerance induced by traditional experimental 
inductions of pain, tolerance of EIP, and endurance performance. Whilst several studies 
have previously investigated the relationship between experimental measures of pain and 
exercise performance, many of these have used experimental pain, including thermal, 
pressure and electric stimuli to test their postulates that pain threshold/tolerance predicts 
exercise capacity. However, these traditional measures of experimental pain poorly reflect 
the nociceptive pathway and sensation of EIP, and so in this study it was important to 
create a test that could measure tolerance specifically to EIP. Accordingly, we found that 
µ53(FODPS¶7XFNHUHWDO., 2006) adequately induced EIP, and tolerance to it could be 
assessed by the level of EIP reached in the test. This experimental study (Chapter 3) 
demonstrated for the first time that tolerance of EIP could be used as a predictor of 
endurance cycling performance, whereas traditional pain measures did not. This reveals 
the importance of using an appropriate method for pain measurement in the area of exercise 
induced pain studies. This experimental study (Chapter 3) provides new evidence for the 
need to consider the link between pain and performance. Indeed, athletes who are capable 
of pushing harder and longer are commonly the ones who are successful. Thus, this study 
laid the framework for the rest of the thesis, and confirmed that endurance exercise is partly 
regulated by the perception of pain, a higher pain tolerance can enhance exercise capacity.  
It is suggested that EIP might provide important perceptual information to the brain 
regarding the state of the exercising periphery, which informs the exerciser whether to 
increase or decrease their work-rate and thus avoiding impending tissue damage. However, 
this assumes that pain perception purely dependent on the size of the nociceptive signal 
and this is known not to be the case. Indeed, pain has a significant subjective element and 
psychological component (Hansen & Streltzer, 2005). There is no doubt that physiological 
factors will ultimately limit a successful endurance athlete (Joyner & Coyle, 2008), but the 
sole emphasis on physiological mechanisms ignores the fact that regulation of exercise 
appears to be ultimately regulated by the brain (Ulmer, 1996). Some models such as the 
CGM (Noakes 2000, 2011) and Psycho-biological model (Marcora, 2007, 2008a, 2008b, 
2009, 2010, Marcora, Bosio & de Morree, 2008; Marcora & Staiano, 2009a, 2010b) try to 
address this, but the role of EIP in these models is either ignored or dismissed. The results 
of 1st study suggest that EIP plays a key role in endurance performance, but whether this 
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is predominantly due to the size of the nociceptive signal (and therefore perhaps a 
secondary perception, related to the sensation of peripheral fatigue but otherwise 
unimportant) or due to the psychological unpleasantness associated but not necessarily 
proportional to the nociceptive signal, was unknown. Consequently, experimental studies 
2-5 were designed to investigate the physiological and psychological impact of EIP, and 
specifically to try to separate the impact of these two facets during endurance performance.  
 
 
The primary purpose of the experimental 2nd study in Chapter 4 was to use the mirror box 
technique to alter perceptions of the exercise task. It was hypothesised that when 
participants believed the task to be easier or harder, performance would be better or worse 
(respectively) and this would be paralleled by the perception of less or more pain 
(respectively). The results of this study confirmed the hypothesis, with participants 
reporting that both increases in both EIP and RPE over time were less affected by task 
difficulty when participants were deceived of the change in task demands. This is an 
important finding because processing of pain is interpreted and perceived by the brain by 
a complex neurological network (Peyron, Laurent & Garcia-Larrea, 2000), yet simple 
factors appear to be able to influence the neural (and consequently perceptual) responses 
to painful stimuli (Mancini, Longo, Kammers & Haggard, 2011). This shows that EIP is 
partly a subjective experience (in the same manner as experimental pain), and its 
perception can be affected by the expectation of pain. Therefore, mirror visual feedback 
could be important in the developments of therapeutic strategies for those who suffer 
increased pain during exercise or movement. Although this study provides insight into the 
psychological element of EIP, and shows that it responds in a similar manner to 
intervention previously tested on experimental pain, the changes in endurance performance 
could not be solely attributed to differences in EIP. Indeed, RPE was affected in the same 
manner by the intervention, and RPE has previously been identified as a key limiter to 
endurance performance. Thus, this study alone cannot present the change in EIP as the 





The 5th experimental study performed in the Chapter 7 further explored the psychological 
aspects of EIP, and how these may drive the change in performance associated with EIP. 
Painful images were used to induce compassionate hyperalgesia, which has previously 
been shown to affect pain perception. Compassionate hyperalgesia was produced, which 
led to negative mood and an increased EIP for a given cycling intensity. The unique 
experimental design of this study then showed that this hyperalgesia led to a decrease in 
endurance performance. It is likely that the induced compassional hyperalgesia activated 
SDLQFLUFXLWULHV WKDW WUDQVLHQWO\DPSOLILHGSDUWLFLSDQWV¶SHUFHSWLRQRISDLQ ,QGHHG fMRI 
experiments have shown that regions of the brain associated with coding the intensity and 
location of pain are affected when observing another person in pain (Jackson et al., 2006; 
Lamm et al., 2007). This study suggests that EIP can be similarly affected by this 
phenomenon. An important finding of this study was that EIP was exacerbated and that 
this occurred alongside a decreased endurance performance. Crucially, no change in RPE 
was observed. Combined with the results from 1st study, this shows that EIP exerts an 
impact on endurance performance independently of perception of effort. This novel finding 
suggests that the notion that RPE is the sole limiter of endurance performance, as predicted 
by the Psychobiological model, is incorrect, and that changes to perception of effort do not 
have to occur for endurance performance to be affected. It may be that such a finding has 
not previously been observed because feelings of pain and discomfort are usually included 
in the general instructions for RPE. However, it has been shown people can distinguish 
between perception of effort and pain, and so studies should seek to use the two scales 
independently (Pageaux, 2016). This methodological approach was used in this thesis, and 
doing so appears to have provided new insight into the importance of perception of effort 
and pain in endurance performance.  
 
 
Where 2nd and 5th studies were designed to investigate the psychological, top-down aspects 
of EIP, 3rd and 4th studies were designed to explore the bottom-up, afferent feedback 
component of EIP, and how moderating the magnitude of this feedback may alter 
performance. In Chapter 5, the 3rd experimental study investigated the effects of 
transcutaneous electrical nerve stimulation (TENS) and interferential current (IFC) on EIP 
during single limb, submaximal isometric contractions in healthy participants. Although 
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TENS and IFC are both well-known as non-invasive non-pharmacologic therapies, that 
have been shown to be more effective than placebo to elicit analgesic effects in a variety 
of conditions (Marchand et al., 1993; Robinson, 1996; Schmitz et al., 1997; Facci et al., 
2011), this is the first study investigating the potential analgesic effect of TENS and IFC 
on the perception of EIP during a sustained single limb, submaximal isometric contraction 
in healthy participants. The primary and novel finding was that both TENS and IFC were 
able to significantly reduce the perception of EIP, and that this intervention elicited a 
significant improvement in time to exhaustion performance (TTE). To our knowledge, this 
is the first study using a randomised, crossover and placebo-controlled design, which 
shows an ergogenic effect for TENS and IFC, and the results provide an interesting insight 
regarding the psychological and physiological mechanisms involved in the generation of 
pain perception during single limb exercise. It is suggested that exercise-induced muscle 
pain is caused by an accumulation of endogenous algesic substances, with an increased 
intramuscular pressure and muscular distortion (Mense, 1993; Dannecker & Koltyn, 2014). 
The accumulated endogenous algesic substances (including: hydrogen ions, potassium, 
histamine, serotonin, bradykinin, acetylcholine, adenosine and substance P) activate and 
stimulate both Group III (A-delta fibres) and Group IV (C fibres) small afferents, which 
then transmit nociceptive signals (regarding actual or potential tissue damage stimuli) and 
synapse in lamina I, II and V in the spinal cord and then to the supraspinal regions of the 
brain, where it is processed and interpreted as pain (Mense, 1993; O'Connor & Cook, 
1999). Sustained sub-maximal isometric contractions used in this experimental study 
(Chapter 5) have been shown to yield endogenous algesic substances, which both prevent 
or inhibit the excitation-contraction coupling process (Kent-Braun, 1999) and provoke a 
nociceptive signal. To mitigate the impact of this metabolic environment, without changing 
the endogenous algesic substances, TENS and IFC were utilised to reduce the transmission 
of the nociceptive signal arriving in the brain. The mechanisms behind this intervention is 
postulated to operate through the Gate-Control Theory of Pain (Sluka & Walsh, 2003), as 
shown in Figure 8.1. According to this theory, Melzack and Wall (1965) suggest the spinal 
cord comprises a neurological "gate" that either allows pain signals or blocks them to pass 
through to the brain. Small-diameter afferent fibres (pain signal) and large-diameter 
afferent fibres (tough, pressure, other senses) both synapse at the dorsal horn and carry the 
transmission of nociceptive information up the spinal cord to the brain. When there is more 
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activity of large afferent fibres in comparison to the activity of small afferent fibres, 
individuals tend to perceive less pain. Indeed, when TENS and IFC was applied during 
time to exhaustion task in this experimental study (Chapter 5), individuals experienced less 
EIP via activating large afferent fibres much more than small afferent fibres activity. This 
intervention appeared to induce analgesia which resulted in a longer time to exhaustion of 
the sustained isometric contraction. The most striking observation to emerge from the data 
in this experimental study (Chapter 5) is that TTE increased following a reduction in 
perception of EIP, but in the absence of changes to RPE between conditions. A variety of 
evidence suggests that the primary generator for RPE is the collorary discharge associated 
with central motor command (McCloskey, 1981), and is independent from afferent 
feedback (in this case pain) from the exercising muscles and other interceptors (Marcora, 
2009; de Morree et al, 2012, 2014). Marcora and Staniano (2010) postulated that the sole 
determinant of endurance performance is primarily the RPE. Marcora (2010) also states 
that perception of muscle pain naturally experienced during high-intensity aerobic exercise 
does not influence endurance performance. However, the results from the study in Chapter 
5 suggest that the nature of EIP perception experienced during exhaustive exercise task 
does limit performance and that it can be moderated independently of RPE in healthy 
participants. Other studies support that these findings demonstrate that an analgesic 
intervention (such as, paracetamol or caffeine) are able to improve exercise performance 
in a variety of exercise models (Mauger et al. 2010; Astorino et al. 2011; Astorino et al. 
2012; Foster et al. 2014; Mauger et al. 2014; Gonglach et al. 2015) and support that 
tolerance of EIP is an important factor in determining endurance performance (Mauger, 
2013, 2104; Astokorki & Mauger, 2016). The results conclude that TENS and IFC elicit 
an analgesic effect for EIP, and that this reduction in EIP perception can improve time to 
exhaustion performance in the absence of changes to perceived exertion. However, the 
limitation of this experimental study (Chapter 5) is that it could be argued that single limb 
exercise creates a metabolic and nociceptive environment that is different to that seen in 
whole-body exercise. Therefore, the analgesia elicited by TENS and IFC may not be 
ergogenic in whole-body exercise. To address this, a follow-up study was conducted to 





In Chapter 6, the 4th experimental study aimed to assess whether the ergogenic effect of 
TENS and IFC observed in Chapter 5 would be replicated in cycling exercise. This is the 
first study to investigate the effect of TENS and IFC on perception of during whole-body 
dynamic exercise. The primary and novel finding of this experimental study (Chapter 6) 
was that TENS improved performance of the cycling TT (~ 2%), and that this was achieved 
by sustaining a higher power output, heart rate and blood lactate concentration. Despite the 
increased physiological strain and metabolic lactic acidosis cause induced by the higher 
PO, participants perceived less EIP in the TENS condition alongside no change in RPE. 
The greater power output result in the higher metabolic demand in the TENS intervention, 
which would have produced a greater noxious environment in and around the exercising 
muscles, which would have been experienced as more EIP. However, the most striking 
result in this experiment performed in Chapter 6 was that despite the higher noxious 
environment caused, participants perceived less EIP in the TENS intervention. These 
findings suggest that during this dynamic whole-body endurance exercise, the participants 
were able to tolerate a greater rate of accumulation of muscle metabolites and physiological 
strain than usually experienced in normal conditions (a placebo control). This data provides 
support for the notion that tolerance of EIP is one of the likely variables that is used to help 
regulate exercise intensity, perhaps to avoid physiological harm. Indeed, it has been 
suggested by the Central Governor Model that endurance performance is regulated through 
a complex integrative system of control that balances perceived demands of the exercise 
via afferent feedback, and capacity of the physiological system. However, there are other 
models that could also explain the observed ergogenic effect. In the Afferent Feedback 
Model, metabolic changes in the exercising muscle produces increased afferent feedback 
that results in a reduced or impeded central motor drive (i.e. central fatigue). It is plausible 
that the TENS intervention impeded the afferent feedback at the spinal cord (in accordance 
with gate control theory), which would have reduced the size of the afferent feedback and 
consequently offset the reduction in central motor drive. However, the findings of this 
study (Chapter 6), and those presented in Chapters 5 and 7, suggest that the 
Psychobiological model is not able to explain the limitations to endurance performance in 
all scenarios. Each of these three studies demonstrate that exercise performance was 
affected by the experimental intervention, but with the absence of any change to RPE. 
Whilst TENS attenuated the perception of EIP and improved performance in this 
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experimental study (Chapter 6), IFC did not reduce pain or improve performance (despite 
this occurring in the previous chapter with single limb exercise). A reason for this may be 
the intrinsic factors of the IFC intervention used to stimulate a large group of quadriceps 
femoris muscles during dynamic whole-body exercise, as this was not the same as the IFC 
intervention that stimulates a small group of muscles (single limb) used in the previous 
experimental study. Indeed, two stimulation channels for the IFC intervention were used 
to activate quadriceps femoris muscles rather than four channels. Consequently, this may 
not have been sufficient to stimulate the whole quadriceps femoris muscles and to reduce 
pain and subsequently improved performance.  
 
 
Figure. 8.1. The circuit diagram of the gate-control theory of pain perception as proposed by 
Melzack and Wall (1965). According to the theory, they proposed that the transmission cells [T 
cells] originally thought to be cells of the spinothalamic tract activate neural mechanisms that 
produce pain perception, i.e., T-cell activity is interpreted by the central nervous system as pain. 
A gate cell, or G cell (originally thought to be cells of the substantia gelatinosa), can modulate the 
activity in afferent pathways (of both large and small fibres) to the T cell, before it gets to the T 
cell. The G cell activity is, in turn, modulated by activity in both large and small primary afferent 
fibres. Specifically, barrages in both large and small fibres excite the T cell (drive its membrane 
voltage toward the critical firing level), whereas the same barrages in large fibres excite the G cell 
to discharge and the same barrages in small fibres inhibit the G cell discharge (drive its membrane 
voltage away from the critical firing level). Activity in the G cell inhibits (reduces or blocks) 
transmission from both large and small fibres to T cells. Cortical and subcortical influences on the 
gate control mechanism, called "Central Control" in the figure, are indicated in the diagram of 
Figure 8.1.  
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8.2 Conclusion and perspectives 
In conclusion, the experimental studies in this thesis provide new insight into how EIP 
affects exercise endurance performance, and how some strategies can mitigate its impact. 
Each experiment in this thesis provides an important contribution to this field, by exploring 
and adding to the existing knowledge base. Overall, this thesis has demonstrated that EIP 
plays a key role in exercise performance, and a higher tolerance of EIP is one of several 
determinants of endurance performance, mainly because it facilitates awareness of the 
physiological state of muscle and subsequently assists to regulate pacing during moderate 
prolonged exercise. By reducing pain through psychological or physiological 
interventions, endurance performance is improved, whereas increasing pain through a 
psychological intervention worsens endurance performance. These are important findings, 
because pain during intense exercise has previously escaped significant attention in the 
empirical literature. Where there has been a focus on this, experiments have largely 
assessed pain through the use of thermal, pressure and electrical stimuli to promote an 
algesic response, which as shown in this thesis, are perhaps not appropriate for exploring 
EIP. To address in this, the experiments of this thesis were designed in such a way as to 
maintain the mechanisms causing EIP, and to explore interventions that are able to offset 
the effect of this. The interventions used to reduce pain and improve exercise performance 
in this thesis may have implications for populations where EIP poses a barrier to physical 
activity. Indeed, devices like TENS are cheap, easy to use and portable, and the results 
from this thesis suggest it can elicit a meaningful analgesic effect during exercise. 
Although there is clearly a physiological component to EIP, this thesis also shows that 
there is an important psychological element, which can be affected by parameters such as 
mood and expectation. This suggests that SHRSOH¶V psychological approach to exercise and 
competition may have consequences for their perceptions during the exercise. This 










All the experimental studies in this thesis utilised a sample of recreationally active, healthy 
male and female participants who exercised regularly (3 h or more per week) were 
recruited. None of the participants were highly trained cyclists. As such interpretation of 
our findings of this thesis should be restricted to matching populations. It is possible that 
highly trained or sedentary groups would show a different response to EIP, therefore, these 
studies should be repeated with a highly trained or sedentary cohort that would assist 
further explanation about the internal protective mechanism of afferent feedback and the 
central governor regulation of exercise intensity. 
 
8.4 Implications and directions for future studies 
The primary results of the experimental studies that consist of this thesis have implications 
for the instruction and interpretation of EIP during endurance exercise performance. An 
awareness of potential changes in perceived pain during intense exercise may practically 
assist athletes, coaches, exercise scientists and health and fitness practitioners to consider 
advice given to their charges. EIP has a strong psychological component, so there is scope 
to look to strategies that can help athletes and individuals better tolerate this pain. Indeed, 
it may be that engaging in particularly painful training to condition the exerciser 
psychologically could be an effective strategy that could be investigated with a training 
study.  
The influence of pain expectation has become the focus of scientific investigation within 
recent years. Whilst this thesis has extended the examination of this theme via mirror visual 
feedback, several essential questions remain unanswered. Although the results of mirror 
study (Chapter 4) give us a better understanding of the importance of how our expectations 
of pain affects the experience of pain, one of the limitations of this study is that brain 
activity was not measured. A functional magnetic resonance imaging study or use of 
electroencephalogram (EEG) would allow the recording of how specific areas of the brain 
may be differently affected when different expectations of the exercise are presented. 
Expectation of pain has been shown to enhance responses to non-painful somatosensory 
stimulation in the anterior cingulate cortex (ACC) and parietal operculum/posterior 
insula (PO/PI), both of which may play roles in regulating pain-dependent behaviour 
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(Sawamoto et al., 2000). Whether a similar effect occurs during exercise would be an 
interesting study to further explore.  
This thesis has shown that TENS and IFC can reduce pain and improve endurance 
performance. However, the theoretical explanation for why this occurs cannot be 
confirmed. To assess whether the Afferent Feedback model provides an appropriate 
explanation, a follow-up study using transcranial magnetic stimulation (TMS) and 
peripheral stimulation to assess neuromuscular parameters including voluntary activation 
level (VAL) and cortical silent period (CSP) would allow this theory to be tested. Of further 
interest, would be to identify why IFC did not elicit a change in performance in cycling 
exercise. To assess this, a stronger IFC protocol could be applied and a measure of 
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School of Sport & Exercise Sciences, University of Kent, The Medway Building, 
Chatham Maritime, Kent. ME4 4AG. 
 
Ali Astokorki 
Tel No: 01634 888903           e-mail: ahya3@kent.ac.uk 
 
 
PARTICIPANT INFORMATION SHEET 
Title of Study: An investigation into the analgesic effects of transcutaneous electrical 




Thank you for showing an interest in participating in the study. Please read this information 
sheet carefully before deciding whether to participate. If you decide to volunteer I would 
be grateful of you for your participation. If you decide not to take part there will be no 
disadvantage to you of any kind and I thank you for considering our request. 
 
What is the aim of the project? 
The aim of this study is to examine how transcutaneous electrical nerve stimulation 
(TENS) and interferential current (IFC) affect pain and cycling performance. 
 
What types of participants are needed? 
We are seeking to recruit 15 males and females (who cycling for more than 3 hours a week) 
aged between 18 and 44. To take part, you must not be within a pregnancy, type I or II 
diabetes, bleeding disorders (e.g. haemophilia), using a cochlear implant hearing device, 
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have a history of heart disorders, or be taking chronic medications that affect the central 
nervous system. 
Transcutaneous electrical nerve stimulation (TENS) is a method of pain relief in which 
a special device transmits low-voltage electrical impulses through electrodes on the skin. 
This device is non-invasive and safe with no side-effects compared with pharmacological 
analgesic modalities.  
 
Interferential Current Therapy (IFC) is a non-invasive therapy indicated for the 
symptomatic relief from, and management of pain. It provides a safe and effective 
alternative to pharmacological approaches to pain control. IFC is similar to TENS, but 
involves passing a moderate frequency weak electrical current across the surface of the 
skin. You may not be able to tell the difference between TENS & IFC. Although 
noticeable, it is not painful but will block the transmission of pain messages at the spinal 
cord level. This interferential stimulation is concentrated at the point of intersection, deep 
in the tissues, between the electrodes. 
 
Assessment of suitability/safety for administering electrical stimulation 
Before undergoing stimulation, on the first visit you will be tested for sensory 
discrimination test by using a sharp and blunt patella hammer. During stimulation, and 
after testing, you will be monitored for signs of skin irritation, swelling and/or pain in the 
tested area and nausea. On completion of stimulation, current will be ramped down before 
turning off the machine.  
 
Assessment of Blood Lactate 
During the time trial test, we will obtain a measure of blood lactate every 4km of the 
16.1km trial. This will involve a small prick on the finger/thumb in order a draw a few 
drops of blood for analysis. This may cause some discomfort, but is not very painful. You 
may find that you have a slight bruise for a few days after. 
 
What will my participation involve? 
The study requires you to come into the laboratory at Medway Park on four separate visits. 
In total, the time of these combined sessions will not exceed 4 hours over approximately 
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two weeks. The first visit will last approximately an hour, the second, third and fourth 
visits will take approximately 45-minutes each, separated by 2-5 days. 
 
Visit 1 
A general health screening will be conducted and your height and weight will be taken. 
This will include a series of tests to ensure it is suitable to administer TENS and IFC to 
you. Following these tests, bipolar surface TENS and IFC electrodes will be placed over 
your thigh, and then we will apply TENS and IFC in order to find the appropriate intensity 
for the following visits for three minutes. The current intensity will be adjusted until you 
report feeling a tingling sensation without causing muscle contraction and/or muscle pain. 
Following this, you will complete an exercise test to exhaustion (VO2max test). This will 
involve cycling against a progressively increasing intensity until you can no longer 
continue. Following a rest period of 30-min, you will complete a familiarisation of mood 
questionnaire (MQ) and you will undertake a familiarisation of the endurance performance 
test by completing a self-paced 16.1-km cycling time trial (TT). You will be asked to give 
a rating of perceived exertion (RPE) and perceived pain every km. After the TT test, 
participants will complete the MQ for the second time.  
 
Visit 2 
During this visit, you will complete the MQ and you will then perform the TT (as described 
in Visit 1). During these exercise tasks, they will be employed to TENS (as described 
above), sham (placebo), or IFC (in a randomised order) during the whole TT test. After the 
TT test, participants will complete the MQ for the second time.  
 
Visit 3 
During this visit, you will perform the same protocol as described in Visit 2 but with one 
of the 2 remaining randomised (sham/IFC/TENS) applies.  
 
Visit 4 
During this visit, you will perform the same protocol as described in Visit 2 but with the 1 
remaining randomised (sham/IFC/TENS) applies.  




During cycling exercise 
There may be shortness of breath and aching muscles during the exercise due to effort 
being undertaken. Water can be provided when carrying out the testing. There are no risks 
associated with this outside of the normal risks of moderate cycling exercise.  
During TENS and IFC 
There are some risks of TENS and IFC, which are small, but include nausea, fainting, skin 
irritation and electrical burns. Our participant exclusion criteria protect against some of 
these, and the pre-tests we will perform in the first visit will also minimise risk. Although 
unlikely, if you are effected by any of these adverse effects we will withdraw you from the 
study and recommend that you visit your GP. 
 
Requirements or abstentions imposed upon the participants prior to and after the 
experiment 
Prior to your lab visits, please do not ingest caffeine 6 hours prior, large quantities of food 
3 hours prior, or alcohol 24 hours, or heavy exercise 24 hours prior to testing. This is very 
important as it may affect the results.  Please try to keep your diet the same prior to each 
test.  
 
If I decide to start the study can I change my mind? 
Your decision to participate in this research is entirely voluntary and you can withdraw at 
any time without penalty against you. If you are a University of Kent student, your decision 
to participate or withdrawal will have no influence upon any judgements made of your 
academic performance. 
 
Will my confidentiality be protected? 
The researchers might use information gained from this study in scientific journal articles 
or in presentations. However, your results will remain anonymous and your individual data 
will not be able to be identified. At no time will names be given or information about you 
with regards to lifestyle etc. If this changes at any point, consent will have to be given by 




How can I get information about the study? 
You will be able to get information about your results and the study findings by contacting 
Ali Astokorki. 
 
What if I have questions? 
If you have questions about this research project, please contact the research supervisor, 

























School of Sport & Exercise Sciences, University of Kent, The Medway Building, 
Chatham Maritime, Kent. ME4 4AG. 
Ali Astokorki 
Tel:  01634 888903   email: ahya3@kent.ac.uk 
 
If you have any queries please contact: Ali Astokorki (see above) 
 
Participant Identification Number for this trial: 
 
CONSENT FORM 
Title of Study:  An investigation into the analgesic effects of transcutaneous electrical 
nerve stimulation and interferential current on exercise-induced pain and cycling 
performance 
 
         Please initial box 
1- I confirm that I have read and understand the information sheet for the above  
study and have had the opportunity to ask questions.    F 
 
2- I understand that my participation is voluntary and that I am free to withdraw 
at any time, without giving any reason, without my legal rights being affected. F 
 
3- I understand that any personal information that I provide to the researchers 
will remain strictly confidential.       F 
 
4- I agree to have a small sample of blood taken for the purposes of this  




5- I agree to take part in the above study.      F 
 
__________________________ ________________ _______________  
Name of Participant   Date   Signature 
__________________________ ________________ _______________ 
Name of Person taking consent Date   Signature 
(if different from researcher) 
__________________________ ________________ _______________ 
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ĂƚĞŽĨŝƌƚŚ ? ? ? ? ? ? ? ? ? ? ?  ? ?   ŐĞ ? ? ? ? ? ?  
 
Please answer these questions truthfully and completely.  The sole purpose of this 
questionnaire is to ensure that you are in a fit and healthy state to complete the exercise test. 
ANY INFORMATION CONTAINED HEREIN WILL BE TREATED AS CONFIDENTIAL. 
SECTION 1: GENERAL HEALTH QUESTIONS 
Please read the 8 questions below carefully and answer each one honestly: check YES or NO. 
 YES NO 
1. Has your doctor ever said that you have a heart condition or high blood 
pressure? 
ප ප 
2. Do you feel pain in your chest at rest, during your daily activities of living, 
or when you do physical activity? 
ප ප 
3. Do you lose balance because of dizziness or have you lost consciousness 
in the last 12 months? (Please answer NO if your dizziness was 
associated with over-breathing including vigorous exercise). 
ප ප 
4. Have you ever been diagnosed with another chronic medical condition 
(other than heart disease or high blood pressure)? 
ප ප 
If yes, please list condition(s) here: 
 
 
5. Are you currently taking prescribed medications for a chronic medical 
condition? 
ප ප 
If yes, please list condition(s) and medications here: 
 
 
6. Do you currently have (or have you had within the past 12 months) a 
bone, joint or soft tissue (muscle, ligament, or tendon) problem that 




answer NO if you had a problem in the past but it does not limit your 
ability to be physically active. 
If yes, please list condition(s) here: 
 
 
7. Has your doctor ever said that you should only do medically supervised 
physical activity? 
ප ප 





If you answered NO to all of the questions above, you are cleared to take part in the 
exercise test 
 




If you answered YES to one or more of the questions in  Section 1 - 
PLEASE  




SECTION 2: CHRONIC MEDICAL CONDITIONS 
 
Please read the questions below carefully and answer each one honestly: check YES or 
NO. 
  YES NO 
1. Do you have arthritis, osteoporosis, or back problems? 
If YES answer questions 1a-1c.  If NO go to Question 2. 
Ƒ Ƒ 
1a. Do you have difficulty controlling your condition with medications 
or other physician-prescribed therapies? (Answer NO if you are 




1b. Do you have joint problems causing pain, a recent fracture or 
fracture caused by osteoporosis or cancer, displaced vertebrae 
(e.g. spondylolisthesis), and/or spondyloysis/pars defect (a crack 
in the bony ring on the back of the spinal column)? 
Ƒ Ƒ 
1c. Have you had steroid injections or taken steroid tablets regularly 
for more than 3 months? 
Ƒ Ƒ 
2. Do you have cancer of any kind? 
If YES answer questions 2a-2b.  If NO, go to Question 3. 
Ƒ Ƒ 
2a. Does your cancer diagnosis include any of the following types: 
lung/bronchogenic, multiple myeloma (cancer of plasma cells), 
head and neck? 
Ƒ Ƒ 
2b. Are you currently receiving cancer therapy (such as chemotherapy 
or radiotherapy)? 
Ƒ Ƒ 
3. Do you have heart disease or cardiovascular disease? This 
includes coronary artery disease, high blood pressure, heart 
failure, diagnosed abnormality or heart rhythm. 
If YES answer questions 3a-3e.  If NO go to Question 4. 
Ƒ Ƒ 
3a. Do you have difficulty controlling your condition with medications 
or other physician-prescribed therapies? (Answer NO if you are 
not currently taking any medications or other treatments). 
Ƒ Ƒ 
  YES NO 
3c. Do you have chronic heart failure? Ƒ Ƒ 
3d. Do you have a resting blood pressure equal to or greater than 
160/90mmHg with or without medication? Answer YES if you do 
not know your resting blood pressure. 
Ƒ Ƒ 
3e. Do you have diagnosed coronary artery (cardiovascular) disease 
and have not participated in regular physical activity in the last 2 
months? 
Ƒ Ƒ 
4. Do you have any metabolic conditions? This includes Type 1 
Diabetes, Type 2 Diabetes and Pre-Diabetes. If YES answer 
questions 4a-4c.  If NO, go to Question 5. 
Ƒ Ƒ 





4b. Do you have any signs or symptoms of diabetes complications such 
as heart or vascular disease and/or complications affecting your 
eyes, kidneys, OR the sensation in your toes and feet? 
Ƒ Ƒ 
4c. Do you have other metabolic conditions (such as thyroid disorders, 
current pregnancy related diabetes, chronic kidney disease, or 
liver problems)? 
Ƒ Ƒ 
5. Do you have any mental health problems or learning 
difficulties?   ǯǡ ǡ ǡ
anxiety disorder, eating disorder, psychotic disorder, intellectual 
disability and down syndrome. 







5a. Do you have difficulty controlling your condition with medications 
or other physician-prescribed therapies? (Answer NO if you are 
not currently taking any medications or other treatments). 
Ƒ Ƒ 
5b. Do you also have back problems affecting nerves or muscles? Ƒ Ƒ 
6. Do you have a respiratory disease? This includes chronic 
obstructive pulmonary disease, asthma, pulmonary high blood 
pressure. 





6a. Do you have difficulty controlling your condition with medications 
or other physician-prescribed therapies? (Answer NO if you are 
not currently taking any medications or other treatments). 
Ƒ Ƒ 
6b. Has your doctor ever said you blood oxygen level is low at rest or 
during exercise and/or that you require supplemental oxygen 
therapy? 
Ƒ Ƒ 
6c. If asthmatic, do you currently have symptoms of chest tightness, 
wheezing, laboured breathing, consistent cough (more than 2 
days/week), or have you used your rescue medication more than 
twice in the last week? 
Ƒ Ƒ 
6d. Has your doctor ever said you have high blood pressure in the 
blood vessels of your lungs? 
Ƒ Ƒ 
7. Do you have a spinal cord injury? This includes tetraplegia and 
paraplegia. 







7a. Do you have difficulty controlling your condition with medications 
or other physician-prescribed therapies? (Answer NO if you are 
not currently taking any medications or other treatments). 
Ƒ Ƒ 
7c. Has your physician indicated that you exhibit sudden bouts of high 
blood pressure (known as autonomic dysreflexia)? 
Ƒ Ƒ 
  YES NO 
8. Have you had a stroke? This includes transient ischemic attack 
(TIA) or cerebrovascular event. 





8a. Do you have difficulty controlling your condition with medications 
or other physician-prescribed therapies? (Answer NO if you are 
not currently taking any medications or other treatments). 
Ƒ Ƒ 
8b. Do you have any impairment in walking or mobility? Ƒ Ƒ 
8c. Have you experienced a stroke or impairment in nerves or muscles 
in the past 6 months? 
Ƒ Ƒ 
9. Do you have any other medical condition which is not listed 
above or do you have two or more medical conditions? 
If you have other medical conditions, answer questions 9a-9c. If 





9a. Have you experienced a blackout, fainted, or lost consciousness as 
a result of a head injury within the last 12 months OR have you had 
a diagnosed concussion within the last 12 months? 
Ƒ Ƒ 
9b. Do you have a medical condition that is not listed (such as epilepsy, 
neurological conditions, and kidney problems)? 
Ƒ Ƒ 
9c. Do you currently live with two or more medical conditions? Ƒ Ƒ 
 Please list your medical condition(s) and any related medications here: 
 
10. Have you had a viral infection in the last 2 weeks (cough, cold, 




11. Is there any other reason why you cannot take part in this 





12. Please provide brief details of your current weekly levels of physical 
activity (sport, physical fitness or conditioning activities), using the 
following classification for exertion level: 
 
L    = light (slightly breathless 
M  = moderate (breathless) 
V   = vigorous (very breathless) 
 
                                           Activity                                Duration (mins.)     Level 












If you answered NO to all of the follow-up questions about your 
medical condition, you are cleared to take part in the exercise test. 
 
 
If you answered YES to one or more of the follow-up questions about 
your medical condition it is strongly advised that you should seek 











SECTION 3: DECLERATION 
 
Please read and sign the declaration below: 
I, the undersigned, have read, understood and completed this questionnaire to the best 









This health questionnaire is based around the PAR-Q+, which was developed by the Canadian 













Please complete the Participant Exclusion Document to 
assess specific contraindications for participating in this 































If any of the questions in SectiRQ,9%LVDQVZHUHGµ\HV¶DIXOOHWKLFVDSSOLFDWLRQPXVWEH
PDGHWRWKH5($*7KLVDOVRDSSOLHVIRUVWXGLHVQRWGHILQHGDVµUHVHDUFK¶LQWKHQDUURZ
sense, i.e. evaluations/audits, etc.  Complete this form and send it to the Faculties Support 
Office along with supporting documentation: a copy of the full research proposal; any 
participant information sheets and consent forms; any surveys, interview schedules; any 
advertising material or proposed website wording. 
Overview 
Name of Applicant(s) 
Ali Astokorki and Dr. Lex Mauger 
Contact Details (Please include your UoK address, email and telephone number) 




Title of Project 
An investigation into the analgesic effects of transcutaneous electrical nerve stimulation 
and interferential current on exercise-induced pain and cycling performance 
Lay Summary (Please provide a brief summary of the study) 
Neuromuscular electrical stimulation (NMES) is widely recognized as the use of therapeutic 
electrical currents for purposes of actuating skeletal muscle to increase, or prevent loss, of 
strength. While previous literature has supported the use of NMES for improving strength in a 
weak but innervated skeletal muscle, there remains much discussion and disagreement regarding 
the optimal current waveform for NMES (Bax, Staes, & Verhagen, 2005; Ward, 2009). To better 
understand the performance capability of electrical currents used for NMES, consistency among 
stimulus parameters must be considered lest erroneous conclusions be drawn. Transcutaneous 
electrical nerve stimulation (TENS) and interferential (IFC) are widely recognized therapeutic 
currents. While these waveforms are capable of stimulating skeletal muscle to produce 
contraction, variations in the electrophysiologic characteristics of each current have led 
investigators to compare the magnitude of the effect of each current on skeletal muscle (Snyder-
Mackler, Garrett & Roberts, 1989).  
TENS interventions tend to be described according to the technical characteristics of TENS as 
µKLJK IUHTXHQF\ ORZ LQWHQVLW\¶ FRQYHQWLRQDO 7(16 RU µORZ IUHTXHQF\ KLJK LQWHQVLW\¶
(acupuncture-like TENS). This has resulted in unclear reporting of TENS interventions because 
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it fails to specify the physiological intention of TENS (Dalal, Sheth & Vyas, 2014). In this regard, 
the physiological intention of conventional TENS is to selectively activate non-noxious skin 
afferents without simultaneously activating noxious skin afferents as this leads to segmental anti-
nociception (Wall, Melzack & Bonica, 1994). Theoretically, high frequency (׽10±250 pps), low 
intensity (non-painful) currents would be most efficient in selectively activating non noxious skin 
afferent (Hansjuergens, 1986). Interferential current (IFC) is the transcutaneous application of 
alternating medium-frequency electrical current for therapeutic purpose. It is widely used in 
physical therapy clinics to provide pain relief in variety of conditions and patients populations 
(Chipchase, Williams & Robertson, 2009). IFC deliver currents to deep tissues through the use of 
kilohertz carrier frequency pulses or sinusoidal currents to overcome the impedance offered by 
the skin. It can be delivered out of phase because very high frequency currents are not 
uncomfortable for subjects; these currents interfere with each other within tissues at the point 
where the currents cross (Hansjuergens, 1986).  
As described by Melzack and Wall, TENS and IFCs are forms of electro analgesia based on the 
gate control theory of pain perception. According to this theory, stimulation of large diameter 
primary sensory afferent cutaneous fibers activates inhibitory interneurons in the spinal cord 
dorsal horn and thus may ease the transmission of nociceptive signals from small diameter A-
delta and C-fibers (Chung et al., 1984). However, as intense exercise is known to elicit feelings 
pain and discomfort, it is curious that no studies have investigated the effect of transcutaneous 
electrical nerve stimulation and interferential current in reducing pain during exercise in order to 
improve performance. Therefore, the purpose of this study is to compare the analgesic effect of 
TENS and IFC using equal stimulus parameters of phase duration, frequency, and current 
amplitude. While will also examine whether TENS and IFC reduce pain perception and 
consequently yield an improvement in time trial cycling performance. It is hypothesized that 
TENS and IFC would be more effective in reducing pain perception and yield greater cycling 
performance than sham stimulation. In the sham stimulation, the electrodes are placed on the same 
muscle site and the TENS machine is turned on, but no current is passed through the electrodes.  
 
Name of Supervisor(s) (If applicable) 
Dr Lex Mauger 
 
Application Reference Number (For office use only) 
      
Risks and ethical issues 
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Please list the principal inclusion and exclusion criteria 
Inclusion: 
Healthy male and female participants 
Aged 18-44  
Appropriate completion of a PAR-Q before exercise 
Participating in regular cycling (>3 h per week) 
 
Exclusion (participants with/having): 
Using cochlear implant hearing device or pacemakers 
History of any cardiovascular disorder 
Chronic medications that affect the central nervous system 
Pregnancy 
Type I or II diabetes 
Bleeding disorders (e.g. haemophilia) 
Deep vein thrombosis 
Impaired sensation 
Acute/chronic infection (e.g. tuberculosis) 
Malignancy 
Recently radiated tissue 
Skin diseases or severely damaged skin 
 
How long will each research participant be in the study in total, from when they give informed 
consent until their last contact with the research team? 
Approximately 2 weeks, which will include a maximum of 5 hours laboratory time  
 
What are the potential risks and burdens for research participants and how will you minimise 
them?  (Describe any risks and burdens that could occur as a result of participation in the research, 
such as pain, discomfort, distress, intrusion, inconvenience or changes to lifestyle.  Describe what 
steps would be taken to minimise risks and burdens as far as possible) 
The usual risks of vigorous physical exercise are present (out of breath, sweating, discomfort, 
tiredness), but these are no greater than participants would experience in their day-to-day exercise 
regime. These risks have also previously been risk assessed and accounted for by the SESS, are 
minimised by clear experimenter instructions to the subject, thorough warm-up and cool-downs 
prior to and after exercise, and risk assessment of the subjects through a general health 
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questionnaire. Subject is allowed to withdraw from the study without needing to give a reason or 
an explanation. Therefore, these risks are considered minimal, easily addressed, and no different 
than those posed by any regular physical activity regime. 
TENS and IFC are generally considered safe with no side-effects compared with pharmacological 
analgesic modalities. However, electrical current that is too intense or that is used incorrectly can 
burn or irritate the skin. The electrodes should not be placed over the eyes, heart, brain, or front 
of the throat. People with heart problems should not use TENS or IFC. The effects of long-term 
use of TENS or IFC on foetuses are unknown. However, there may be additional side-effects with 
use of TENS and IFC in pregnancy, bleeding disorders, diabetes or heart conditions. As such, 
WKHVHSRSXODWLRQVDUHOLVWHGLQWKHVWXG\¶VH[FOXVLRQFULWHULD,ISDUWLFLSDQWVUHSRUWDQ\VHULRXVVLGH-
effects following use of TENS or IFC, they will immediately be withdrawn from the study. 
We will take a fingertip blood sample for analysis of blood lactate from participants immediate 
testing and then disposal it (thus complying with the Human Tissue Act) and we will remind the 
subject that he/she has the right to withdraw from the study without needing to give a reason or 
an explanation. 
 
Please describe what measures you have in place in the event of any unexpected outcomes or 
adverse effects to participants arising from involvement in the project 
All higher risk populations (from exercise) will be excluded from participating in the study.  A 
trained first aider is always on site to give emergency first aid if required. If participants report 
any serious side effects after testing, they will be recommended to visit their GP.  
 
Will interviews/questionnaires or group discussions include topics that might be sensitive, 
embarrassing or upsetting, or is it possible that criminal or other disclosures requiring action could 
occur during the study? 
No 
 
If yes, please describe the procedures in place to deal with these issues 
N/A 
 
What is the potential benefit to research participants? 
There are no immediate benefits to the participants 
 




Recruitment and informed consent 
How and by whom will potential participants, records or samples be identified? 
Fifteen recreationally active males and females participants (>3 h exercise per week), aged between 
18-44 yrs will be recruited to take part in the study. They will be trained and used to moderate 
physical activity will be approached as a potential recruitment pool. Participants will be recruited 
through the use of posters, flyers, emails and word of mouth. 









details.  If you are not planning to gain consent, please explain why not). 
Yes ± full written and verbal informed consent will need to be given by participants. Procedures 





Will there be any risks to the University?  (Consider issues such as reputational risk; researches 
that may give rise to contentious or controversial findings; could the funder be considered 
controversial or have the potential to cause reputational risk to the University?) 
No 
 
Will any intervention or procedure, which would normally be considered a part of routine care, 
be withheld from the research participants?  (If yes, give details and justification).  For example, 








How long will you allow potential participants to decide whether or not to take part? 
A minimum of 24 h will be given to prospective participants to decide whether to participate 
 
What arrangements have been made for persons who might not adequately understand verbal 
explanations or written information given in English, or have special communication needs?  (eg,  
translation, use of interpreters?) 
None ± due to funding limitations we cannot provide this service and will consequently only recruit 
participants who are fluent speakers of English 
 





In this section personal data means any data relating to a participant who could potentially be 
identified.  It includes pseudonymised data capable of being linked to a participant through a unique 
code number.  
If you will be undertaking any of the following activities at any stage (including in the identification 
of potential participants) please give details and explain the safeguarding measures you will employ 
x Electronic transfer by magnetic or optical media, email or computer networks 
x Sharing of personal data outside the European Economic Area 
x Use of personal addresses, postcodes, faxes, emails or telephone numbers 
x Publication of direct quotations from respondents 
x Publication of data that might allow identification of individuals, either directly or indirectly 
x Use of audio/visual recording devices 
x Storage of personal data on any of the following: 
± Manual files 
± University computers 
± Home or other personal computers 
± Private company computers 
± Laptop computers 
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All hard files will be kept in a locked cabinet by the supervisor. All electronic files will be kept on 
password protected computers by the researchers. 
 
How will you ensure the confidentiality of personal data?  (eg, anonymisation or pseudonymisation 
of data) 
Subject number coding. A master code will be kept in a locked filing cabinet by the supervisor (Dr. 
Lex Mauger). The PhD student researcher will have access by permission to this code. 
 
:KRZLOOKDYHDFFHVVWRSDUWLFLSDQWV¶SHUVRQDOGDWDGXULQJWKHVWXG\" 
Mauger and Astokorki 
 
How long will personal data be stored or accessed after the study has ended?  (If longer than 12 
months, please justify) 
Personal data will be stored for a period of 6 months, after which time is will be destroyed. De-
identified data will be kept for a period of 5 years ± this is to allow data to be analysed and written 
up to allow subsequent publication. 
 
Please note:  as best practice, and as a requirement of many funders, where practical, researchers 
must develop a data management and sharing plan to enable the data to be made available for re-use, 
eg, for secondary research, and so sufficient metadata must be conserved to enable this while 




Publication and dissemination 
How do you intend to report and disseminate the results of the study?  If you do not plan to report or 
disseminate the results please give your justification 
Conference and/or peer-reviewed paper 
 
Will you inform participants of the results?  (Please give details of how you will inform participants 
or justify if not doing so) 





Management of the research 
Other key investigators/collaborators.  (Please include all grant co-applicants, protocol authors and 
RWKHUNH\PHPEHUVRIWKH&KLHI,QYHVWLJDWRU¶VWHDPLQFOXGLQJQRQ-doctoral student researchers) 
None 
 
Has this or a similar application been previously rejected by a research Ethics Committee in the UK 
or another country?  (If yes, please give details of rejected application and explain in the summary of 
main issues how the reasons for the unfavourable opinion have been addressed in this application) 
No 
 
How long do you expect the study to last? 
x Planned start date: 
September 2015 
x Planned end date: May 2016 x Total duration:   8 months 
Where will the research take place? 
Medway Park, University of Kent 
 
Children 
Do you plan to include any participants who are children under 16?  (If no, go to next section) 
No 
 
Please specify the potential age range of children under 16 who will be included and give reasons for 
carrying out the research with this age group 
N/A 
 
Please describe the arrangements for seeking informed consent from a person with parental 
responsibility and/or from children able to give consent for themselves 
N/A 
 
If you intend to provide children under 16 with information about the research and seek their consent 









Participants unable to consent for themselves 
Do you plan to include any participants who are adults unable to consent for themselves through 




of those with that condition? 
   Yes ,Iµ\HV¶SURFHHGWRQH[WTXHVWLRQ 
   No 
,I µQR¶ WKH VWXG\ VKRXOG SURFHHG ZLWKRXW
involving those who do not have the capacity to 
consent to participation 
Could the research be undertaken as effectively with people who do have the capacity to consent to 
participate? 
   Yes 
,I µ\HV¶ WKHQ WKH VWXG\ VKRXOG H[FOXGH WKRVH
without the capacity to consent to participation 
   No 
,I µQR¶ WKHQ WKH LQFOXVLRQ RI SHRSOH ZLWKRXW
capacity in the study can be justified 
Is it possible that the capacity of participants could fluctuate during the research?  (If yes, the research 
must be reviewed by an NHS REC or SCREC) 
No 
 
Who inside or outside the research team will decide whether or not the participants have the capacity 
to give consent?  What training/experience will they have to enable them to reach this decision? 
Dr Mauger ± has been an active researcher for 9 years, including successful NHS project ethics 
submission and completion of NHS Good Clinical Practice Training 
 
What will be the criteria for withdrawal of participants? 
If a participant, who has given consent, subsequently loses capacity to give consent, they will be 
withdrawn from the study. Subjects will be advised that they can withdraw from the study at any time, 





To be signed by the Chief Investigator 
 
x I agree to comply, and will ensure that all researchers involved with the study comply with all 
relevant legislation, accepted ethical practice, University of Kent policies and appropriate 
professional ethical guidelines during the conduct of this research project 
x If any significant changes are made to the design of the research I will notify the Faculty of 
Sciences Research Ethics and Advisory Group (REAG) and understand that further review may 
be required before I can proceed to implement the change(s) 
x I agree that I will notify the Faculty of Sciences Research Ethics Advisory Group of any 
unexpected adverse events that may occur during my research 
x I agree to notify the Faculty of Sciences Research Ethics Advisory Group of any complaints I 
receive in connection with this research project 
 
 
Signed:        
 
Name:  Ali Astokorki 
             Dr Lex Mauger 
Date: / /2016 
 
 
What to do next 
Send your completed form, along with all supporting documentation, to the Faculties Support 





Please ensure you have included the following with your application (where relevant): 
 
x Full research proposal (current project) 
x Participant information sheet 
x Consent form 










x Any questionnaires/interview schedules/topic guides to be used 
x Any approved instruments/measures to be used 
x Any advertising material to be used to recruit participants 















































The RPE scale instructions used were the following: ³'XULQJWKLVWHVWZHZDQW
you to rate your perception of effort defined as the sensation of how hard you are driving 
your arm/legs in order to lift the weight/cycle. Look at the scale before you; we want you 
WRXVHWKLVVFDOHIURPWRZKHUHPHDQV³QRH[HUWLRQDWDOO´DQGPHDQV³PD[LPDO
H[HUWLRQ´7RKHOS\RXFKRRVHDQXPEHUWKDWFRUUHVSRQGVWRKRZ\RXIHHOZLWKLQWKLVUDQJH
consider the following. When you do not have the sensation of driving your arm/legs, 
FKRRVHQXPEHU³QRH[HUWLRQDWDOO´- e.g. at rest with no contraction. When you have 
WKHVHQVDWLRQRIGULYLQJ\RXUDUPOHJV³KDUG´FKRRVHQXPEHU1XPEHU³0D[LPDO
H[HUWLRQ´FRUUHVSRQGVWRWKHIHHOLQJRIHIIRUWZKHQ\RXDUH exercising maximally (i.e. as 
hard as you can for that given moment). Try to appraise your perception of effort as 
KRQHVWO\DVSRVVLEOHZLWKRXWWKLQNLQJZKDWWKHDFWXDOSK\VLFDOORDGLV'RQ¶WXQGHUHVWLPDWH
your perception of effort but do not overestimaWHLWHLWKHU,W¶V\RXURZQIHHOLQJRIHIIRUW
WKDW¶V LPSRUWDQW QRW KRZ LW FRPSDUHV WR RWKHU SHRSOH :KDW RWKHU SHRSOH WKLQN LV QRW
important either. Look at the scale and the expressions and then give a number. Any 
questions? from (Borg, 1998). 
 
 
The pain scale instructions used were the following: ³7KH VFDOH EHIRUH \RX
contains the numbers 0 to 10. You will use this scale to assess the perceptions of pain 
during the exercise test. For this task, pain is defined as the intensity of hurt that you feel 
as a UHVXOWRIWKHH[HUFLVH'RQ¶WXQGHUHVWLPDWHRURYHUHVWLPDWHWKHGHJUHHRIKXUW\RXIHHO
just try to estimate it as honestly and objectively as possible.  
7KHQXPEHUVRQWKHVFDOHUHSUHVHQWDUDQJHRISDLQLQWHQVLW\IURP³YHU\IDLQWSDLQ³QXPEHU
WR³Hxtremely intense pain±DOPRVWXQEHDUDEOH³QXPEHU:KHQ\RXIHHOQRSDLQ
you should respond with the number zero. When the pain from the exercise becomes just 
noticeable, you should respond with the number 0.5. If you feel extremely strong pain that 
is almost unbearable, you should respond with the number 10. You can also respond with 
numbers greater than 10. If the pain is greater than 10, respond with the number that 
represents the pain intensity you feel in relation to 10. In other words, if the pain is twice 
as great then respond with the number 20.  
Repeatedly during the test, you will be asked to rate your level of pain. When rating these 
pain sensations, be sure to report only the specific sensations arising from the exercise (e.g. 
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arm contraction) and not report other pains you may be feeling (e.g., seat discomfort). It is 
very important that your ratings of pain intensity reflect only the degree of hurt you are 
feeling arising from the exercise. Do not use your ratings as an expression of fatigue (i.e., 
inability of the muscle to produce force) or exertion (i.e., how hard is it for you to drive 
your leg).  
,QVXPPDU\\RX¶OOEHDVNHGWRDSURYLGHSDLQLQWHQVLW\UDWLQJVDULVLQJIURPWKHH[HUFLVH
only; (b) give ratings as accurately as possible; and (c) not under-or-over- estimate the 
pain, but simply rate your pain honestly. You should use the verbal expressions to help 
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An investigation into the analgesic effects of transcutaneous electrical nerve 
stimulation and interferential current on exercise-induced pain and performance. 
Oral presentation at the Endurance Research Conference, Kent, 2-4 September, 2015. 
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Chatham Maritime, ME4 4AG, UK  
 
Abstract 
Introduction: Transcutaneous electric nerve stimulation (TENS) is the application of low 
intensity electrical impulses at frequencies between 0-200 Hz, whereas interferential 
current (IFC) is a medium frequency (3000-5100 Hz) alternated current with a various beat 
frequency ranging from 0-250 Hz. These methods have been shown to reduce pain in a 
variety of conditions (Marchand et al., 1993; Robinson, 1996; Schmitz et al., 1997). 
Compared with TENS, IFC delivers lower impendence of an electrical circuit on skin and 
subcutaneous tissue, and so IFC should activate deeper fibres than that of TENS 
(Robertson, Low, Ward and Reed, 1994; Cheing and Hui-Chan, 2003). However, the 
relative effectiveness of these two modulations on exercise-induced pain (EIP) has not 
been considered. Therefore, the purpose of this study was to investigate whether TENS or 
IFC elicits an analgesic effect during EIP and improves time to exhaustion (TTE) 
performance.  
 
Methods: 18 recreationally active, male (n= 11) and female (n= 7) participants were 
recruited. A single-blind, crossover, randomised design with TENS, IFC, and sham 
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conditions was used (on separate visits). The TENS and IFC were administered on the 
bicep of the dominant arm, whereas in the sham condition a dummy simulator produced 
no current. In each condition, participants initially performed 3x5 second maximal 
voluntary contractions (MVCs) against a load cell. The maximum of the values was used 
to establish the 20% MVC for the TTE task. The TTE task involved the participant 
maintaining a 20% isometric MVC of the bicep until task withdrawal. During the TTE 
task, perceived pain and RPE were recorded every 30 seconds. 
  
Results: Analysis of the results revealed that TENS and IFC significantly increased TTE 
when compared to sham stimulation (P = 0.003). ANOVA also revealed a significant main 
effect of condition for pain intensity during the TTE test (P = 0.035). No significant 
changes in rating of perceived exertion (RPE) were found between the three conditions (P 
> 0.05). A 3 x 8 (condition x iso-time) ANOVA revealed a significant interaction effect 
for pain intensity during the TTE test with lower pain intensity in the TENS and IFC 
conditions (P = 0.013). No interaction effects for RPE were found between the three 
conditions (P > 0.05).  
 
Conclusion: The findings of the study suggest that TENS and IFC elicit an analgesic effect 
for EIP, and that this reduction in pain can improve time to exhaustion performance in the 
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Abstract 
Introduction: Pain is an unpleasant, subjective experience that includes sensory and 
emotional components (Rainville, 2002). Several studies have shown that observing 
RWKHU¶VSDLQFDQHQKDQFHWKHLQWHQVLW\RISDLQIXOVWLPXOL± an effect termed compassional 
hyperalgesia (Godinho et al., 2012). Intense exercise causes a noxious environment in the 
PXVFOHWKDWHOLFLWVµH[HUFLVH-LQGXFHGSDLQ¶(,3DQGWROHUDQFHRIWKLVVHQVDWLRQKDVEHHQ
associated with endurance performance. It is unknown the degree to which this sensation 
is effected by top-down processing, such as compassional hyperalgesia.  
Methods: Twenty-one participants, trained in cycling, completed 5 laboratory visits. The 
first visit involved an assessment of aerobic capacity (VO2max test) and a familiarisation 
of the fixed power (FP) and time trial (TT) tests. The second visit provided a further 
familiarisation of the FP and TT. In the subsequent three visits, in a counter-balanced 
manner, participants performed a FP and TT. Immediately prior to these, participants 
viewed a collection of images from the International Affective Picture System database 
that were either pleasant, unpleasant (painful) or neutral. Participants were asked to rate 
each image with respect to affective valence and their level of emotion. During the TT and 
FP, participants were asked their EIP, RPE and had measures of HR and B[La] recorded.  
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Results: ANOVA revealed a significant difference in TT performance, PO and HR (P < 
0.05) between conditions during the TT cycling performance, but no significant effect of 
condition for mean RPE or EIP (P > 0.05). For the FP, a significant main effect of condition 
for EIP, but no difference for RPE, HR or B[La]. A significant effect of condition for 
Depression, Tension, Anger, and Confusion following viewing the images (P < 0.05), but 
no differences for fatigue and vigour were found.  
Discussion: The results of this study demonstrate that viewing painful images prior to 
exercise decreased TT performance. This study demonstrates that there is an emotional 
element to the processing of EIP that can be influenced by compassional hyperalgesia. It 
is suggested that the dorsolateral prefrontal cortex (DLPFC) plays a crucial role in physical, 
somatosensory pain perception, and in emotional pain (Borckardt et al., 2007). Future 
studies should seek to examine cortical changes in the DLPFC during exercise that elicits 
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Introduction: Muscle pain is a natural consequence of intense and prolonged exercise and 
has been suggested to be a limiter of endurance performance (Mauger et al., 2010, J Appl 
Physiol, 08, 98-104). Transcutaneous electrical nerve stimulation (TENS) and 
interferential current (IFC) have been shown to reduce both chronic and acute pain in a 
variety of conditions. However, no studies have administered TENS or IFC during exercise 
with the purpose of reducing exercise-induced pain (EIP) during cycling time trial 
performance. Therefore, the purpose of this study was to ascertain whether TENS and IFC 
could reduce EIP and whether this would affect endurance exercise performance.  
Methods: Following University ethics approval, twenty-two healthy male and female 
participants, trained in cycling, completed 4 laboratory visits. d In the first visit, 
participants underwent a test for skin integrity and sensory discrimination using a sharp 
and blunt patella hammer. To be familiarised with the TENS and IFC stimulation, 
participants were briefly administered TENS and IFC pulses which were delivered at a 
pulse wiGWKRIȝVDQGIUHTXHQF\RI+]XVLQJD9HFWUD*HQLV\VPXOWL-waveform 
stimulator (Chattanooga Group, Hixon, TN, USA). Following familiarisation to TENS and 
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IFC, participants completed a VO2max test (GXT) and a familiarisation of the time trial 
(TT) tests. In experimental visits 2-4, participants completed a 16.-km cycle time trial 
whilst receiving TENS, IFC or a Sham placebo in a repeated measure, a cross-over, 
randomized, and placebo-controlled design. 
Results: ANOVA revealed a significant difference in TT performance; TENS significantly 
improved (P = 0.003) participants¶time trial completion time (~2% improvement) through 
an increased power output and higher physiological strain (increased heart rate and blood 
lactate concentration). There was a significant difference in the mean EIP between 
conditions during the TT (F (2, 44) = 4.210, P = 0.022). Paired t-tests revealed that 
participants perceived significantly less pain during the TENS condition (3.5 ± 1.8) than 
in the sham condition (4.0 ± 2.0) (t (21) = 3.037, P = 0.006). No differences were observed 
between the TENS and the IFC condition (3.8 ± 1.9) or the IFC and Sham condition (P > 
0.05). No significant differences in mean RPE were found between conditions during the 
TT (P > 0.05). 
Conclusion: These findings demonstrate that TENS can attenuate EIP in healthy 
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full version of the article can be attained as Open Access at the following link: 
https://link.springer.com/article/10.1007%2Fs00421-016-3532-6  
 
 
 
